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Abstract 
Annuloplasty is a common technique used for repair of the mitral valve. It is 
hypothesised that an acellular biological ring may provide a superior solution by 
encouraging tissue integration and improved annular dynamics whilst offering 
similar structure and composition to the native annulus.  
Human mitral valve annuli (n=3) were characterised using histological methods to 
reveal the histoarchitecture of the native tissue. The histological features of porcine 
mitral valve annuli (n=5) were compared to the human annuli, as an alternative 
source of tissue. Haematoxylin and eosin, alcian blue and Sirius red Miller’s stained 
sections illustrated the morphology of both species revealing a highly fibrous region 
at the anterior of the annulus compared to the posterior region. The continuum of 
the fibrosa layer in the mitral leaflet into the fibrous region around the annulus was 
also visualised. Differences between species were observed at the trigones where 
cartilaginous tissue was present in the porcine annuli compared to fibrous tissue in 
the human tissue. The human mitral valve annuli were heavily calcified and showed 
signs of ossification, hence porcine annuli were used as the starting material for 
developing a biological acellular annuloplasty ring. 
Porcine mitral valve annuli (n = 36) were decellularised using a series of eight 
iterative protocols. The annuli were successfully decellularised using a protocol 
comprising two freeze thaw cycles (one cycle in hypotonic buffer), followed by four 
alternate cycles of washing in hypotonic buffer plus proteinase inhibitors and 0.1% 
(w/v) sodium dodecyl sulfate in hypotonic buffer plus proteinase inhibitors followed 
by treatment with nuclease solution, washing in hypertonic buffer and final 
disinfection wash in 0.1% (v/v) peracetic acid. Histological analysis of the treated 
tissue revealed removal of nuclei apart from apparent “ghost nuclei” in the trigones. 
Immunohistochemical analyses revealed loss of collagen IV and laminin associated 
with the basement membrane but retention of collagens I, II and III responsible for 
structural integrity. Total DNA content of the processed tissue was less than 50 
ng.mg-1 wet weight and in-vitro biocompatibility assays showed decellularised 
porcine mitral valve annulus tissue was not cytotoxic to BHK and L929 cells. 
Biomechanical tensile tests using low strain rate to failure of the decellularised 
porcine mitral annuli showed increased tensile strain and transition strains and 
stresses compared to the native porcine annuli. A method for functional testing 
revealed that the acellular rings performed as well as synthetic annuloplasty rings in 
static tests of regurgitant porcine hearts.  
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Chapter 1 
Introduction  
1.1 General Introduction 
Annuloplasty is a common surgical procedure used to treat mitral valve 
dysfunction by reconstructing a part of the heart valve called the annulus. 
The technique is used to treat people who have a leaky valve, known as 
regurgitation. Annually there are over 300,000 people who undergo open 
heart surgery for mitral valve treatment (Bonow et al., 2006). Mitral 
regurgitation is the second most common valve disease in European 
treatment centres (Iung et al., 2007) and the most common valve disease in 
the US (Nkomo et al., 2006) which equates to a prevalence in the US 
population of 1.7% (Nkomo et al., 2006). There has been a year on year 
increase in the number of mitral valve repair operations and the requirement 
for improved materials for repair is an important factor for providing better 
outcomes for patients who have valve disease.  
Current annuloplasty strategies predominantly use synthetic annuloplasty 
rings to reconstruct the annulus. This benefits the patient by reducing the 
valve orifice area which allows the leaflets to coaptate during systole, 
thereby removing or reducing valve regurgitation. Many types of ring are 
available which each have their advantages and disadvantages but none 
have been found to be significantly better than another (Chee et al., 2008; 
Bothe et al., 2010a). The main drawbacks to using the synthetic rings 
include a change in normal annular dynamics, geometry and force 
distribution when compared to a healthy valve (Yamaura et al., 1997; 
Glasson et al., 1999; Jensen et al., 2008). Moreover, they are not suitable 
for use in children as the rings do not grow with the child.  
A biological acellular annuloplasty ring could reduce mitral valve 
regurgitation by ensuring effective leaflet coaptation whilst offering improved 
performance compared to annuloplasty rings currently in use. The main 
advantage of using a biological acellular ring would be that it could integrate 
with the mitral valve of the patient and remodel over time. It is anticipated 
that the remodelling process will permit the ring to closely match the 
dynamics of the valve for the duration of the cardiac cycle whilst eliminating 
mitral regurgitation. 
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This thesis is concerned with using novel techniques to remove all the cells 
from annulus tissues to produce a biological acellular annuloplasty ring, 
removing the risk of tissue rejection whilst retaining the biological and 
biomechanical properties of the tissue extracellular matrix.  
1.2 The Heart 
The heart pumps blood around the body via the arteries, capillaries and 
veins. The blood contains oxygen and nutrients required by the cells in the 
body to function normally. The heart is encased in the pericardium, a double 
walled membrane which encloses the pericardial cavity, containing serous 
fluid. The pericardium helps protect the heart and reduces friction during the 
cardiac cycle. There are four chambers of the heart, these are composed of 
myocardium which is lined with endocardium on the inside and epicardium 
on the outside, the endocardium surface is smooth to prevent clotting as the 
blood interacts with it. The top two chambers are called the left and right 
atria which have relatively thin walls compared to the bottom two chambers. 
The bottom two chambers are called the left and right ventricles which are 
thick walled in comparison.  
The right atrium receives deoxygenated blood from the body via the superior 
vena cava and the inferior vena cava and delivers it to the right ventricle, 
between the right atrium and right ventricle is the tricuspid valve. This valve 
prevents backflow of blood into the right atrium during systole. During 
systole the ventricle contracts and pumps blood to the lungs via the 
pulmonary artery, from the lungs oxygenated blood flows into the left atrium 
via four pulmonary veins. During diastole blood flows from the left atrium into 
the left ventricle via the mitral valve, this valve prevents backflow of blood 
into the left atrium during systole. The wall of the left ventricle is the thickest 
of all the heart chambers, this is to enable blood within the ventricle to be 
pumped to the rest of the body. The blood leaves the left ventricle via the 
aorta; this is the largest artery in the body (Sanders & Scanlon, 1997). The 
heart undergoes a specific sequence of muscular contractions during the 
cardiac cycle. The atria simultaneously contract followed by the 
simultaneous contraction of the ventricles. The atria contract at a point when 
blood delivered into the atria from the veins reaches a pressure which forces 
the atrioventricular valves to open, the main volume of blood is delivered into 
the ventricles passively but the final milliliters of blood are delivered by the 
contraction of the atria. Once delivered the atria relax and the ventricles 
contract which forces the atrioventricular valves shut, this contraction forces 
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the blood into the arteries and the ventricles start to relax. The cardiac cycle 
continuously repeats this sequence (Sanders & Scanlon, 1997).   
The blood within the atrium at pressure P1 is forced through into the ventricle 
at pressure P2 when there is a difference in blood pressure across the valve 
(P1-P2), known as the pressure gradient (ΔP). The pressure gradient is the 
force driving the flow which can be calculated as the flow (Fl) multiplied by 
the resistance to the flow (R): 
ΔP = FlxR 
The pressure gradient increases if either the flow rate or resistance 
increases. A valve that is functioning normally has a small resistance to flow 
which minimises the pressure gradient. If the valve experiences stenosis the 
resistance will increase due to the narrowing of the valve which increases 
the pressure gradient. Exercise further exacerbates the pressure gradient by 
increasing the flow rate (Klabunde, 2011). In a regurgitant valve there is 
normally a smaller change in the pressure gradient, this is due to the heart 
remodelling to increase its size in an attempt to pump more blood around the 
body. 
The cardiac skeleton encircles the aortic, pulmonary, mitral and tricuspid 
valves which are positioned in a plane, often referred to as the base of the 
heart. It is composed of dense connective tissue which provides structure 
and support for the dynamic heart tissue, including the myocardium, leaflets 
and arteries. The skeleton helps anchor the valves and prevents them from 
distending under pressure during the cardiac cycle. It also provides an 
insertion point for the atrial and ventricular muscle whilst separating them 
(Hill, 1986), this insulates the atria and ventricles which helps regulate the 
cardiac cycle by preventing a singular contraction of the muscle (du Plessis 
et al., 2014). The strongest region of the cardiac skeleton is the central 
fibrous body, this is formed from the membranous region of the ventricular 
septum and the right trigone. The right fibrous trigone is located between the 
anterior mitral valve and the aortic valve leaflets. The left fibrous trigone also 
makes up this area of fibrous tissue but is smaller in size and situated 
towards the left zone of the region (Bateman et al., 2013). A membranous 
region is formed between the right and left trigone, known as the mitral to 
aortic continuum or the intertrigonal space, which lacks the fibrous skeletal 
structure that forms the cardiac skeleton (Kunzelman, 1997). From the 
fibrous trigones and an additional smaller fibrous body which is situated at 
the right coronary leaflet of the aortic valve, the cardiac skeleton extends 
around the cardiac valves of the heart (Zimmerman, 1966), thereby 
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providing the supporting function to the valves alongside the additional roles 
previously mentioned. 
1.2.1 Atrioventricular Valves 
Heart valves open and close approximately 40 million times per year, this 
equates to about three billion times over an average lifetime (Schoen, 2008). 
The atrioventricular valves (AV) are situated between the atria and ventricles 
on both sides of the heart. They act as fluid control components which 
permit only unidirectional blood flow during the cardiac cycle (Sacks et al., 
2009). The AV valves comprise the mitral valve (MV) and the tricuspid valve 
which vary only slightly in their anatomical structures (Fig 1.1). The 
interactions between the components of the valve are important to consider 
when the valve is being repaired (Fedak et al., 2008). A valve that is 
functioning normally coordinates each component of the valve, this enables 
the leaflets to coaptate and provide low leaflet stresses during systole 
(Schoen, 2008). The AV apparatus consists of a set of leaflets, chordae, a 
set of papillary muscles and an annulus. The main focus of this study will be 
the mitral valve and so this will be described in further detail. 
- 5 - 
 
 
Fig 1.1 – Anatomical view of the heart during diastole1  
Normal healthy leaflets of the mitral valve are thin, flexible, soft and 
translucent (Ho, 2002). In the mitral valve the leaflets are split into the 
anterior and posterior leaflets which are separated by two depressions; 
these are the anterolateral and posteromedial commissures. At this point the 
commissural chordae insert into the ventricular surface of the leaflet. The 
leaflets are never completely separate from each other. The anterior leaflet 
is located in close proximity to the aortic root (Ho, 2002). The anterior leaflet 
can be split into a rough zone and clear zone which are separated by a 
ridge; this ridge forms the site of leaflet closure during systole. The rough 
zone is a region where the marginal chordae insert and is located close to 
                                            
1  Reprinted from OU Human Physiology: Heart Anatomy, Eric Bright & 
Heather Ketchum. OpenStax CNX. Jun 17, 2015 
http://cnx.org/contents/ba66e9d1-0a16-49a5-8724-233dcec203f5@1 
Licensed under Creative Commons BY 4.0.  
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the free edge of the leaflet on the ventricular surface. During systole the 
rough zone will coapt with the corresponding rough zone on the posterior 
leaflet (Ranganathan et al., 1970). The clear zone is located between the 
rough zone and the annulus and is so called because it is void of any 
chordae insertions. The posterior leaflet is located close to the coronary 
sinus and is opposite the aortic root. The posterior leaflet surrounds a larger 
portion of the perimeter of the valve than the anterior leaflet (Ho, 2002). The 
posterior leaflet comprises of three zones; the rough zone, the clear zone 
and the basal zone. The rough and the clear zones have the same 
characteristics as the anterior leaflet zones. In addition, the basal zone, 
which is located between the clear zone and the annulus, is the insertion 
point for the basal chordae. 
 
Fig 1.2 – Microstructure of the mitral valve anterior leaflet layers in 
sheep. Red arrow denotes direction of blood flow from left atrium 
(LA) to left ventricle (LV).2  
 
The mitral valve leaflets are composed of four layers (Fig 1.2): these are the 
ventricularis, fibrosa, spongiosa and atrialis (Gross & Kugel, 1931; 
Kunzelman et al., 1993; Flanagan & Pandit, 2003). Situated closest to the 
ventricular side of the leaflet is the ventricularis. This layer is the thinnest 
layer composed of collagen and profuse with elastin, functionally this permits 
the leaflets to undergo repeated cyclic deformation during the cardiac cycle 
(Kunzelman et al., 1993; Culav et al., 1999). The fibrosa is the central layer 
of the leaflet, the layer consists of thick collagen bundles orientated 
predominantly circumferentially. Collagen is crimped during diastole and 
                                            
2  Reprinted from Stephens et al., (2008) The Effects of Mitral Regurgitation 
Alone Are Sufficient for Leaflet Remodeling, Circulation, 118, 14-1, 
S243-249 Copyright © 2008 by Wolters Kluwer Health, Inc. Reprinted by 
permission of Wolters Kluwer Health, Inc.  
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uncrimps during systole, this uncrimping of the collagen allows the leaflets to 
close. The thick collagen bundles of the fibrosa form the load bearing 
element of the mitral valve leaflets which help prevent prolapse of the valve 
leaflets when the valve is closed during systole (Kunzelman et al., 1993). 
The spongiosa bounds the fibrosa on the atrial side of the leaflet, loose 
randomly orientated connective tissue and proteoglycans make up this layer, 
the glycosaminoglycan’s (GAGs) in this layer absorb the compressive forces 
produced during the cardiac cycle. On the outer atrial side of the leaflet is 
the atrialis, composed predominantly of elastin fibres which are able to 
tolerate the cyclic loading which the leaflets experience throughout systole 
and diastole. The relative thicknesses of the four layers vary from the free 
edge to the attachment at the annulus (Kunzelman et al., 1993). The fibrosa 
is abundant at the annular junction but absent from the free edge, replaced 
by the spongiosa, atrialis and ventricularis where the high GAG content in 
the spongiosa help buffer the leaflets as they oppose each other when the 
valve is closed (Kunzelman et al., 1993). 
The papillary muscles originate close to the apex and the middle third of the 
left ventricle wall (Lam et al., 1970). They prevent the leaflets from 
prolapsing during systole by contracting and tethering the leaflets via the 
chordae attachments. There are two regions of papillary muscle, the 
anterolateral papillary muscle and the posterolateral papillary muscle (Fig 
1.3). The anterolateral papillary muscle is supplied by the left anterior 
descending artery whilst the posteromedial papillary muscle is supplied by 
the right coronary artery. The chordae arise from the tips of the papillary 
muscles which then insert into the ventricular surfaces of the mitral valve 
leaflets (Ho, 2002). The chordae tether the leaflets to the papillary muscles; 
during systole chordae prevent the movement of the mitral valve into the 
atrium ensuring regurgitation does not occur (Sacks et al., 2009).  
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Fig 1.3 – Heart right lateral view of the left ventricle.3  
Chordae must be elastic, strong and resistant to fatigue in order to transmit 
forces through them during the cardiac cycle (Millington-Sanders et al., 
1998). Chordae tendineae have two structural levels; a dense collagen core 
and an elastin sheath. During the cardiac cycle the valves experience three 
types of loading; tension when preventing back flow, shear when blood is 
passing and flexure when the valve is opening and closing (Sacks et al., 
2009). The anterior leaflet comprises of two types of chordae, the marginal 
chordae and strut chordae. The posterior leaflet comprises of three types of 
chordae; marginal, basal and the commissural chordae (Liao & Vesely, 
2003). Collagen in the chordae consists of crimped fibrils, these orientate in 
the direction of maximum stress  (Shi & Vesely, 2004) whilst interwoven 
elastin fibres are found spread around the inner core, as well as in a distinct 
layer near the outer surface surrounding by a layer of endothelial cells.  
                                            
3  "Heart right lateral view" by Patrick J. Lynch, medical illustrator - Patrick J. 
Lynch, medical illustrator. Licensed under CC BY 2.5 via Wikimedia 
Commons - 
https://commons.wikimedia.org/wiki/File:Heart_right_lateral_view.jpg#/media
/File:Heart_right_lateral_view.jpg 
.  
Anterolateral 
papillary muscle 
Posteromedial 
papillary muscle 
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The ventricular myocardium is a highly organised structure which is mainly 
composed of fibroblasts and cardiac myocytes; it is the cardiac myocyte that 
provides the primary contractile function to the myocardium (Walker & 
Spinale, 1999). The wall contains three layers; the endocardium, the 
myocardium and the epicardium. The endocardium is composed of simple 
squamous epithelium and thin subendothelial tissue.  The myocardium is 
composed of the cardiac muscle fibres and the epicardium is composed of 
simple squamous mesothelium and subepicardial tissue (Ho, 2002). The 
ventricular myocardium is responsible for the change in circumference of the 
posterior part of the mitral valve during the cardiac cycle (Walmsley, 1978).  
The myocardium has been studied by Ho (2009) who observed that the 
myocardium of the left ventricle comprised of three layers; the superficial 
(subepicardial), middle and deep (subendocardial) layers. The fibre 
orientation in each layer changed, but the layers interconnected with each 
other and were not isolated. The superficial layer contained fibres which 
were orientated approximately 10-20° to the long axis, originating at the 
mitral valve and occupying approximately 25% of the myocardial wall 
thickness. The middle layer contained fibres which were circumferentially 
orientated, these aligned almost parallel to the orifice of the mitral valve but 
did not insert into it. The middle layer occupied approximately 53-59% of the 
wall thickness. The deep layer of the myocardium was found to contain 
muscle fibres which were longitudinally orientated and inserted into the 
mitral valve.  
The primary contractile cell of the ventricle is the myocyte, this is surrounded 
by collagenous connective tissue known as the basement membrane, 
endomysium and the perimysium. The basement membrane is present 
between the myocyte and the network of endomysium (Fratzl, 2008). The 
membrane functions to provide the myocyte with an interface for adhesion 
and to act as a barrier for exchange of macromolecules between the 
myocyte and extracellular space (Walker & Spinale, 1999). The endomysium 
surrounds the myocyte and provides a supporting structure and coordinates 
force transmission. The perimysium surrounds groups of myocytes and 
absorbs shear forces (Fratzl, 2008).  
The collagen content of the mitral valve leaflets and chordae has been 
analysed. In normal valves 83 % of the content has been shown to be water 
and 67 % of the dry weight was collagen. The types of collagen found in 
normal valves were collagens I, III and V ( Hammer et al., 1979; Cole et al., 
1984). Type I accounted for 49 % of the dry weight, type III accounted for 
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16.1 % and type V accounted for 1.4 % of the dry weight (Cole et al., 1984). 
The cardiac myocardium contains collagen IV. This is primarily found in the 
basement membrane of the myocardium, found between the extracellular 
space and intracellular space of the myocyte (Walker & Spinale, 1999). The 
basement membrane also contains glycoproteins, laminin, fibronectin, 
glycosaminoglycans and proteoglycans.  
 
1.2.2 Mitral Valve Annulus 
1.2.2.1 Structure 
The mitral valve annulus is a junction where the atrial and ventricular 
muscles are separated and the leaflets intersect the valve. The annulus has 
been described as a thin fibrofatty membrane (Silbiger & Bazaz, 2009) that 
is divided into posterior and anterior regions which are separated by the left 
and right trigones (Ormiston et al., 1981) (Fig 1.4).  
 
Fig 1.4 – Top view of the mitral annulus and surrounding mitral 
complex. P1, P2, P3 are the posterior leaflet clefts; A1, A2, A3 are the 
anterior leaflet clefts.  
In the region of the left and right trigones there is a thick and organized 
fibrous structure (Angelini et al., 1988), at this point the annulus acts as a 
hinge for the anterior leaflet into which the atrial myocardium inserts. The 
right fibrous trigone accommodates the atrioventricular conduction bundle 
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(Ho, 2002) and is situated in the midline of the heart. This forms a link 
between the aortic, mitral and tricuspid valves (Ormiston et al., 1981). The 
left trigone forms an attachment for part of the fibrous skeleton of the heart 
and links the left margin of the aortic and mitral valves (Ormiston et al., 
1981). The annulus forms a hinge point with the atrial myocardium, the mitral 
valve leaflet and the ventricular myocardium. The posterior part of the 
annulus has muscular and flexible properties, whilst the anterior region is 
fibrous and stiff (Levine et al., 1989; Jimenez et al., 2003). The posterior 
region is more prone to dilation and is more likely to be affected by 
calcification (McCarthy et al., 2010) due to the lack of fibrous tissue (Ho, 
2002). The anterior region makes up a third of the annulus; it is in continuity 
with the aortic valve and the fibrous trigones, this results in the anterior 
annulus being fibrous and relatively stiff. Angelini et al. (1988) performed a 
histological study to visualize the histioarchitecture of the mitral annulus in 
human hearts. The fibrous tissue of the annulus was found to be organized 
in segments as a thin curtain like structure or a cord like structure. Adipose 
tissue was often found in the gaps where the atrial myocardium did not meet 
the hinge of the leaflet and only one of the hearts analysed (n=11) had a 
fibrous cord like structure running around the whole of the heart. The human 
annulus has been studied by using ventricular illumination and histological 
analysis (Berdajs et al., 2007). A translucent band like membrane structure 
was found between the left ventricular myocardium and the atrial 
myocardium when using ventricular illumination. The band separated the 
atrial myocardium and the ventricular myocardium and provided attachment 
to the leaflets centrally to it. The band surrounded the mitral orifice and 
continued to the fibrous trigones, extending to the membranous septum. At a 
histological level the translucent membrane was found to be a fibrous band 
connecting the posterior leaflet, the left atrium and left ventricle. The hinge 
point of the valve was the attachment point of the left atrium close to the 
leaflet. The ventricular side of the mitral leaflet was found to continue into the 
fibrous membrane whilst the atrial side of the leaflet continued into the left 
atrium. The atrial muscle on the posterior portion of the valve extended into 
the proximal half of the posterior leaflet. This was thought to provide a 
sphincter like contraction. The aortic to mitral continuum at the anterior 
region of the valve was anchored across the valve orifice by the fibrous 
tissue between the trigones. Histological analysis of the anterior leaflet 
showed no apparent membrane or fibrous condensations in the anterior 
region.  
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1.2.2.2 Function 
The function of the annulus is to assist the leaflets to coapt during systole 
and provide stress reduction around the mitral valve through its fibrous 
structure and saddle like geometry (Fig 1.5). The annulus undergoes 
complex 3-dimensional changes throughout the cardiac cycle, including; 
changes to the saddle height, anterior-posterior diameter, commissure – 
commissure diameter and to the annular area (Glasson et al., 1996; 
Watanabe et al., 2005).  
 
Fig 1.5 – Reconstruction of the human mitral annulus acquired by 
transesophageal echocardiography. The low points of the saddle are 
the commissures (Based on Salgo, 2002).  
The healthy annulus deforms into a saddle shape during systole and reverts 
into a flat profile at diastole; the maximum ratio of the height of the annulus 
to the width of the annulus at the commissures is approximately 15% (Levine 
et al., 1989; Salgo, 2002; Timek et al., 2005; Jensen et al., 2008). 
There have been multiple studies using 2D and 3D echocardiography to 
examine the shape and motion of the mitral annulus. The dimensions of the 
annulus have been studied by Ormiston et al. (1981). Using 2D 
echocardiography the mitral valve annulus dimensions were calculated by 
taking recordings of the annular diameter at 30° intervals around the 
circumference and reconstructed 12 times during the cardiac cycle. Eleven 
healthy human volunteers were selected for the study which took place over 
a period of eight months. The average maximum area was 7.1 ± 1.3 cm2 
(mean ± SD) which occurred at late diastole, this reduced by 26 ± 3 % to a 
minimum of 5.2 cm2 at mid-systole (Fig 1.6).  The average maximum 
circumference was 9.3 ± 0.9 cm which reduced by 13 ± 3 % to 8.0 cm during 
systole. During systole the annulus was found to move down towards the 
apex of the heart. The main limitation of this study was that data was 
processed from 2D echocardiography, the 3D motion and geometry could 
not be measured and it was assumed that the annulus was flat in profile.  
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Fig 1.6 – The changes of annular area index (annular area/body area) 
during the cardiac cycle. Reprinted by permission of Wolters Kluwer 
Health, Inc.4  
Flachskampf et al. (2000) conducted a study of the annulus in ten healthy 
adults using 3D transoesophageal echocardiography (TOE).  The results 
showed that during systole the annular area contracted by approximately 
23.8 %; this reached a minimum at end-systole and a maximum at end-
diastole. The average area was 11.8 ± 2.5 cm2 which agreed with a similar 
study by Kaplan et al. (2000). Ormiston et al. (1982) also conducted a study 
to investigate annular area but the area was found to be smaller. The 
reasons for these differences may have been in the way that the perimeter 
of the annulus was calculated either using 2D or 3D methods.  
Salgo et al. (2002) conducted a study on three healthy adults using 3D TOE 
and undertook computational analysis of the results to recreate the annular 
perimeter. The aim of the study was to further understand what effect the 
dynamic annular shape had on the function of the valve during the cardiac 
cycle. Using computational methods, the saddle height to inter-valley 
distance ratio (SVR) was altered in order to understand how the changes 
                                            
4 Reprinted from Ormiston et al., (1981) Size and motion of the mitral valve 
annulus in man. I. A two-dimensional echocardiographic method and 
findings in normal subjects, Circulation, 61, 4, 113-120 Copyright © 
1981 by Wolters Kluwer Health, Inc. Reprinted by permission of 
Wolters Kluwer Health, Inc. 
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affected stresses in the annular perimeter.  It was found that the lowest 
stresses were found when the parabola had a SVR of between 15-25 % and 
highest when the parabolic surface was flat. 
The saddle shape of the annulus is thought to reduce systolic strain on the 
central region of the mitral valve anterior leaflet (Jimenez et al. 2007), 
reduce leaflet stress (Salgo, 2002) and optimize the distribution of chordal 
forces (Jimenez et al., 2003; Padala et al., 2009). The highpoints of the 
saddle shaped annulus are found close to the mid-anterior and mid-posterior 
regions, the low points are found at the antero-lateral and postero-medial 
commissures (Rausch et al., 2011). The saddle shape is associated with the 
normal function of the mitral valve; any deviation away from the normal 
geometry can cause MV insufficiency (Rausch et al., 2011). 
In an in vitro study by Jimenez et al. (2003), eight porcine mitral valves were 
tested under normal physiological haemodynamic conditions in a left heart 
simulator. The aim of the study was to identify the stress and strains 
experienced by the leaflets from an increasing annular saddle curvature. The 
authors found that as the saddle curvature increased there was a significant 
reduction in the area for the anterior region of the anterior leaflet. The largest 
reduction in strain was in the radial direction of the annulus, with a smaller 
reduction in the circumferential strain. These findings illustrated that a 
change in the annulus saddle curvature causes anisotropic behaviour in the 
mitral leaflets. 
Two main types of motion have been identified during the cardiac cycle 
(Silbiger & Bazaz, 2009); sphincteric contraction and translation in the 
vertical plane. The movement of the annulus is the product of the contraction 
in the muscles of the atrium and ventricles (Pai et al., 2003). During systole 
the annulus translates along the left ventricular major axis resulting from 
torsion at the base of the left ventricle (Burns et al., 2008). This translation 
generates an increase in left atrial filling (Keren et al., 1988). Through the 
period of diastole the annulus experiences an increase in area and 
translates from the apex of the left ventricle towards the atrium; this motion 
assists in the transfer of blood from the atrium into the ventricle (Toumanidis 
et al., 1992).  
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1.3 Mitral valve disease 
1.3.1 Epidemiology 
Every year over 300,000 people undergo treatment for mitral valve 
dysfunction worldwide. In Europe mitral regurgitation (MR) was found to be 
the second most common form of valve disease in a survey of treatment 
centres, with just under half of the patients with MR undergoing mitral valve 
repair (Iung et al., 2003). Approximately 44,000 people undergo treatment 
for mitral valve dysfunction per year in the US (Bonow et al., 2006). The 
prevalence of heart valve disease in the US population is approximately 
2.5% and this approximates to 4.2-5.6 million US adults (Nkomo et al., 
2006), a number which is expected to double by 2030 due to longer life 
expectancy and population growth. Mitral regurgitation was found to be 
prevalent in 1.7% of this population, making it the most common form of 
valve disease in the US (Nkomo et al., 2006). The type of therapeutic 
procedure that is undertaken depends on the experience of the surgeon, the 
mechanisms involved and the cause of regurgitation as these factors 
determine if a valve is suitable for repair (Carpentier, 1983).  
The main causes of mitral valve regurgitation in developed countries are 
mitral valve prolapse due to degenerative disease and ischemia due to 
coronary artery disease. In developing countries rheumatic disease is the 
main cause (Enriquez-Sarano et al., 2009). Mitral regurgitation can often 
progress without any symptoms because the heart is initially able to balance 
the reduction in left ventricle output by remodeling the left atrium and left 
ventricle to a larger volume which can lead to poor long term outcomes for 
the patient (Enriquez-Sarano et al., 2009). 
1.3.2 Types of disease 
There are two main forms of mitral valve dysfunction; mitral valve stenosis 
and mitral regurgitation. Mitral valve stenosis can be treated with a 
replacement valve or by balloon catheter valvuloplasty, regurgitation can be 
treated with repair or valve replacement. Annuloplasty is the repair of choice 
for valves that suffer from mitral regurgitation. 
1.3.2.1 Mitral regurgitation 
There are two types of mitral regurgitation (MR); primary and secondary. 
Primary MR, also known as organic MR, is caused by a valve apparatus 
which has been structurally disrupted or compromised (Schmitto et al., 
2010). Secondary MR, also known as functional MR, results from the failure 
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of coaptation between the leaflets when the valve is structurally normal and 
regurgitation is caused by disease extrinsic to the valve (Schmitto et al., 
2010). In this type of regurgitation the papillary muscles, chordae, leaflets 
and annulus all appear normal.  
1.3.2.1.1 Primary mitral regurgitation 
Primary MR is often caused by degenerative or congenital MV disease. 
Degenerative MV disease can result from a range of conditions in which 
changes in the tissue cause rupture or elongation of the MV chordae, this 
can result in leaflet prolapse and annular dilation (Anyanwu & Adams, 2007). 
The main types of degenerative diseases are; primary myxomatous, primary 
flail leaflet and annular calcification. A valve with myxomatous disease is 
associated with mitral valve prolapse (Etchells et al., 1997; Anyanwu & 
Adams, 2007). Prolapse can be described as a valve leaflet which moves 
into the left atrium during systole (Levine et al., 1987). Myxomatous 
degeneration has been found to alter the leaflets in the mitral valve; an 
increase in glycosaminoglycans (GAGs) and change in matrix composition 
alters the spongiosa layer, valve water content and increases leaflet 
thickness (Grande-Allen et al., 2003). In a study by Gupta et al. (2009) the 
primary proteoglycans involved were found to be decorin, bigylcan and 
versican which were more abundant in valves with myxomatous disease 
than in normal controls.  
In developing nations, rheumatic fever is the most prevalent form of MV 
disease, in its chronic stage rheumatic disease causes chordal shortening 
and leaflet retraction along with annular dilation (Acar et al., 2004). In 
developed nations the incidence of patients with rheumatic fever has 
reduced when compared to the start of the twentieth century but there has 
been an increase in recent years (Ryan et al., 2000). 
When the endothelial lining of the heart is damaged due to intravascular 
trauma, the change to the endothelium combined with increased coagulation 
leads to the deposition of platelets and fibrin on the injured site of the tissue. 
The correct environment is established for bacterial attachment and 
proliferation which most commonly occurs in the mitral valve (Karchmer, 
2001), resulting in infective endocarditis. The frequent sites of attachment in 
the valves are downstream from regurgitant flow; in the case of the mitral 
valve this would be the atrial surface. The effects of endocardial infection 
can be severe, ranging from; valve regurgitation due to the destruction of 
tissue, embolic infarction from the debris of the vegetative infection, the 
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spread of the infection to other organs and tissue damage because of 
immune complex deposition (Karchmer, 2001). Antibiotics are the first line of 
treatment used to manage endocarditis with the choice of antibiotic 
depending upon the etiological organism, the type of valve (native or 
prosthetic) and the immune status of the patient (Bonow et al., 1998). 
1.3.2.2.2 Secondary Mitral Regurgitation 
Secondary MR commonly results from left ventricular systolic dysfunction. 
The dysfunction of the left ventricle coexists with neuro-hormonal activation, 
myocyte loss and local hemodynamics which produce dilation of the left 
ventricle and left ventricle remodeling (Andrus & Baldwin, 2006). The lack of 
leaflet coaptation due to secondary MR results from annular dilation, a 
reduction in annular contraction during systole and displacement of the 
papillary muscles due to left ventricle dysfunction and dilation (Schmitto et 
al., 2010). Other reasons for secondary MR include ischaemic papillary 
muscle dysfunction which occurs when the muscle or muscle wall 
attachment is ischaemic. This causes abnormal muscle contraction (Andrus 
& Baldwin, 2006) leading to lack of leaflet coaptation. Severe hypertension 
and extrinsic volume overload can also be the cause for secondary MR 
(Andrus & Baldwin, 2006). Treatment for secondary MR is not well defined 
and controversy still exists regarding the pathophysiology and best 
treatment. Current opinion generally agrees with the view that secondary MR 
derives from a ventricular etiology which has caused ventricular dilation. 
Treatment for this type of MR has remained controversial because of its 
association with poor long term survival (Schmitto et al., 2010).  
Ischaemic heart disease is commonly a chronic disease which causes 
secondary mitral regurgitation. The valve appears normal in ischaemic heart 
disease. Regurgitation occurs due to the displacement of the apex of the left 
ventricle and tethering of the chordae which results in lack of leaflet 
coaptation. The displacement of the apex caused by left ventricle 
remodelling in patients who have had myocardial infarction leads to 
movement of the papillary muscles away from the annulus (Iung, 2003), 
which increases tension on the chordae and tethering of the leaflets (Messas 
et al., 2001; Tanemoto, 2005; Yiu et al., 2000). If ischaemic heart disease is 
caused by myocardial infarction then ventricular function will often be 
reduced, decreasing the leaflet closing force (He et al., 1997). Dysfunction in 
the ventricle is further compounded by ventricular remodeling resulting from 
ischaemic mitral regurgitation. There is an increase in left ventricular end-
diastolic volume and wall stress resulting from an increased pre-load 
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(Laskey et al., 2007; Yiu et al., 2000), this causes further dysfunction and an 
increase in tenting from papillary muscle displacement (Rumberger, 1994). 
The annulus can enlarge if the left ventricle dilates which will further increase 
ischaemic mitral regurgitation (Kron et al., 2002). Grande-Allen et al. (2005) 
assessed if mitral valves that appeared normal in patients with heart failure 
exhibited signs of primary MR. Regurgitation in patients with congestive 
heart failure is normally thought of as secondary because the valve appears 
normal on echocardiographs or on gross pathological examination.  
Changes to the structure of the valve are thought to occur because the 
geometry of the ventricle and valves alter from their normal state, this leads 
to an increase in loading on the valves after long term changes to valvular 
loading patterns. In the study by Grande-Allen et al. (2005) they established 
that the extracellular matrix components in mitral valves were significantly 
different from those of normal control subjects matched for age. It was 
suggested that the loading conditions experienced by the valve contribute to 
the remodeling. When compared to the controls the patient`s valves were 
found to have become fibrotic with significantly increased proportions of 
collagen, concentrations of GAG’s and DNA with a decrease in water 
concentration. 
1.3.3 Annulus remodeling due to disease 
Mitral valve disease can change the annular geometry which can have a 
negative impact on the whole of the valve. The dimensions of the human 
annulus in normal and diseased valves were found to be significantly 
different by Ahmad et al. (2004). Using three dimensional echocardiography 
normal valves were compared to regurgitant valves. The results showed that 
there was a significant increase in the annular perimeter and annular area of 
regurgitant valves during the whole cardiac cycle compared to the normal 
controls (Table  1.1 and 1.2). At end-systole (Table 1.2) the inter-trigonal 
distance and posterior area of the regurgitant valves also showed a 
significant difference when compared to the controls. 
Table 1.1 – Comparison of the annular geometry of normal valves 
(controls) to valves suffering from ischaemic mitral regurgitation 
at end-diastole  
Variable Controls IMR p Value 
Annular perimeter (cm) 8.6 ± 0.2 10.7 ± 0.7 0.03 
Anterior annular perimeter (cm) 4.1 ± 0.2 5.0 ± 0.4 0.08 
Posterior annular perimeter (cm) 4.5 ± 0.2 5.6 ± 0.5 0.06 
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Intertrigonal distance (cm) 2.1 ± 0.1 2.8 ± 0.3 0.06 
Annular area (cm2) 5.7 ± 0.3 9.1 ± 1.2 0.03 
Anterior annular area (cm2) 2.5 ± 0.2 4.0 ± 0.7 0.08 
Posterior annular area (cm2) 3.2 ± 0.3 5.1 ± 0.9 0.08 
Values are mean ± standard error of the mean 
IMR = ischaemic mitral regurgitation 
Adapted from Ahmad et al., (2004) 
Table 1.2 – Comparison of the annular geometry of normal valves 
(controls) to valves suffering from ischaemic mitral regurgitation 
at end-systole  
Adapted from Ahmad et al., (2004) 
In pathological conditions the posterior part of the annulus was initially 
thought to increase in circumference whilst the anterior annulus did not, this 
was thought to be due to the vicinity of the fibrous trigones to the annulus. 
Research by Hueb et al. (2002) and Ahmad et al. (2004) however, 
established that the anterior annulus dilated in patients with pathological 
conditions which could trigger mitral regurgitation. Ahmad et al. (2004) used 
3D echocardiography to characterise annular geometry and motion in 
patients with ischaemic MR. Patients were found to have annular dilation 
with an increase in inter-trigonal distance and anterior and posterior 
perimeters; this was coupled with restriction in annular motion. This was in 
agreement with a study by Nguyen et al. (2008) who established that 
Variable Controls IMR p Value 
Annular perimeter (cm) 9.5 ± 0.4 10.2 ± 0.6 0.03 
Anterior annular perimeter (cm) 4.4 ± 0.4 4.6 ± 0.3 0.06 
Posterior annular perimeter (cm) 5.2 ± 0.2 5.6 ± 0.4 0.04 
Intertrigonal distance (cm) 2.3 ± 0.2 2.7 ± 0.2 0.01 
Annular area (cm2)  7.1 ± 0.5 8.3 ± 1.0 0.03 
Anterior annular area (cm2) 2.9 ± 0.5 3.4 ± 0.5 0.06 
Posterior annular area (cm2) 4.1 ± 0.2 4.9 ± 0.7 0.03 
Values are mean ± standard error of the mean 
IMR = ischaemic mitral regurgitation 
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annular dilation occurred predominantly in the septal-lateral dimension in 
patients and was accompanied by a flattening of the annular 3D saddle 
shape. Jimenez et al. (2005) conducted a study to investigate the effects of 
annular motion, annular flexibility and papillary muscle displacement on the 
distribution of chordal forces in an in-vitro model on human mitral valves. 
The investigators used a left heart simulator with a flexible annulus model 
and established that papillary muscle displacement significantly increased 
force on the anterior strut, posterior intermediate and commissural chordae. 
They also found that annular motion increased tension on the basal chords. 
The displacement of the papillary muscles induced tenting of the leaflets 
because of increased tension on the intermediate chords which lead to 
regurgitation.  The authors also hypothesized that the lengths of the basal 
chords may cause the annulus to be saddle shaped during systole. 
Mihalatos et al. (2007) investigated the effects that remodeling of the mitral 
annulus had on mitral regurgitation. A 3D echocardiography imaging study 
was completed which established that as the severity of MR increased there 
was an associated increase in the majority of 3D systolic annular dimensions 
as well as an increase in diastolic measurements. It was also established 
that the sphericity index decreased as MR increased which demonstrated 
that either the length of the left ventricle decreased or the left ventricle width 
increased. The sphericity index was measured by dividing the length of the 
left ventricle by the width of the left ventricle, the length was defined as the 
distance between the mitral annulus to the apex. With an increase in MR 
there was a significant increase in all the systolic and diastolic 
measurements for the left ventricle and left atrium (P < 0.001).  Annular 
tension was studied by He & Bhattacharya (2008) during valve closure. The 
annulus experienced two different types of force whilst the valve was closed; 
it received centripetal forces from the leaflets and the left ventricle 
myocardium delivered centrifugal forces. In the study the tension increased 
with an increase of annulus area, trans-mitral pressure and in apical 
papillary muscle displacement. Nguyen et al. (2008) found that the mitral 
annular dimensions for valves suffering from pure mitral regurgitation 
underwent dilation only in the commissure to commissure dimension. 
  
- 21 - 
 
1.4 Mitral Valve Disease Treatment 
1.4.1 Replacement 
The surgical procedure most commonly used for advanced valvular heart 
disease is valve replacement (Schoen & Levy, 1999). Mechanical heart 
valves were the first replacement valves to be introduced clinically in 1960’s 
(Bonow et al., 1998). Mechanical, bioprosthetic, donor and synthetic valves 
have all been investigated for valve replacement. The majority of prostheses 
available have been designed for aortic valve replacement and are inverted 
for use in the mitral valve position. The flow characteristics through the mitral 
valve differ from the aortic valve; therefore, prosthetic valves are not always 
suited for mitral valve implantation (Daebritz et al., 2003).  
 
1.4.2 Types of Replacement Valve 
1.4.2.1 Mechanical valves 
Mechanical valves were the first type of replacement to be used. Mechanical 
valves have the inherent problems of thrombogenicity and perivalvular leak 
when the valve is in a closed position (Hammermeister et al., 1993). 
Mechanical valves have excellent durability, which means they are often 
used in younger patients and those who have an active lifestyle. However 
lifelong use of anti-coagulants are required to reduce the risk of thrombosis 
(Jones, 1994).  
1.4.2.2 Bioprosthetic valves 
Bioprosthetic valves are constructed from glutaraldehyde treated xenogeneic 
tissue obtained from bovine or porcine sources (Mohammadi & Mequanint, 
2011), which are either sewn into a synthetic stent or are stentless. 
Bioprosthetic valves are often used when it is thought the valve will outlive 
the patients, this limits their use to older patients and those with chronic 
diseases (Jones, 1994). Compared to mechanical valves bioprosthetic 
valves allow a central flow providing good haemodynamics.  
Bioprosthetic valves do not require the use of anticoagulants, but compared 
to mechanical valves they have a reduced lifespan of between 10-15 years 
because of the effect that cross-linking has on durability (Oliveira & Antunes, 
2006).  
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1.4.2.3 Pulmonary autograft 
Valve replacement with an inverted pulmonary autograft has been used in 
patients with mitral valve dysfunction (Kumar et al., 2009). The technique is 
based around the Ross procedure. The pulmonary autograft is inserted onto 
a Dacron conduit 2.5 cm long. The mitral valve is prepared by excising the 
valve whilst preserving the papillary muscles. The Dacron conduit is sutured 
onto the mitral annulus, which fastens the valve into place. Subsequently, a 
cryopreserved pulmonary homograft is used to replace the pulmonary valve. 
By using an autograft, lifelong anticoagulation is avoided whilst retaining 
valve function and combined with a tissue that is living leads to a graft that 
offers good durability and good haemodynamics (Kumar et al., 2009).  
1.4.2.4 Synthetic valves  
Early hopes with synthetic valves were based on the hypothesis that they 
could combine the advantages of bioprosthetic and mechanical valves by 
offering good durability, good haemocompatibility and reduced risk from 
thrombosis (Zdrahala & Zdrahala, 1999; Bernacca et al., 2002). Although 
they offer good haemocompatibility and reduced thrombogenic risk, 
durability is a major problem which has been attributed to low biostability and 
calcification during in-vivo animal studies (Ghanbari et al., 2009). This has 
limited their use and they are not yet clinically used.  
1.4.3 Repair 
Compared to mitral valve replacement and medical management, mitral 
valve repair has been found to offer improved long term survival, freedom 
from cardiac morbidity and quality of life in patients with mitral regurgitation 
(Gillinov et al., 2001; Grossi et al., 2001).  
Five main techniques have been used for mitral valve repair; quadrangular 
resection, edge to edge repair, re-suspension of leaflet, bow-tie and 
annuloplasty. Of these techniques, annuloplasty has often been performed 
simultaneously with other techniques. The outcomes of mitral valve repair 
are assessed by freedom from residual or recurrent mitral regurgitation. 
Mitral regurgitation is commonly associated with annular deformation 
(Raffoul et al., 1998) highlighting the requirement for annulus reconstruction 
as an important factor for this type of repair.  
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1.5 Annuloplasty 
Annuloplasty is a repair procedure performed to optimise annular 
dimensions and shape (Rausch et al., 2011) when the annulus has 
undergone dilation, or it can be used to provide support and reinforcement to 
the valve when used in association with other repair techniques. The aim of 
annuloplasty is to increase leaflet coaptation and preserve annular shape 
and motion. Ideally a repair to the annulus should reconstruct the native 
valve apparatus while preserving the dynamic nature of the annulus 
(Kheradvar & Gharib, 2007). Reconstruction of the annulus is conventionally 
performed using an annuloplasty ring or pericardial patch, of which four main 
types are available; rigid ring, flexible ring, semi-rigid ring and bioprosthetic 
ring. Rings are usually only available in adult sizes, these range from 26 mm 
to 40 mm in diameter measured commissure to commissure.  
1.5.1 Annuloplasty rings 
1.5.1.1 Synthetic rings 
The rigid ring has been designed to provide reshaping of a substantially 
dilated annulus occurring with left ventricular dysfunction (De Bonis et al., 
2011).The flexible ring has been designed to retain the three dimensional 
geometry of the native annulus (Cosgrove et al., 1995). The semi-rigid ring 
has been designed to provide leaflet coaptation and maintain valve integrity 
during systole and offer good hemodynamics during valve opening in 
diastole (Carpentier et al., 1995).  
1.5.1.1.1 Rigid ring 
Carpentier created the rigid ring. These rings employed the philosophy of 
preserving the systolic shape of the mitral annulus. The Carpentier rigid ring 
is constructed from a titanium core and polyester fabric sheath. The core 
provides the strength and durability whilst the fabric allows integration of the 
mitral valve tissue into the ring.  
1.5.1.1.2 Flexible Ring 
Duran et al. (1978) proposed the idea of a flexible ring that would permit 
continuous changes of the geometry of the mitral annulus during the cardiac 
cycle.  Functionally, it was thought that they would cause less restriction on 
annular dynamics, improve interaction between the valve and ventricle and 
preserve left ventricle function.  Flexible rings were also introduced in an 
attempt to prevent geometric deformation and annular fixation during the 
annuloplasty procedure (Borghetti et al., 2000).  
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1.5.1.1.3 Semi-rigid 
The semi-rigid ring is flexible in the posterior segment becoming increasingly 
rigid in the anterior segment to accommodate the motion of the annulus. The 
rigidity in the ring was incorporated in order to reduce the stress on the 
sutures whilst supporting remodelling of the annulus (Bruno et al., 2009). 
There are many different types of ring on the market. The Carpentier-
Edwards Physio Annuloplasty Ring is a semi-rigid ring, it is constructed from 
layers of Elgiloy bands separated by polyester film strips and is surrounded 
by a silicon layer covered in polyester knit fabric. Elgiloy is a cobalt 
chromium alloy which has high strength, good ductility, long fatigue life, 
corrosion resistance and good biocompatibility (Shrivastava, 2003). The 
Sorin Memo 3D ring is a semi rigid complete ring. Its core consists of nitinol, 
which is a shape memory alloy; this alloy is used to re-establish the systolic 
diameter ratio during the cardiac cycle. On the outer core there is a sewing 
ring for attachment to the mitral valve. This is made from silicone and knitted 
polyester fabric and coated in turbostratic carbon (Carbofilm, Sorin 
Biomedica, Italy) to enhance haemocompatibility and biocompatibility (Bruno 
et al., 2009). Saddle shaped annuloplasty rings were introduced to create a 
ring that was closer to the physiological shape of the native annulus. Saddle 
shaped rings do not lift the papillary muscles in the direction of the posterior 
annulus unlike planar rings, this allows greater leaflet mobility in the valve 
(Jensen et al., 2011).   
1.5.1.1.4 Pathology Specific rings 
To improve outcomes annuloplasty rings addressing specific pathologies 
have also been produced. These include the Edwards Geform and IMR-
ETlogix ring. The IMR-ETlogix ring was developed to deal with geometric 
asymmetric changes that can occur in the annulus and ventricle. Short term 
results have been positive, and have shown improvement in mitral annular 
diameter, tethering area and tenting height for ischaemic mitral regurgitation; 
although no long term results currently exist for this ring (Daimon et al., 
2006).  Currently there is no treatment for ischaemic mitral regurgitation that 
provides improved outcomes. The most common procedure is an undersized 
annuloplasty using size 24 to 26 rings, alternative repair techniques using 
pericardial bands and patches have been found to deliver poor long term 
outcomes (McGee et al., 2004). The results from a study involving 585 
patients over a 17 year period showed that postoperatively 28% of patients 
had moderate MR or above (Tahta et al., 2002). 
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1.5.1.1.5 Partial ring 
Partial rings have also been used clinically, these were suggested by Odell 
et al., (1995) because it was thought that the posterior annulus dilated and 
the anterior section was fixed with mitral valve disease. The ring is attached 
onto the posterior portion of the annulus to improve the posterior dynamics 
and restore the natural antero-posterior to transverse diameter ratio. There 
is now evidence that the dilation of the anterior mitral annulus increases in 
proportion with the posterior dilation of the annulus (Hueb et al., 2002) and is 
not fixed as previously thought. 
1.5.1.1.6 Ring comparisons 
Of the techniques available for repair, annuloplasty is recommended 
because it offers improved outcomes when compared to all other type of 
repair but there are still limitations. There are limitations  to synthetic 
annuloplasty use as current rings can change annular dynamics, geometry 
and force distribution of the MV (Yamaura et al., 1997; Glasson et al., 1999; 
Jensen et al., 2008;). Studies in sheep (Quick et al., 1997; Kunzelman et al., 
1998b) established that increased stress can increase collagen deposition, 
this may lead to thicker leaflets and affect leaflet closure. Computer models 
have been used to predict that if leaflet mobility is preserved then closing 
stresses are distributed more evenly (Kunzelman et al., 1998a). Using 
standard sized flexible or semi-flexible rings may reduce the annulus area 
during diastole by 30% or more (Glasson et al., 1999) which can affect the 
transfer of blood during filling. As well as reducing the annular area, it has 
been reported in ovine animal studies that the posterior leaflet was frozen in 
the closed position which resulted in a single leaflet opening process (Green 
et al., 1999).  
In a study by Kunzelman et al. (1998a) a finite element model was used to 
compare rigid to flexible rings. For rigid rings, simulated by loss of annular 
flexibility, there was increased stress in the leaflets and chordae and delayed 
leaflet coaptation. In an ideal flexible ring there was normal coaptation 
between leaflets and close to normal stresses (Kunzelman et al., 1998a), 
although it was found that both sets of rings often behaved similarly when 
comparing annular dynamics (Dagum et al., 2001; van Rijk-Zwikker et al., 
1990). 
Another study investigated the annular dynamics of valves that were 
implanted into sheep with flexible partial (Tailor, St Jude Medical, Inc, St 
Paul, Minn) or complete rings (Duran, Medtronic, Inc, Minneapolis) (Dagum 
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et al., 2001). Radiopaque markers were sutured around the mitral annulus in 
the sheep. It was found that mitral annular folding, described as when the 
anterior section of the annulus flexes towards the atrium relative to the 
posterior part, was dampened in the complete ring group but was no 
different in the partial ring group when compared to the control. The partial 
ring in this instance preserved the mitral annular folding dynamics seen in 
normal valves. Importantly it was found that both of the ring types fixed the 
annular area throughout the cardiac cycle and no change in septal to lateral 
dimensions or commissural to commissural dimensions was observed 
showing that no annular contraction took place and leaflet coaptation was 
restricted. Tibayan et al. (2004) hypothesized that by preserving annular 
dynamics, coaptation between leaflets was likely to be assisted as the 
annulus contracts during systole.  
The results from a completely randomised trial involving both rigid and 
flexible rings using 363 patients with mitral regurgitation showed that there 
was no significant difference in the rate of recurrence of significant mitral 
regurgitation over an eight year period (Chang et al. 2007). In the study a 
Carpentier Rigid Ring (n=186) or Duran Flexible Ring (n=170) was randomly 
assigned. Data was collected prospectively. The mean follow up was 46.6 ± 
32.6 months (mean ± SD). Left ventricle end diastolic diameter, left ventricle 
end systolic diameter and left atrial size significantly decreased for each 
group. Overall actuarial survival at ten years was 85.9% ± 4.9 % (±95 % CI) 
(Rigid Ring) and 75.7 % ± 7.2 % (Flexible Ring). Eight year freedom from 
recurrence of significant MR (grade≥3) was 62.6 % ±19 % (± 95 % CI) (Rigid 
Ring) and 55 % ± 14.1 % (Flexible Ring) (p=0.172) using the Kaplan-Meier 
method. Rings implanted in those with a degenerative disease had the best 
durability with ten year freedom from operation of 87.6% ± 8.1% (±95% CI). 
Freedom from recurrence of significant MR (grade ≥ 3) was 95.5% ± 2.2% at 
4 years and 53.8% ± 17% at 8 years. 
Chee et al. (2008) conducted a best evidence review for patients with mitral 
regurgitation and found that flexible rings improved left ventricle systolic 
function compared to rigid and semi-rigid rings but did not improve clinical 
outcomes. Other studies have reported varying degrees of mitral 
regurgitation over the medium to long term of grade three or above with a 
range from 18% (Flameng et al., 2003) at seven years to close to 45% 
(Chang et al., 2007) at eight years. The incidence of ischaemic MR is 
increasing which poses a challenge because ring annuloplasty is more likely 
to fail in this set of patients (Fedak et al., 2008). Recurrence of severe MR in 
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this group is as high as 25% one year after surgery (McGee et al., 2004; 
Tahta et al., 2002).  
A study of 169 patients with ischaemic mitral regurgitation by (Silberman et 
al., 2009) comparing flexible rings (117 patients) to rigid rings (52 patients) 
found an increased frequency of regurgitation for those who had flexible 
rings. The postoperative follow up for the flexible ring group was 58 ± 30 
months and 14 ± 7 months for the rigid ring group; 34% of the flexible group 
had residual mitral regurgitation of moderate grade or greater compared to 
15% for the rigid group (p=0.03). Late mortality was observed in 32 of the 
patients within the flexible group. It was suggested that the rigid ring has 
improved results because it determines the annular shape by maintaining 
the anteroposterior to lateral diameter ratio more than the flexible ring. The 
large difference in the follow up period between the two groups and the 
retrospective nature of the study were shortfalls. Hu & Zhao (2011) 
performed a meta-analysis of flexible and rigid rings and established that 
flexible rings offer improvements in ejection fraction and in preserving the 
mitral orifice area. The flexible ring remained comparable to rigid rings for 
overall survival, mortality, reoperation, recurrence of regurgitation and left 
ventricle performance.  
A study that compared the effectiveness of complete rings and partial rings 
for patients with chronic ischaemic mitral regurgitation found that complete 
rings achieved better results. Partial rings (semi-rigid ring Colvin-Galloway 
Future band) demonstrated 55.6 ± 12.7% freedom from recurrent mitral 
regurgitation and complete rings demonstrated 92.3 ± 7.4 % (Semi rigid 
symmetric Carpentier-Edwards Physio ring) and 94.1 ± 5.7 % (Semi rigid 
asymmetric Carpentier-McCarthy-Adams ring) freedom from recurrent MR  
(Onorati et al., 2009).  
A summary of the main papers describing the clinical outcomes of mitral 
valve annuloplasty repair are described in Table 1.3.  
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Table 1.3 – Summary of papers presenting patients who have 
undergone mitral valve annuloplasty with synthetic rings 
Author ,date Patient 
Group 
Variable Results 
Chang et al,. 
2007 
Flexible Ring 
n=170 
Rigid Ring 
n=186 
10 year survival 
 
 
 
 
8 year freedom 
from significant 
regurgitation 
 
Flexible ring: 
75.7 ± 7.2 % (95 % CI) 
Rigid ring: 
85 ± 4.9 % 
 
Flexible ring: 
55 ± 14.1 % 
Rigid ring: 
62.6 ± 18 % 
Flameng et 
al,. 2003 
Rigid Ring 
n=218 
Flexible 
Ring: 
n=24 
 
7 year freedom 
from severe 
regurgitation 
 
Rigid ring (90% of 
operations) and flexible 
ring (10% of 
operations): 
71.1 ± 7.4 % (95 % CI) 
No comparison of 
outcomes between ring 
types 
Hu & Zhao. 
2011 
Flexible 
Rigid 
Meta 
analysis 
 Rigid:  
Improvement in ejection 
fractions and in 
preserving the mitral 
orifice area 
Flexible:  
Comparable to rigid 
rings for overall 
survival, mortality, 
reoperation, recurrence 
of regurgitation and left 
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ventricle performance 
Silbiger & 
Bazaz. 2009 
Ischaemic 
mitral 
regurgitation. 
Flexible: 
n=117 
Rigid: 
n=52 
Freedom from 
moderate mitral 
regurgitation 
 
Flexible ring:  
66 % (follow up 58 ± 30 
months) 
Rigid ring:  
85 % (follow up 14 ± 7 
months)  
Onorati. 
2009 
Ischaemic 
mitral 
regurgitation. 
Partial semi 
rigid: n=17 
Complete 
semi rigid 
Physio ring: 
n=22 
Complete 
semi rigid 
asymmetric: 
n=25 
2 year freedom 
from chronic mitral 
regurgitation 
Partial semi rigid:  
55.6 ± 12.7% (SD) 
Complete semi rigid 
Physio ring:  
92.3 ± 7.4 % 
Complete semi rigid 
asymmetric:  
94.1 ± 5.7 % 
 
Due to the multitude of different rings available it is difficult to determine 
which rings provide the best outcomes. Bothe et al. (2010) conducted two 
studies investigating the effects different types of rings have on mitral 
annular dimensions and dynamics using sheep.  Five rings were used in 
both of the studies, these were; the Cosgrave Edwards rigid ring, St Jude 
rigid saddle shaped ring, Carpentier Edwards Physio flat ring, Edwards IMR 
ETLogix and the Edwards GEOForm cause specific rings. Of these, one ring 
was a partial ring (Cosgrave Edwards) and the rest were complete rigid rings 
of different geometries.  The main findings showed that the maximum valve 
orifice size was reduced by all ring types, only the partial ring did not 
increase movement of the central region of the anterior leaflet and all except 
the ETLogix ring increased the closing and opening velocities of the anterior 
leaflet belly (Bothe et al., 2010b). The four rigid rings reduced the anterior 
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mitral leaflet commissure to commissure distance during diastole but there 
was no effect on the septal to lateral dimensions. All of the rings decreased 
the septal to lateral and commissure to commissure distances when 
compared to the control. It was also found that the rings prevented changes 
in annular dimensions during systole and three of the rings, the Physio, IMR- 
ETlogix, and GeoForm produced a more planar annulus (Bothe et al., 
2010a). 
Few studies had investigated the impact of device implantation on 
deformation, strain and curvature in the mitral valve; Rausch et al. (2012) 
conducted a study on 34 sheep to quantify how three frequently used 
annuloplasty rings affected native annular dynamics. Flexible incomplete, 
semi-rigid complete and rigid complete rings were implanted into the annuli 
of sheep and marked with tantalum markers around the circumference of the 
annulus. Biplane video-fluoroscopic images were sampled at a frequency of 
60 Hz and mathematical splines were used to calculate changes to the mitral 
annulus. The splines were polynomial functions used to interpolate and 
approximate a given set of data points. The parameters that were analysed 
were septal to lateral and commissure to commissure dimensions taken from 
the best fit plane, using this data eccentricity and annular area were 
determined. From a line on the arc-length perimeter the three-dimensional 
perimeters were approximated. The saddle height was calculated as the 
distance of the commissure points to a plane passing through the mid 
anterior and posterior points. Using this data, strain, deformation and 
curvature were calculated. Without the devices implanted the changes in 
dimensions were -14.4 ± 5 % septal to lateral, -5.7 ± 2.1 % commissure to 
commissure, +15.9 ± 6.4 % in eccentricity, -17.9 ± 6.2 % in mitral annular 
area, - 6.4 ± 2.1% in annular perimeter and + 61 ± 38.4 % saddle height. 
The strains in the normal annulus were 8 % contraction in the posterior 
annulus and approximately 4 % dilation in anterior annulus, relative to the 
strain at the minimum ventricular pressure. At all time-points for the flexible 
ring the strain did not go below zero in the posterior region, in contrast to this 
the normal annulus underwent contractile strains of -8 %. Anterior strains 
remained unaffected when compared to the normally functioning annulus. At 
all time-points for the semi-rigid ring the posterior contractile strains were 
eliminated and tensile strains in the anterior region were smaller. For rigid 
rings the strain was significantly reduced in both the posterior and anterior 
annulus. All the rings exhibited reduced variation in curvature compared to 
the normal valves in which curvature increased from diastole to systole. The 
native dynamics of the valve were affected by all the rings, it has been 
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suggested that preventing normal mechanical dynamics may be 
unfavourable to mitral valve function and reduce repair outcomes 
(Carpentier et al., 1995; Cosgrove et al., 1995). In this study, only the flexible 
ring maintained the saddle height of the native valve. It has been suggested 
that the prevention of annular folding into the MV orifice, which occurred with 
the other rings, may negatively affect the motion of the left ventricle outflow 
tract during systole (Lansac et al., 2002). The study established that for all 
devices there was significant reduction in annular dynamics, with loss of 
anterior dilation and posterior contraction, confirmed by strain and curvature 
analysis. The flexible incomplete ring retained the native annular dynamics 
the greatest when compared to the semi-rigid and rigid complete devices. 
Rausch et al. (2012) concluded that the heterogeneous nature of the strain 
and curvature of the annuli implies that a heterogeneous design solution 
should be sought. 
Other limitations of current synthetic annuloplasty rings are that they can 
also cause secondary MV stenosis in children. Synthetic rings are also 
contraindicated to prosthesis use when there is presence of active bacterial 
endocarditis, there is risk of fibroblastic pannus growth and when there is a 
presence of a heavily calcified valve with reduced mobility. 
The advantages and disadvantages of the conventional annuloplasty rings 
can be summarised as follows: 
Partial: 
 Used to retain physiological properties of anterior annulus whilst 
correcting the dilation of the posterior annulus. 
 Does not correct dilation occurring with the anterior annulus 
Complete: 
 Restricts both anterior and posterior annulus 
 Can be homogenous or heterogeneous  
Rigid:   
 Used to stabilise and restore mitral annulus geometry.  
 Restricts annular dynamics and natural geometry of the annulus. 
 Restricts contraction of left ventricle inflow tract and may obstruct left 
ventricle outflow tract.  
Flexible:  
 Provides flexibility for annular dilation and reduces annular size. 
Advantage of preserving left ventricular function. 
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 Only corrects dilation of the annulus and does not ensure normal 
configuration of the MV. 
Semi-Flexible:  
 Stiff anterior and flexible posterior.   
 Thought to interfere less with the normal mitral annulus motion.  
 Reduces stress on sutures while maintaining annulus remodeling 
1.5.1.2 Biodegradable ring 
Biodegradable rings were developed by Kalangos (2006). This type of ring 
consists of a curved ‘C’ shaped segment, manufactured from polydioxanne 
polymer. A suture, manufactured from monofilament polypropylene, runs 
throughout the whole of the segment and extends out of either end. Attached 
at the distal ends of the suture are stainless steel needles. Two types of ring 
exist, a paediatric ring and an adult ring. The paediatric ring is available in 
sizes 26 and below. The paediatric ring differs from the adult ring because 
the suture does not run through the polymer, this is to ensure that the 
annulus can grow and remodel over time rather than be restricted in size by 
the suture. 
During the biodegradation of the ring a fibrous tissue is formed at the 
annulus where the absorbed ring existed. This type of repair has the 
advantage of remodelling as the heart grows and therefore can be used in 
children without the need for re-operation. Biodegradable rings provide 
mechanical support only after the initial stages of implantation, subsequent 
growth of fibrous tissue provides mechanical support as the polydioxanane 
ring is degraded by hydrolysis. A sub-endocardial fibrous reaction to the ring 
allows remodelling of the mitral annulus (Kalangos, 2006) but this has only 
been observed in animal models. The advantage of this method is that the 
ring is implanted within the annulus and therefore does not come into 
contact with the patient’s blood, reducing the risk of thrombosis.  
In preliminary tests in animals (model not described) inflammatory tissue 
found around the ring one month after implantation consisted of 
macrophages, polymorphonucleated cells, multinucleated giant cells, 
lymphocytes, fibrin and proliferating fibroblastic cells as well as there being 
evidence of collagen production. After three months there was still a foreign 
body reaction at the site of the ring but this had decreased compared to the 
one month reaction and it was suggested by the authors that the reaction 
could be surgery related rather than material related. Six months after the 
implantation the ring had started to degrade and had been replaced by a 
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thickened fibrous material, and the foreign body reaction to the ring had 
decreased over this period. At nine months there were limited signs of the 
original material and the reaction was composed predominantly of 
macrophages, multinucleated giant cells and lymphocytes. Fibrous scar 
tissue had formed at the implant site which was on average 1250 µm in 
diameter along the annulus. At 12 months there was a little biodegradable 
ring present and the inflammatory reaction had decreased with respect to 
the reaction at 9 months (Kalangos, 2006).  
 A four year trial in human patients (n=17) revealed that there was little or no 
regurgitation in 11 patients and mild regurgitation in 3 (Pektok et al., 2010). 
There was also significant reduction in left ventricular dimensions after the 
repair. Three patients had died postoperatively within the first 35 days of the 
trial.  Limited studies exist for this ring and no long-term results are available 
so the effects over longer periods are currently unknown.  
1.5.1.3 Biological replacement ring 
Autologous pericardium has been used clinically to treat patients who have 
valvular calcification or valvular destruction due to shrinkage of leaflets and 
chordae due to rheumatic carditis (Ng et al., 2001) and endocarditis (Güden 
et al., 2004). Pericardial patches have been used to reconstruct the calcified 
annulus in conjunction with mitral valve replacement, replace commissural 
tissue after tissue shrinkage, substitute part of a leaflet and re-implant 
ruptured papillary muscles and as replacement chordae (Ng et al., 2001). 
Mitral valve replacements used for treating these problems are associated 
with complications such as atrioventricular rupture, paravalvular leakage and 
thrombosis (Güden et al., 2004) and high rates of mortality and morbidity 
(Shinn et al., 2009). Salati et al. (1991) performed an annuloplasty with an 
autologous pericardial ring, utilising a long strip of autologous pericardium. 
The tissue was marked with metal clips and rolled up into a tube ensuring 
that the smooth serosal surface was positioned on the outside of the tube. 
The ring was placed in close proximity to the posterior annulus and sutured 
into place just after the commissures (Salati et al., 1991). A biological patch 
can also be used in annulus reconstruction; this involves full or segmented 
annular resection. A patch approximately 2cm wide is sutured into the left 
ventricle wall, positioned close to the posterior annulus and into the left atrial 
posterior wall, covering the annulus. Autologous pericardium (Fig 1.7) have 
been used in order to retain some of the dynamic motion of the annulus 
(Borghetti et al., 2000). It is also readily available and cost effective, shows 
fast recovery and has resistance against infection (Güden et al., 2004).  
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Fig 1.7 – Pericardial strip used for posterior annuloplasty5  
Various problems have been associated with the use of autologous 
pericardium including; tissue contracture, progressive fibrosis, degeneration, 
loss of flexibility and endocarditis (Ng et al., 2001). Glutaraldehyde treated 
patches have been considered to prevent early deterioration and prevent 
thickening, but cross-linked tissue has been associated with long-term 
degeneration (Vesely, 2003). In a study by Güden et al. (2004) autologous 
pericardial patches were sewn into eight patients who had calcification of the 
mitral annulus due to endocarditis. Pre-operatively, 50% of patients were in 
New York Heart Association (NYHA) class 2 and 50% in classes 3-4. One 
patient died postoperatively. During a short-term follow up of 6.5 ± 1.5 
months, a NYHA class of 1-2 was observed for all patients with no reported 
perivalvular leakage, dehiscence, calcification or thrombosis. It was 
concluded that annular reconstruction using a pericardial patch could 
decrease mortality for patients with complicated mitral pathologies. Scrofani 
et al. (1996) used autologous pericardium in 113 patients and found that the 
majority of patients were in NYHA class I and had no or mild residual 
regurgitation over a follow up period of 32.41 ± 20.09 months. Borghetti et al. 
(2000) used glutaraldehyde treated pericardial strips for annuloplasty (group 
1) and compared them against a group of patients who had undergone rigid 
ring annuloplasty with Carpentier-Edwards rings (group 2). At midterm follow 
up of 61.4 ± 12 months for group 1 and 46 ±15 months for group 2, there 
was no or trivial mitral regurgitation observed in either group. There was a 
significant increase in left ventricle ejection fraction under stress conditions 
                                            
5 Reprinted from Clinics,  60, Maria et al., Mitral valve annuloplasty with a 
bovine pericardial strip - 18-year results, 305–310 (2005): taken from - 
http://www.scielo.br/scielo.php?pid=S1807-
59322005000400008&script=sci_arttext#. Licensed under Creative 
Commons Attribution-NonCommercial 4.0 International. 
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for group 1 (59.5 ± 6% to 65.8 ± 6% p<0.005) whilst group 2 showed no 
significant increase (61.4 ± 5% to 61.9± 5%). This was reported as improved 
mitral dynamics and preserved left ventricular function in the pericardial 
group. These results were not compared against flexible or semi-flexible 
rings which would have given more relevant results. Other studies using 
autologous pericardium also concur with these results. In a study by Choi-
Keung et al. (2001) 63 patients who had complex mitral valve pathologies 
underwent repair of their mitral valve using autologous glutaraldehyde 
treated pericardium. Repair included leaflets, chordae, annulus and 
reattachment of papillary muscle. Before the operation the mean 
regurgitation grade was 3.5 and patients were in NYHA class III or IV. At 
follow-up (mean 61.1 months) mitral regurgitation was absent in 92.1% of 
patients and freedom from re-operation was 95.2% at one and five years 
with no reported thromboembolic events.  
1.5.2 Annuloplasty in children 
Congenital heart disease is uncommon in children and often relates to other 
cardiac complications. The management of mitral valve disease in children is 
difficult because there are a range of pathologies with a high incidence of 
cardiac abnormalities present alongside the disease (Lee et al., 2010). Mitral 
valve repair is desirable in children because left ventricle function is better 
preserved by retaining the subvalvular apparatus and geometry of the 
ventricle and the procedure is well established for congenital repair. Children 
who require valve replacement because either the repair has failed or the 
valve is comprehensively damaged have poor long term survival (Caldarone 
et al., 2001; Ackermann et al., 2007; Beierlein et al., 2007; Selamet Tierney 
et al., 2008; Alsoufi et al., 2009). There are further problems because there 
are a limited number of replacement devices available in the correct size 
(Lee et al., 2010) and they will require a secondary replacement later in life 
to ensure the valve is large enough for the adult heart. Due to the risk of 
stenosis in children, annuloplasty rings are normally only used when the 
child’s annulus is large enough in diameter to accept the adult size 
annuloplasty rings; these rings are generally more than 26 mm in diameter. 
For children whose annulus is expected to grow further a commissuroplasty 
is used. A commissuroplasty involves stitching the commissures so that 
annular size is reduced and the anterior leaflet is moved so it is more in 
opposition with the posterior leaflet (Hillman et al., 2004). 
A retrospective study of repairs that took place between 1986 and 2003 
focused on children that predominantly suffered from congenital MV 
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anomalies (Wood et al. 2005). The median age was 2.16 years with 40% of 
the children under 1 year of age. Just under 37% of cases had a pathology 
caused by annular dilation which lead to mitral regurgitation. The study 
found that the 15 year freedom from reoperation was 81.7% and had an 
event free rate of 73.5% over the same time period. Overall survival for the 
group was 86.5%. For this study the children were split into two groups; 
group 1 children were deemed as having a mitral anomaly with or without 
atrial septal defect or patent ductus arteriosus and group 2 were classified 
as complex which involved having a mitral anomaly with intracardiac disease 
or left ventricle outflow tract obstruction. Group 1 had a better 15 year 
survival of 93% compared to group 2 of 73% (Wood et al., 2005). For the 
repairs the mitral orifice size was originally measured with a Hager dilator, 
this was compared to the normal MV diameter relative to the body surface 
area. For repair, complete synthetic rings were avoided in order to prevent 
the risk of stenosis due to valve growth and risks from endocarditis and 
thromboembolism. Partial posterior rings were only used if the child’s mean 
body surface area was greater than 0.9 m2. The most common technique 
used by Wood et al. (2005) was commissural plication annuloplasty in which 
sutures were used to reduce the size of the annulus at the commissures.   
Lee et al. (2010) reviewed 139 cases of children who underwent MV repair 
between 1988 and 2007. The median age was 2.3 years (2 months – 17.6 
years) and 90% of the group had mitral regurgitation. The aim of the study 
was to analyse the 20 year results of MV repair in children. In the 
retrospective study the freedom from reoperation was 77% and freedom 
from MV replacement was 90% with an overall survival of 97%. Various 
repair techniques were used which depended upon the functional and 
pathological findings of a saline injection test which evaluated the annulus, 
leaflets and subvalvular apparatus. Annular dilation was repaired using a 
variety of techniques (Table 1.4). The primary method used early on in the 
study used was Wooler-Kay annuloplasty but this was replaced in later years 
using artificial ring annuloplasty for older children and suture plication or 
posterior strip annuloplasty for younger children.  
  
- 37 - 
 
Table 1.4 – Repair techniques used in children (more than one 
technique could be used per repair)  
Repair technique Patients % of patients undergoing 
procedure  
Mitral regurgitation  
Wooler-Kay annuloplasty 57 45.6 
Cleft repair 22 17.6 
Strip annuloplasty 18 14.4 
Ring annuloplasty 14 11.2 
Artificial chordae 12 9.6 
Chordae shortening 10 8.0 
Posterior annulus placation 9 7.2 
Papillary muscle splitting 7 5.6 
Secondary chordae resection 6 4.8 
Edge-to-edge repair 5 4.0 
Commissure obliteration 5 4.0 
Chordae transfer 4 3.2 
Mitral stenosis  
Papillary muscle splitting 11 78.6 
Commissurotomy 4 28.6 
Resection of supravalvular  
ring 
4 28.6 
Secondary chordae resection 2 14.3 
Leaflet slicing 1 7.1 
Fenestration of chordae 1 7.1 
Adapted from Lee et al. (2010) 
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1.6 Tissue Engineering 
A more recent approach to repair and replacement of the mitral valve is 
through the emerging science of tissue engineering. This field has the 
potential to overcome the limitations associated with current strategies of 
mitral valve replacement such as the use of anticoagulation treatments, poor 
durability and unsuitability of current strategies for the paediatric population. 
1.6.1 Overview  
The field of tissue engineering has developed from unmet clinical needs for 
tissue reconstruction and repair. The aim of tissue engineering is to produce 
functional tissues in the laboratory that can be used to replace, repair, 
maintain, or improve diseased or damaged tissues or, potentially whole 
organs (Yang et al., 2001). Approaches to tissue engineering include the 
development of (a) acellular scaffolds designed to regenerate with the 
patients endogenous cells following implantation (b) scaffolds seeded with 
living cells and conditioned in vitro prior to implantation and (c) use of cell 
therapies or biologics to induce endogenous repair.  For the purposes of this 
review, only approaches (a) and (b) are relevant to the replacement or repair 
of the mitral valve. 
Tissue engineering scaffolds need to offer comparable biological and 
biomechanical properties to the tissue that they designed to replace or repair 
in order that they might regenerate appropriately in the body. Two major 
types of tissue engineering scaffold have emerged, biological and synthetic 
substitutes. Scaffolds can be assembled from biodegradable synthetic 
polymers or natural polymers  or produced via the decellularisation of natural 
allogeneic donor or xenogeneic tissues and used with or without cell seeding 
(Neuenschwander & Hoerstrup, 2004).  
The scaffold for any type of application needs to provide the correct 
environment for cell attachment and proliferation (Sheridan et al., 2000; 
Teebken et al., 2001) whilst being non-inflammatory, non-immunogenic and 
provide suitable mechanical properties and durability (Khalil & Sun, 2007; 
Boloori Zadeh et al., 2013). The scaffolds also need to have the correct 
mechanical characteristics to provide the appropriate environment for new 
tissue formation and correct function when implanted. The structure should 
provide porosity and permeability for cell integration and nutrient exchange 
along with the correct surface topography for cell attachment (Yang et al., 
2001), which is thought to contribute to the tissue engineered construct 
developing the required biological functions (Cima et al., 1991).  
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Acellular scaffold approaches rely on the patient’s own cells to grow into the 
scaffold and remodel the scaffold to provide a functional outcome post-
implantation. The main drawback to this approach is the lack of cellular 
functionality of the tissue replacement/ repair immediately upon implantation. 
For acellular scaffolds with a primarily mechanical function, such as would 
be the case with an annuloplasty ring, which undergoes cyclic loading during 
the cardiac cycle, the initial lack of living cells to repair and remodel the 
scaffold may lead to scaffold degradation and alter the biomechanical 
characteristics. 
In the approach of using scaffolds seeded with living cells, which to prevent 
immunological rejection would need to be autologous, the aim is to condition 
the cells with the purpose of producing a living construct that has the same 
function as the tissue it is replacing prior to implantation. Cell seeded 
scaffolds that have been conditioned in vitro prior to implantation have the 
potential for improved survival and integration compared to the acellular 
scaffold approach. However, a potential limitation to this approach is that, 
once implanted, the cells within living tissue engineered constructs may die 
by necrosis as a result of hypoxia, leading to degradation of the implanted 
construct. Moreover, the costs of the cell-seeded scaffold approach would 
be substantially higher compared to the acellular scaffold approach.  
1.6.2 Synthetic polymer matrices in cardiovascular tissue 
engineering  
There are a number of synthetic biodegradable polymers that are 
biocompatible and biodegradable and have been used in cardiovascular 
tissue engineering. These include; polygalactin (Shinoka et al., 1995), PGA 
(polyglycolic acid) (Shinoka et al., 1996), PLA (polylactic acid), and PLGA 
(copolymer of PGA and PLA) (Zund, 1997). PGA coated with P4HB (poly-4-
hydroxybutyrate) has been used to manufacture complex three dimensional 
structures for example trileaflet heart valves (Hoerstrup et al., 2000, 2002). 
Synthetic polymers can be tailored so that the biomechanical properties and 
biodegradation rate are designed for the function required of the scaffold. It 
is also possible to incorporate growth factors into the scaffold so that specific 
cell types  can be targeted to promote tissue remodelling (Hubbell et al., 
1991; Zisch et al., 2003). Shinoka et al. (1995) seeded a synthetic 
polyglycolic acid fiber matrix with fibroblasts and endothelial cells and 
implanted the cell- seeded scaffold into the right posterior leaflet of the 
pulmonary valve in sheep. Results showed no evidence of stenosis and 
minimal regurgitation and analysis of the explanted tissue revealed the 
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development of an extracellular matrix and appropriate cellular distribution. 
In a similar study Hoerstrup et al. (2000) fabricated heart valves using 
bioabsorbable polymers and seeded them with autologous ovine 
myofibroblasts and endothelial cells. The cell-seeded constructs were 
conditioned in a bioreactor for 14 days before implantation into the 
pulmonary position in the hearts of lambs. Their results showed degradation 
of the polymers at 8 weeks and a fully functioning valve during the study. 
The explanted constructs showed comparable characteristics to a normal 
heart valve in terms of the microstructure and mechanical properties. 
Biodegradable polymers have also been seeded with CD133(+) cells derived 
from umbilical cord blood with the aim of developing new strategies for the 
treatment of congenital defects (Sodian et al., 2010). The constructs were 
placed in a bioreactor to encourage cell growth; analysis of the tissue 
showed signs of endothelialisation and connective tissue formation. 
There are disadvantages associated with the use of synthetic polymers as 
scaffold materials. These relate to the isotropic nature of the manufactured 
scaffolds which may not lead to appropriate cell-signalling and 3D tissue 
remodelling. Native valves have an anisotropic structure coupled with non-
uniform mechanical properties (Merryman et al., 2006). To obtain anisotropic 
properties that characterise the structure of native heart valves Masoumi et 
al., (2014) fabricated tri-layered scaffolds of micro-fabricated poly(glycerol 
sebacate) (PGS) and fibrous PGS/poly(caprolactone) (PCL) electrospun 
sheets. Mesenchymal stem cells and valve interstitial cells (VICs) grew 
within the scaffolds and deposited extracellular matrix on the scaffolds when 
conditioned in a bioreactor. An ex-vivo porcine heart model demonstrated 
that the constructs opened and closed similarly to native valve leaflets.  
To the author`s knowledge, there have been no studies that have used 
synthetic polymer scaffolds, either seeded with cells or without cells for 
mitral valve repair or replacement strategies.    
1.6.3 Natural polymer scaffolds in cardiovascular tissue 
engineering  
Natural polymers can be categorised as proteins, polysaccharides or 
polynucleotides. Proteins include actin, collagen, elastin, fibrinogen, gelatin, 
keratin and myosin; polysaccharides include amylose, cellulose and 
glycosaminoglycans whilst polynucleotides include DNA and RNA 
(Alexander & Brunski, 1996). A number of these polymers have been used 
in the fabrication of cardiovascular tissue engineered scaffolds. Shi and 
Vesely (2003) produced chordae constructs utilising a collagen gel 
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suspension. The construct was placed into a rig which exerted tensile forces 
through the material, aligning crimped collagen fibrils longitudinally and 
producing a sheath of elastin around the core, replicating the native chordae 
structure. Mechanical properties of early constructs were far weaker than 
native chordae, but were improved with the use of a bio-reactor and 
enhanced material and clamp design. 
Hyaluronan, a glycosaminoglycan, is a natural polymer being investigated as 
a replacement for the native aortic valve leaflets which are characterised by 
GAG and elastin layers (Ramamurthi & Vesely, 2005). Directed collagen gel 
shrinkage has been used alongside a hyaluronan and divinyl sulfone GAG 
matrix to fabricate aortic valve leaflets (Shi et al., 2002). Fibrin has also been 
investigated as a possible scaffold for valvular tissue engineering (Flanagan 
et al., 2007; Jockenhoevel, 2001). Fibrin based tissue engineered heart 
valves were fabricated using moulds which were seeded with ovine carotid 
artery derived cells and conditioned in a bioreactor system for 12 days. 
Results showed increased cell attachment and cell alignment alongside 
deposition of extracellular matrix (ECM) proteins including collagens type I 
and III, fibronectin and laminin compared to controls (Flanagan et al., 2007). 
An alternative fabrication approach is layer by layer 3D bioprinting. Using 
this method Duan et al. (2013) printed alginate and gelatin hydrogel valves 
incorporating sinus smooth muscle cells (SMCs) and aortic VICs. Cells were 
regionally constrained, the SMCs to the valve root and the VICs in valve 
leaflets which showed increased expression of α-smooth muscle actin and 
vimentin after 7 days of cell culture. Scaffolds have also been seeded with 
aortic valve interstitial, endothelial cells, endothelial progenitor cells 
(Simionescu et al., 2012) and mesenchymal stem cells (Tedder et al., 2011).  
Cells that are entrapped in gel scaffolds undergo contraction, these 
processes have been compared to the processes involved with wound 
healing when collagen gels are utilised (Tamariz & Grinnell, 2002) and 
promote uniform cell distribution when used with fibrin gels (Jockenhoevel, 
2001). Collagen gel shrinkage can be advantageous in enhancing properties 
of the construct (Tranquillo et al., 1992) but can cause excessive shrinkage 
of the scaffold (Jockenhoevel, 2001). Cells entrapped in collagen can also 
promptly enter apoptosis, causing the synthesis of matrix metalloproteinases 
which degrade scaffold proteins (Grinnell, 2003).  
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1.6.4 Biological scaffolds in cardiovascular tissue engineering 
The native ECM comprises of structural and functional proteins, 
glycoproteins and proteoglycans. Utilising the native ECM of the tissue that 
needs to be replaced or repaired offers many advantages such as retaining 
the components of the ECM. The ECM of each tissue is organised in a 
specific three-dimensional ultrastructure depending upon the function of the 
tissue in question. The ECM of each tissue provides attachment sites for cell 
surface receptors and growth factors which in turn influence processes such 
as cell migration, cell function and angiogenesis. The ECM also possesses 
the correct mechanical and structural properties for the function it plays in 
the body. This makes the natural ECM of a tissue a suitable material for 
tissue repair and replacement (Badylak, 2002). 
The complexity of the mitral valve poses enormous challenges for tissue 
engineering to produce scaffolds that recapitulate the complex structure and 
function. The leaflets are of different sizes, chordae are numerous and have 
different mechanical characteristics (Ritchie et al. 2005). In addition, in a 
successful tissue engineering approach, the ECM composition and different 
phenotypes of the valvular cells would need to be reproduced. As a result of 
these difficulties, research has mainly focused on engineering individual 
mitral valve components. The major limitation of the current valve repair and 
replacement strategies is the inability for growth, repair and remodelling of 
the valve (Sacks et al., 2009). Current strategies for tissue engineered 
solutions for the mitral valve have centred on the tissue engineering of 
chordae and mitral valve leaflets but more recently the whole mitral valve 
complex (Iablonskii et al., 2015). 
1.6.4.1 Decellularised biological scaffolds  
Morticelli et al., (2013) developed a decellularised porcine pericardium for 
repair of the mitral valve leaflets and found that the decellularised porcine 
pericardium could be a suitable option for the regeneration of the mitral 
leaflets. A recent approach has been the decellularisation of the whole mitral 
valve complex in sheep including the leaflet, chordae and papillary muscles 
(Iablonskii et al., 2015). Acellular valves were reseeded with ovine 
endothelial progenitor cells in-vitro, preliminary studies showed that the 
leaflets were repopulated by endothelial cells and retained comparable 
mechanical properties to native tissue. 
Whilst the development of tissue engineered mitral valves has been isolated 
mainly to preliminary studies of chordae, pericardium and the whole mitral 
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valve, acellular allogeneic and xenogeneic aortic and pulmonary valves have 
been implanted in humans. Acellular pulmonary valve allografts have been 
used to reconstruct the right ventricular outflow tract during the Ross 
procedure, with favourable results with the SynerGraft valve developed by 
CryoLife Inc (Goldstein et al., 2000) in the short to medium term (Hawkins et 
al., 2003; Bechtel et al., 2005; Tavakkol et al., 2005; Konuma et al., 2009; 
Brown et al., 2010b; Burch et al., 2010; Ruzmetov et al., 2012) and with 
valves decellularised using a process developed at the University of Leeds 
(Booth et al., 2002; Korossis et al., 2002) with excellent short to medium  
term performance (da Costa et al., 2009). Decellularised CryoLife 
SynerGraft aortic valve allografts have also been implanted in humans which 
have shown good short term results (Zehr et al., 2005). Acellular aortic valve 
allografts decellularised using the process developed at Leeds have shown  
good early and midterm results with valves maintaining structural integrity, a 
low rate of calcification, and acceptable haemodynamics (da Costa et al., 
2010).  
Tissue engineered valve xenografts have also been implanted into humans 
but have shown variable regenerative capabilities. Studies using the 
SynerGraft decellularisation process (Goldstein et al., 2000) on unseeded 
porcine pulmonary valves that were implanted into children failed 
catastrophically due to severe inflammatory reaction. Analysis of the 
explanted valves revealed whole cells, DNA and the α-gal epitope present in 
the walls of the explanted valves caused by the incomplete decellularisation 
of the valves before implantation (Simon et al., 2003). Matrix P acellular 
porcine pulmonary valves developed by AutoTissue (GmbH, Berlin, 
Germany) have shown good short term performance (Erdbrügger et al., 
2006; Konertz et al., 2005) and comparable results between CryoLife 
allografts in medium term studies (Erdbrügger et al., 2006). Matrix P 
acellular pulmonary valves seeded with autologous endothelial cells have 
also demonstrated good performance long term (Dohmen et al., 2011). 
There have however, also been reports of destruction of the pulmonary 
xenograft (Hiemann et al., 2010) and poor results with the Matrix P Plus, a 
composite pulmonary valve of a glutaraldehyde fixed equine pericardial 
patch and the Matrix P porcine pulmonary valve (Cicha et al., 2011). In this 
analysis Matrix P control valves showed signs of incomplete decellularisation 
and a foreign body reaction to implanted valves at the luminal surface of the 
acellular porcine tissue. There have been no studies of acellular aortic 
valves xenografts in humans. Using the methods developed for the 
pulmonary valves at the University of Leeds it was found that acellular 
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porcine aortic valves implanted into sheep showed signs of cellular 
repopulation (Paniagua Gutierrez et al., 2015). Histological analysis of the 
explants displayed evidence that macrophages play an important role in the 
regeneration response. Calcification was present in some of the explanted 
valves which suggested incomplete DNA removal during the 
decellularisation process before implantation of the valves.  
1.7 Decellularisation 
Decellularisation is a technique in which host cells, cell fragments and 
antigens of a tissue are removed via chemical or mechanical processes. The 
presence of these components is largely responsible for the immunogenic 
response when donor human (allogeneic) or xenogeneic tissue used as a 
graft. The matrix of the tissue is preserved during decellularisation but 
damage to the structure may occur, changes to the biomechanics, GAG and 
collagen composition have all been reported (Booth et al., 2002; Cartmell & 
Dunn, 2000; Korossis et al., 2005; Schenke-Layland et al., 2003; Woods & 
Gratzer, 2005; Gilbert et al., 2006). It is important to retain the ECM during 
the decellularisation procedure as it has been shown to effect cell 
mitogenesis and chemotaxis (Bornstein & Sage, 2002; Vorotnikova et al., 
2010), influence cell differentiation (Allen et al., 2010; Barkan et al., 2010; 
Cortiella et al., 2010) and the tissue remodeling process (Parekh et al., 
2009; Valentin et al., 2010; Xu et al., 2010). Studies that have looked at how 
the GAG content of tissue has been altered by the cell removal procedure 
have found that the majority of detergents remove at least some of the 
GAGs from the extracellular matrix which can impact the viscoelasticity of 
the scaffold (Lovekamp et al., 2006; Mendoza-Novelo et al., 2011).  
Implanting a decellularised scaffold permits the body’s own cells to integrate 
into the scaffold and remodel it in response to the environment it has been 
placed in. The decellularisation process has to be designed so that the 
underlying biomechanical and biochemical architecture of the tissue is not 
damaged so that it changes the nature of the tissue it has been derived from 
(Crapo et al., 2011). Methods have been developed to decellularise a 
diverse spectrum of tissues. These include using hypotonic or hypertonic 
buffers (Wilson et al., 1995; Bader et al., 2000; Steinhoff et al., 2000), 
detergents to extract the cells (Bader et al., 1998; Booth et al., 2002; Wilson 
et al., 1995), enzymes for digestion (Gilbert et al., 2006), photo-oxidation 
(von Rechenberg et al., 2003) and freeze drying to puncture cell membranes 
and create cavities for repopulation of native cells (Curtil et al., 1997).  
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Studies have established that some growth factors retain bioactivity in 
biological scaffolds after terminal sterilization and long term storage 
(McDevitt et al., 2003). Decellularisation retains most of the components of 
the native extracellular matrix which should match or be similar to the tissue 
it is replacing. This offers considerable advantages over other methods of 
tissue engineering scaffold fabrication, such as those that use only individual 
components of the ECM (Brown et al., 2010a). 
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Rationale for the project  
An acellular biological annuloplasty ring could offer improved outcomes 
compared to current annuloplasty rings. The acellular ring could integrate 
with the patient’s valve and remodel with it over time. This remodelling 
process would ensure that the ring would closely match the dynamics of the 
valve during the cardiac cycle whilst reducing the size of the annular area. 
The reduction in annular area would increase leaflet coaptation and 
decrease mitral regurgitation as with current strategies but the integration 
has the potential to offer improved annular dynamics and offer improved 
repair options in children.   
Human mitral valve annuli will be investigated as a starting material for 
decellularisation because they retain the properties of the native annulus, 
including geometry and extracellular matrix components. Porcine tissue will 
also be investigated because of its comparable macroscale characteristics to 
native human annulus and increased availability compared to the human 
tissue. 
Methods developed at the University of Leeds will be applied and adapted 
for the annuloplasty ring. The tissue will be decellularised by modifying 
existing protocols and assessing the acellular scaffold for suitability to be 
used as an annuloplasty ring. The decellularisation methods developed at 
the University of Leeds have delivered excellent results in aortic and 
pulmonary valves and will provide a suitable starting point for developing an 
acellular biological annuloplasty ring. 
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Specification for a proof of concept decellularised annuloplasty ring 
 
 Diameter for the ring within the same range as a traditional 
annuloplasty ring (24 mm to 40 mm) 
 Mechanical characteristics should closely match those of the native 
region of the mitral valve annulus to preserve the dynamics of the 
valve 
 Biological characteristics should closely match the native region of the 
mitral valve annulus to enhance cell adhesion and integration 
 Tissue needs to be readily available  
 Tissue should be easy to handle for repair purposes 
 Tissue should be void of cells to prevent an immune response and 
permit call adhesion and integration 
 Tissue should perform as well as synthetic annuloplasty rings during 
functional testing 
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1.8 Aims and objectives 
It is hypothesised that an acellular biological annuloplasty ring will improve 
valve function, annular dynamics and grow with the mitral valve when 
compared to current annuloplasty rings on the market. The aim of this 
project is to develop a process for the decellularisation of a natural mitral 
valve annulus, characterise the tissue and undertake preliminary studies of 
functional performance in an in-vitro model. The objectives of the study are 
to: 
 
 Determine the biological characteristics of the native human annulus 
using histological and immunohistological analysis. 
 Determine the biological properties of the porcine mitral valve annulus 
and compare them to the human annulus using histological and 
immunohistological analysis. 
 Determine the biomechanical properties of the porcine mitral valve 
annulus. 
 Develop decellularisation protocols for the tissue most suitable for 
mitral valve repair based on existing protocols. 
 Evaluate the effects of decellularisation on the tissue through 
assessment of the histoarchitecture, total DNA content, the retention 
of selected ECM proteins and the mechanical properties of the tissue 
by comparison with native tissue.  
 Determine the in-vitro biocompatibility of the decellularised tissue.  
 Investigate appropriate in-vitro mitral valve regurgitation models for 
annuloplasty repair using static regurgitation testing. 
 Functionally test the decellularised tissue using static regurgitation 
testing and by comparison to synthetic annuloplasty rings. 
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Chapter 2 
Materials and Methods 
This chapter describes the general methods used in the histological, 
immunohistochemical and biomechanical analysis of the native and 
decellularised porcine mitral valve annulus and the native human mitral 
valve annulus. The cell culture techniques used for biocompatibility assays 
are also described. 
2.1 Materials 
2.1.1 Equipment 
Equipment used in this research is listed in Table 2.1 along with the 
suppliers and product code where applicable.  
Table 2.1 – Equipment used during the research 
Equipment Supplier Product code 
150 ml sterile 
containers 
Scientific Laboratory Supplies 
(SLS) 
CON7580 
250 ml sterile 
containers 
SLS CON7570 
500 N static load cell Instron  2580-105 
Autoclave KUHN Rikon 5 L pressure 
cooker 
Automatic pipettes Gilson Various 
Balance Jencons PLC AND GR-200 
Biopsy punch (5mm) World Precision Instruments, inc. 504532 
Cell^B Olympus UK Cell^B 
Class II safety 
cabinet 
Kendro Heraeus H518 
Custom made tissue 
cutter 
Bioengineering labs, mechanical 
engineering, University of Leeds 
  
Stone personal Stone Eco saver 80+, 
- 50 - 
 
computer Windows 7 
Digital Camera Olympus XC50 
Digital callipers Mitutoyo digital callipers   
Dissection Kit Thackray Instruments N/A 
Four figure balance AND GR-200-EC 
Fridge Jencons PLC Lab cold 23 
Histology moulds Raymond A Lamb E10.8/4161 
Histology Water Bath Barnstead Electrothermal MH8515 
Hot wax dispenser Raymond A Lamb E66 
Hotplate Raymond A Lamb E18/1 
Incubator Heraeus Jencons PLC 
Instron 3130-100 
BioPuls Bath 
Instron  3130-100 
Instron 3365 
materials testing 
machine 
Instron  3365 
Magnetic Stirrer Stuart Scientific CB161 
Microtome Leica RM2125 RTF 
Microtome blade Fisher Scientific SD3050835 
Orbital shaker IKA KS 130 
pH meter Jenway 3510 
Pipette boy Integra Bioscience Integra acu 
Plastic histology 
cassettes 
Thermo Fisher Scientific CMB-160-030R 
Retractors Mercian SP4003-14 
Single use filter unit Sartorius Stedim 16532 
Slide holder Raymond A Lamb E102 
Static Test Rig Bioengineering, Mechanical 
Engineering, University of Leeds 
N/A 
Table shaker IKA KS130 
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Tissue processor Leica TP1020 
Upright microscope Olympus UK Ltd. BX40 
Wax Oven Raymond A Lamb E18/31 
Zen software Zeiss Zen Blue edition 
2011 
The consumables and plastic ware used in the study are described in Table 
2.2 together with the supplier and product code/model. 
Table 2.2 – Consumables and plastic ware used during the research.  
Item Supplier Product 
code/ 
Model 
3-0 Sutures Mersilk Suture Taper 
Point  
 
Ethicon W583 
Bijous SLS select SLS7522 
Biopsy punch WPI 5.0 mm 
W/Plunge 
World Precision 
Instruments 
504532 
Cable tie (190 x 4.8 mm) RS 178-484 
Carpentier-Edwards Classic. 
Annuloplasty ring with Duraflo 
Treatment - Mitral 
Baxter  4425M30 
Cell culture flasks Thermo Scientific 75cm 
Thermo Scientific 175cm 
156699 
159910 
Eppendorf  Starlab E1420-
2000 
Filter paper Whatman International Ltd  Whatman 
Grades 1-5 
G-clamp Olympic 100 mm 
Glass cover slips SLS MIC3228 
Heart holder Genzyme 80 77/78 
Histology cassettes Simport Histosette, 
with lid 
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M490-2  
ImmEdge Hydrophobic Barrier 
Pen 
Vector Laboratories H-000 
Medium temperature cauterisers FIAB F7288 
thick tip 
Measuring cylinders Fisher Scientific   
Microtome blades Fisher Scientific SD3050835  
Optiplate 96 PerkinElmer  6005290 
'O' ring 40mm RS 128-978 
PEN-Membrane 1mm glass PALM Membrane slides 1440-1000 
Parafilm M Sigma-Aldrich Ltd    
Pipette tips Starlab   
Plastic container Otto Burkle 
D7850 
Plastic syringe 1ml Terumo  GS572 
Pots Bibby Sterillin   
Retractors Mercian SP400 3-
14 
Spigot (15mm diameter x 55 mm 
length) 
Bioengineering laboratory, 
University of Leeds 
 
Static test rig (120 mmHg max 
column pressure) 
Bioengineering laboratory, 
University of Leeds 
 
Superfrost glass slides SLS MIC3040 
Superfrost plus glass slides SLS MIC3022 
Surgical Marker Pen Universal Hospital 
Supplies  
MAR001T 
Stop watch (calibrated) RS 278-682 
Syringe needles 19G Terumo NN-19382 
Test rig clamp 
 
Bioengineering laboratory, 
University of Leeds 
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Test tubes Bibby Sterillin   
Universals SLS SLS7500 
Well plates  
6 well plate 
96 well plate 
Thermo Scientific  
140675 
167008 
 
2.1.2 Chemicals and reagents 
The chemicals and reagents used in the study are described in Table 2.3 
alongside the supplier and product code.  
Table 2.3 – The chemicals and reagents used during this study. 
Chemical/Reagent Supplier Product 
code 
Αlpha -galactosidase  Sigma-Aldrich G8507 
Aprotonin (10000 KIU.ml-1) Mayfair house AP012 
Acetone European Bios LS8/1970/
G 
Alcian blue Atom scientific RRSP4-E 
Ammonium formate Sigma-Aldrich 15-626-4 
Antigen unmasking solution, Citrate 
based 
Vector Laboratories H-3300 
Biotinylated GSL I – isolectin B4
 Vector Laboratories B-1205 
Bovine serum albumin Sigma-Aldrich 85041C 
Benzonase (nuclease) Millipore 70746 
Calcium acetate Thermo Fisher 
Scientific Ltd 
C/0920/50 
CarboFree Blocking Solution 10x 
concentrate 
Vector Laboratories SP-5040 
Cyanoacrylate Henkel 1575596 
Disodium ethylenediaminetetraacetic  
acid (EDTA) 
Thermo Fisher 
Scientific Ltd. 
E/P140/53 
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DNase Sigma-Aldrich DN25-1 
DPBS Lonza BE17-513F 
DPX mountant Thermo Fisher 
Scientific 
M81330/C 
Dulbecco’s PBS tablets Oxoid BR0014 
Envision+ Dual Link System-HRP 
(DAB+) 
Dako K4065 
Eosin VWR International 1.09844.10
00 
Ethanol Thermo Fisher 
Scientific Ltd 
E/0555DF/
25 
Foetal bovine serum (FBS) Lonza DE14-870F 
Galactose (360 mg) Vector Laboratories S-9003 
Gentamycin Sigma-Aldrich G1397 
Gills number 3 haematoxylin Sigma GH5316 
Haematoxylin Thermo Fisher 
Scientific 
PS50/C 
Hanks Balanced Salts Solution 
(HBSS) 
Sigma H9269 
Histo-clear III National diagnostics HS-204 
HEPES 1M Sigma-Aldrich H4034 
HEPES buffer 1M in 0.85% (w/v) NaCl Lonza BE 17-
737E 
Hydrochloric acid (6M) VWR International 2611.5 
Hydrochloric acid (specific gravity 
1.18) 
Thermo Fisher 
Scientific Ltd. 
H1200/PB1
7 
Hydrogen peroxide (30 %; v/v) Sigma-Aldrich H1009 
ImmEdge Hydrophobic Barrier Pen Vector Laboratories H-4000 
ImmPACT DAB Peroxidase (HRP) 
Substrate kit 
Vector Laboratories SK-4105 
Low melting point Agarose 15517-014 Invitrogen 
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Magnesium chloride hexahydrate MP 195304-
1000G 
Mayer's Haematoxylin (Mayer's 
Haemalum) 
RRSP60 Atom 
Scientific 
Methanol 428 Vickers 
Laboratorie
s 
Methylated spirits Biostain Ready 
Reagents 
GPS1000-
K 
Miller’s Stain Raymond A Lamb LAMB/080-
D 
Oxalic acid VWR International 1E+06 
Paraffin wax Thermo Fisher 
Scientific Ltd 
PS138/E 
Penicillin/streptomycin solution 5000 
U.ml-1 
Lonza DE17-603E 
Peracetic acid (32 wt. % solution) Sigma-Aldrich 26933-6 
Periodic Acid-Shiff (PAS kit): 
Aqueous periodic acid solution 0.1% 
Shiff’s reagent 
Hematoxylin solution 
Sigma 395B-1KT 
Picric acid Sigma-Aldrich 36011 
Potassium permanganate Thermo Fisher 
Scientific Ltd 
P/6520/53 
Proteinase K Dako S302080 
RNase Sigma-Aldrich 123879 
Saline (0.9%) Fresanius Kabi 31-58-736 
Scott’s tap water Thermo Fisher 
Scientific Ltd 
PS138/E 
Silver nitrate AnalaR 1023335 
Sirius red VWR International F3B 
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Sodium azide 1 % (w/v) solution G Biosciences  786-299  
Sodium chloride Thermo Fisher 
Scientific Ltd 
 42429-
5000  
Sodium dodecyl sulphate (SDS) Sigma-Aldrich 71725-
100G 
Sodium hydroxide Thermo Fisher 
Scientific Ltd 
S/4920/53 
Sodium thiosulphate AnalaR 10268 
Streptavidin/Biotin blocking kit Vector Laboratories SP-200 
Streptavidin, Horseradish Peroxidase, 
R.T.U 
Vector Laboratories SA-5704 
pH standards (4,7,10) 
pH 4  
 
pH 7 
 
pH 10 
SLS  
pH4-
PHB1310 
pH7-
PHB1312 
pH10-
PHB1314 
Trizma base Sigma-Aldrich  T-1503  
Trypsin Sigma-Aldrich T-7409 
Trypsin inhibitor Sigma-Aldrich T-9128 
Tween 20 Sigma-Aldrich  P1379  
Ultra Vision One Large Volume 
Detection System, DAB plus 
substrate System: 
DAB Plus substrate 
DAB Plus Chromagen 
Thermo Scientific TA-125-
HDX 
TA-125-
HSX 
TA-004-
HCX 
Ultra Vision One detection system: 
HRP polymer 
DAB Plus substrate 
Thermo Scientific  
TL-125-
HLJ 
TA-125-
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HDX 
Weigerts haematoxylin 
Solution A 
Solution B 
Atom Scientific  
RRSP72-D 
RRSP73-D 
Zinc acetate Sigma-Aldrich 383317 
Zinc chloride Fluka 96470 
 
2.1.3 General stock solutions 
2.1.3.1 Phosphate buffered saline (PBS) 
Ten Oxoid Dulbecco PBS tablets were dissolved in 1 L of distilled water and 
the pH adjusted to 7.2 – 7.4. Solutions were placed in an autoclave for 20 
minutes at 121 oC at a pressure of 103 kPa. Items were stored for up to one 
month at room temperature. 
2.1.3.2 Tris buffered saline (TBS) 
Tris solution (25 ml; 2 M) was added to 50 ml 3 M sodium chloride solution, 
925 ml of distilled water was added to the solution and the pH adjusted to 
7.6. Solutions were placed in an autoclave for 20 minutes at 121 oC at a 
pressure of 103 kPa. Items were stored for up to one month at room 
temperature. 
2.1.3.3 TBS containing 0.05% (w/v) Tween 20 
Tween 20 (500 µl) was mixed with 1000 ml of autoclaved TBS and adjusted 
to a pH of 7.6. Solutions were used on the day. 
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2.1.4 Cells 
The cell lines used in this study and suppliers are listed in Table 2.4 
Table 2.4 – Cell lines used in this study. 
Cells Type Species Supplier 
BHK Fibroblast Hamster Health Protection 
Agency 
L929 Fibroblast Murine European 
Collection of 
Animal Cell 
Culture 
 
2.1.5 Glassware 
Glassware was cleaned with 1 % (v/v) solution of phosphate-free detergent 
(Neutracon, Decon Laboratories Ltd) for 1 hour. Glassware was then rinsed 
with tap water followed by three rinses with distilled water. Items were then 
left to dry and sterilised at 180 oC for 4 hours by dry heat. 
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2.2 Methods 
2.2.1 General methods 
2.2.1.1 Measurement of pH 
A Jenway 3020 pH meter was use for carrying out pH measurement. The 
meter was calibrated by using solutions with a pH of 4, 7 and 10. 
Temperature compensation was included in the measurement of solutions. 1 
M or 6 M hydrochloric acid or sodium hydroxide were added drop-wise with 
stirring to solutions that required their pH adjusted.  
2.2.1.2 Microscopic analysis 
The histology slides were viewed using bright field microscopy using an 
Olympus BX51 microscope. The images were captured using an Evolution 
MP Colour digital camera attached to the microscope and then viewed and 
manipulated with the Olympus Cell^B or Zeiss Zen software. Polarised light 
microscopy involved the use of a polariser and analyser, incorporated in the 
same system. Fluorescence microscopy included the use of the fluorescent 
vertical illuminator (BX51-RFA) and selection of the correct filters. An 
inverted microscope (Olympus IX71) was used for viewing cells by using 
phase contrast microscopy and images were captured using Cell^B software 
via the attached camera.  
 
2.2.1.3 Sterilisation  
Three procedures were used depending upon suitability. 
 Dry heat sterilisation - Suitable items were placed in a hot air oven for 
4 hours at 180 oC. 
 Moist heat sterilisation - Items not suited for dry heat sterilisation were 
placed in an autoclave for 20 minutes at 121 oC at a pressure of 103 
kPa. 
 Filter sterilisation - Solutions not suited for previous methods were 
filtered using 0.2 µm pore sized filters and a disposable syringe inside 
a class II safety cabinet.  
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2.2.2 Tissue processing 
2.2.2.1 Dissection equipment 
Equipment used for dissection are listed in Table 2.5. 
Table 2.5 – Equipment used for dissection. 
Equipment Supplier Model 
Forceps, straight fine 
point 
- - 
Scalpel handle Swann-Morton 8112 Size 4 
Scissors, straight with 
fine point 
Scissors, curved with a 
fine point 
- 
 
- 
- 
 
- 
Tissue clamps Thackray Medical 
GU London 
50-2650 
GU-3800 
 
2.2.2.2 Ethics and tissue tracking 
 
The human mitral annulus tissue was used for research under research 
ethics approval. The REC reference for the research was 13/NW/0147 and 
the committee used for obtaining approval was Lancaster. The planned start 
date of the study using the tissue was 01/01/2013 and the end date of the 
study was 31/12/2016, the approval of using human hearts for research of 
the mitral valve annulus in this study was granted on 14/02/2013. All human 
tissue used for this study was provided by NHS Blood and Transplant, 
Tissue Services based in Liverpool. Human tissue used in the study was 
tracked using the Achiever system which logged all of the locations of the 
tissue used throughout the study. Tissue was disposed of using the 
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University of Leeds guidelines for human tissue disposal and recorded via 
Achiever. 
 
2.2.2.3 Dissection 
Porcine and human mitral annuli were removed using similar methods. The 
native porcine mitral valves were dissected from porcine hearts of Large 
White pigs, supplied by local abattoirs and taken from animals approximately 
24-26 weeks old and slaughtered within 24 hours. The native human mitral 
valves were dissected from hearts of cadavers aged between 57 and 84 
which had been stored at -20 oC and warmed to room temperature using a 
water bath set at 37 oC. The pulmonary trunk, superior vena cava and the 
aortic arch were removed, if required, being careful not to damage the aortic 
valve. Any other excess tissue such as the pericardium was removed. An 
incision was made approximately half of the way up from the bottom of the 
apex of the heart (Fig 2.1a; a). The heart was cut at this point around the 
circumference to remove the apex (Fig 2.1a; b). The left and right ventricles 
of the heart were identified from the anterior inter-ventricular artery which 
runs down the septum of the heart. Once identified, an incision was made 
near to the base of the heart which followed the anterior inter-ventricular 
artery towards the pulmonary trunk, being careful to cut towards the side of 
the right ventricle to avoid the mitral valve, situated between the left ventricle 
and left atrium (Fig 2.1a; c). The posterior descending inter-ventricular artery 
was identified on the posterior side of the heart and an incision was made 
close to the base up towards the right atrium where the right hand side of the 
heart was removed, being careful not to remove the aortic valve (Fig 2.1a; 
d). The left auricle of the mitral valve was removed (Fig 2.1a; e) to reveal the 
top of the mitral valve (Fig 2.1a; f). Viewing the mitral valve from the base, 
an incision was made at the point just above where the papillary muscles 
and chordae combine (Fig 2.1a; g), the incision was carried out around the 
circumference of the heart (Fig 2.1a; h). The aorta was removed up to the 
aortic-mitral valve continuum and a cut made through the septum separating 
the left and right ventricles (Fig 2.1b; i). Incremental steps of muscle removal 
were then made on the ventricular side of the mitral valve (Fig 2.1b; j) and 
the atrial side of the mitral valve (Fig 2.1b; k). The mitral leaflets were 
trimmed until they were just large enough to be identified for histology 
purposes (Fig 2.1b; l). Approximately 5 mm of muscle was retained at the 
junction between the mitral valve leaflets and the heart muscle (Fig 2.1b; j). 
Small incremental incisions were made to remove parts of the atrium until 5 
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mm of tissue was left between the atrium and junction of the mitral leaflets 
(Fig 2.1b; m). The remaining tissue was stored in PBS at room temperature 
and processed as described in the various methods. 
a) b) 
c) d) 
e) f) 
g) h) 
Fig 2.1a – Dissection of porcine and human mitral valve annulus. 
Images of the porcine dissection. Cutting the apex (a, b), removal of 
the right side of the heart (c, d), removal of left auricle (e, f), cutting 
chordae and papillary muscles (g, h). 
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i) j) 
k) l) 
m)  
Fig 2.1b – Dissection of porcine and human mitral valve annulus. Images of 
the porcine dissection. Splitting the aorta (i), removal of the 
myocardium from the left ventricle (j), steps of incremental muscle 
removal (k), cutting the anterior and posterior leaflets up to the annulus 
(l), atrial side of the annulus (m). 
 
2.2.3 Histological techniques 
2.2.3.1 Fixation 
Zinc fixation was utilised as a replacement to neutral buffered formalin 
(NBF). NBF can mask antigens on the surface of tissue which may affect the 
immunohistochemical characterisation of the mitral valve annuli. Zinc fixative 
offers improved antigen survival whilst maintaining the underlying 
morphological structure that is associated with the use of formalin 
(Beckstead, 1994). Zinc has also been used with formaldehyde based 
fixatives to improve morphology (Jensen et al., 2010). Additional advantages 
are that it is non-hazardous, cheap and quick to prepare. Little has been 
- 64 - 
 
reported about the exact mode of operation for zinc, it is thought that the 
acetate may destabilise protein structures (Jensen et al., 2010) whilst the 
zinc ions help stabilise the tertiary structures of proteins when exposed to 
chaotropic agents, such as acetate (Selevsek et al., 2009). It has been 
suggested these work in tandem to cause mild denaturation of proteins 
which may harden them into a more rigid configuration so that they can be 
used as a fixative (Jensen et al., 2010).  
Reagents: 
 Zinc fixative solution 
Calcium acetate (0.5 g) was dissolved in 1000 ml of 0.1 M tris solution 
and adjusted to a pH of 7.0 – 7.4. Zinc acetate (5.0 g) was dissolved into 
the solution using a magnetic stirrer followed by 5.0 g of zinc chloride and 
stirred using a magnetic stirrer until dissolved.    
Method  
Each sample of the mitral valve annulus was cut vertically along its long axis 
and split into regions in order to facilitate placement in histocassettes. The 
annulus was split into suitable regions by using visible anatomical markers 
visible. The main markers were the left coronary sinus and non-coronary 
sinus for the anterior section, the commissures separating the anterior and 
posterior leaflets and the medial, middle and lateral scallops for the posterior 
section.  
  
- 65 - 
 
 
 
Fig 2.2 – Top view of mitral valve. All sections were cut along the long 
axis. S1 was cut vertically between the left trigone and the left 
commissure. S2 was between the left commissure and part of P1 
scallop. S3 was half of the P1 scallop and part of the P2 scallop. S4 
was half of the P2 scallop. S5 was half of the S5 scallop. S6 was part of 
the P2 and P3 scallop. S7 was part of the P3 scallop to the right 
commissure. S8, S9, S10 and S11 were part of the anterior mitral 
valve; S8 was from the right commissure to the right trigone, S9 was 
cut from the right trigone to half of the posterior leaflet of the aortic 
valve, S10 was cut from the second half of the posterior leaflet to half of 
the left leaflet of the aortic valve. S11 was the region of half of the left 
leaflet up to the left trigone.A1, A2, A3 are the anterior leaflet cleft. P1, 
P2 and P3 are the posterior leaflets clefts.  
 
The plane of sectioning throughout was through the long axis. Samples were 
cut vertically and separated into 11 regions using anatomical markers as 
shown in Fig 2.2. Region S1 was the section between the left trigone and the 
left commissure. Region S2 encompassed the left commissure and part of 
the posterior leaflet (P1) scallop. Region S3 comprised of half of the P1 
scallop and part of the P2 scallop. Region S4 comprised of half of the P2 
scallop. Region S5 comprised of the second half of the S5 scallop, section 
S6 traversed part of the P2 and part of the P3 scallop. Region S7 comprised 
of part of the P3 scallop up to the right commissure. Regions S8, S9, S10 
and S11 encompassed the aortic valve and were split into five regions; S8 
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comprised of the region from the right commissure to the right trigone, S9 
encompassed the right trigone up to the first half of the posterior leaflet of 
the aortic valve, S10 comprised of the second half of the posterior leaflet and 
first half of the left leaflet of the aortic valve and finally, S11 was the region of 
the second half of the left leaflet up to the left trigone. Once cut into sections 
the samples were placed into histocassettes ready for processing. The 
vertical sections were placed into the cassettes and orientated so the cross 
sections would face the microtome blade.  The cassettes containing the 
tissue samples were left for 24 hours in the zinc fixative which fixed the 
tissue for embedding. 
 
2.2.3.2 Paraffin wax embedding 
Following fixation the tissue samples were placed into a Leica Microsystems 
tissue processor. The processor was set to program three which processed 
the tissue as shown in Table 2.6. 
Table 2.6 – Tissue processor station solutions and durations.  
Station number Solution Time 
1 70 % (v/v) ethanol 1 h 
2 90 % (v/v) ethanol 1 h 
3 100 % (v/v) ethanol 1 h 
4 100 % (v/v) ethanol 1 h 
5 100 % (v/v) ethanol 1 h 
6 Xylene 1 h 
7 Xylene 1 h 
8 Xylene 1 h 
9 Paraffin Wax 1 h 
10 Paraffin Wax 1 h 
11 Paraffin Wax 1 h 
Samples were taken from the tissue processor, removed from the cassettes 
and placed into wax block moulds and covered with molten wax. The tops of 
the cassettes were placed on top of the wax moulds and then left to cool 
until set. When set, the blocks were removed from the moulds and any 
excess wax trimmed off. 
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2.2.3.3 Tissue sectioning 
The tissue was sectioned using a Leica microtome. Sections were cut at a 
thickness of 6 µm at a microtome blade angle of 5°. The sections were 
placed onto a water bath set at 45°C and collected onto glass superfrost or 
superfrost plus slides. The slides were left to dry on a hot plate at a 
temperature of 45°C for four hours. 
2.2.3.4 Dewaxing and rehydration 
The slides were placed into a slide holder and immersed into histoclear for 
ten minutes and then a second pot of histoclear for a further ten minutes. 
The slides were then placed into three consecutive pots of ethanol (100% 
v/v) for dehydration for three minutes, two minutes and a further two 
minutes.  The slides were transferred to another pot of ethanol (70% v/v) for 
a further two minutes and then rinsed under running tap water for three 
minutes for rehydration of the sections. 
2.2.3.5 Dehydration and mounting 
Sections were dehydrated by placing the slides into ethanol (70% v/v) for 
five seconds, moving the slides into three consecutive pots of ethanol (100% 
v/v) for one minute, two minutes and finally three minutes. The slides were 
removed from the ethanol and placed into histoclear for ten minutes and a 
second pot of histoclear for a further ten minutes. A disposable pipette was 
used to drop DPX on each of the tissue sections which were then covered 
with cover slips, removing any air bubbles with stainless steel forceps. The 
slides were left to dry for 4 hours in a fume hood. 
 
2.2.4 Histological staining methods 
2.2.4.1 Haematoxylin and Eosin staining 
Haematoxylin was used to stain nuclei and eosin was used to stain for the 
tissue architecture. After the dewaxing process (Section 2.2.3.4) the slides 
were placed into haematoxylin for one minute and then rinsed with running 
tap water until the water ran clear. The sections were then immersed into an 
eosin counter stain for three minutes. This was followed by dehydration and 
mounting (Section 2.2.3.5). Sections were viewed under the microscope 
using Koehler illumination. Distances were measured using ImageJ software 
(National Institute of Health, USA). 
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2.2.4.2 Sirius red Miller’s staining 
Sirius red Miller’s staining was used to visualise collagen and elastin.  
Reagents: 
 5 % (w/v) potassium permanganate. 
Potassium permanganate (15 g) was added to 300 ml of distilled water 
and stirred using a magnetic stirrer until dissolved 
 
 1 % (w/v) oxalic acid 
Oxalic acid (1 g) was added to 100 ml of distilled water and stirred with a 
magnetic stirrer until dissolved. 
 
 0.1 % (w/v) Sirius red 
Sirius red (0.1 g) was dissolved into 100 ml of aqueous saturated picric 
acid solution and magnetically stirred. 
Sirius red stains collagen fibres and the Miller's stains elastin fibres blue. 
Following dewaxing and rehydration (Section 2.2.3.4) the slides were rinsed 
under running tap water for three minutes and immersed in potassium 
permanganate (5 % (w/v)) for five minutes and rinsed using distilled water. 
The slides were then placed into oxalic acid (1 % (w/v)) for two minutes and 
rinsed twice using distilled water for one minute and then a further four 
minutes. Each slide was placed into ethanol (70 % (v/v)) for one minute and 
then into ethanol (95 % (v/v)) for a further minute. The slides were placed 
into Miller’s stain and left for one hour and then rinsed using 70 % (v/v) 
ethanol until the ethanol ran clear. The slides were placed into ethanol (95 % 
(v/v)) for a further one minute and then rinsed using tap water for two 
minutes. The slides were then immersed in Weigerts haematoxylin for ten 
minutes and rinsed using tap water for one minute and then a further 30 
seconds using distilled water. The final stain of picro sirius red was applied 
for one hour and the slides were then rinsed using distilled water and blotted 
dry before being dehydrated and mounted (Section 2.2.3.5). Sections were 
viewed using polarised light microscopy. 
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2.2.4.3 Alcian Blue staining 
This staining procedure was used to visualise glycosaminoglycan 
localisation. Periodic acid and Schiff's reagent were used as a counter stain 
to visualise other structures, Gills number 3 haematoxylin was used to stain 
the nuclei. After the dewaxing process (Section 2.2.3.4) the slides were 
placed into Alcian blue (1% v/v) for 15 minutes, immersed in running tap 
water for one minute and then rinsed with distilled water. The slides were 
then placed into periodic acid for five minutes and rinsed with distilled water 
three times. The next step involved placing the slides into Schiff`s reagent 
for 15 minutes and then rinsing the slides with running tap water for five 
minutes. The slides were placed into haematoxylin for 90 seconds before 
being dehydrated and mounted (Section 2.2.3.5). Sections were viewed 
under the microscope using Koehler illumination. 
2.2.4.4 DAPI staining of paraffin wax embedded tissue samples 
DAPI staining enables visualisation of double stranded DNA and cell nuclei if 
present within paraffin embedded tissue sections on glass slides. 
Reagents 
 Dye buffer (10 mM Tris, 1 mM NA2EDTA, 1 mM NaCl) 
Trizma base (1.211g) was dissolved into 1L of distilled water along with 
0.3724 g disodium ethylenediaminetetraacetic acid and 0.058 g sodium 
chloride and autoclaved at 121 oC, 15 psi for 20 minutes. 
 
 DAPI dye solution (1 mg.ml-1) 
Nuclease free water (10 ml) was added to 10 mg of DAPI and stored at -
25oC until required. 
 
 Working dye solution (0.1 µg.ml-1) 
 
DAPI dye solution (20 µl) was added to 200 ml of dye buffer in a dark 
bottle and mixed by inverting with the pH adjusted to 7.4 and used 
immediately.  
The slides containing sections for staining were placed into a slide holder 
and dewaxed and rehydrated (Section 2.2.3.4). The slide holder was placed 
into 200 ml of DAPI working solution in the dark and incubated at room 
temperature for ten minutes. The slides were washed using PBS in the dark 
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for ten minutes and this was repeated twice. Glass cover slips were mounted 
onto each slide using Dako fluorescence mounting medium and dried in the 
dark until set. Sections were stored in the dark at 4oC until visualised. 
Sections were viewed using an upright fluorescent microscope and a DAPI 
filter. 
2.2.4.5 Von Kossa staining 
Von Kossa staining was used to help visualize regions of calcium deposits. 
The silver ions react with phosphate or carbonate anions that are bound to 
the calcium deposits in the tissue.   
Reagents: 
 
 Silver nitrate (1 % w/v solution) 
Silver nitrate (2g) was added to 200 ml dH2O to give a 1 % (w/v) solution. 
 
 Sodium thiosulphate (2.5 % w/v solution) 
Sodium thiosulphate (5 g) was added to 200 ml dH2O to give a 2.5 % 
(w/v) solution. 
 
The slides containing sections for staining were placed into a slide holder 
and dewaxed and rehydrated (Section 2.2.3.4). The slide holder was placed 
into 200 ml of silver nitrate solution (1 %) at room temperature for 18 hours 
under a bright light (1 x 60 watt bulb). Slides were washed in sodium 
thiosulphate (2.5 %) for five minutes and rinsed in distilled water for one 
minute. Slides were counterstained with eosin for one minute before being 
dehydrated and mounted (Section 2.2.3.5). Sections were viewed under the 
microscope using Koehler illumination. 
2.2.4.6 Immunohistochemistry 
Immunohistochemistry was used to visualise specific antigens in the tissue 
sections.  
Reagents: 
 Hydrogen Peroxide solution (3 % (v/v)) 
Hydrogen peroxide (20 ml; 30 % (v/v)) was added to 180 ml PBS 
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 Antibody diluent (TBS; 0.1 % (w/v) bovine serum albumin; 0.1 % (w/v) 
sodium azide) 
Sodium azide (6 ml; 10 % (w/v)), 300 µl of 5 % (w/v) bovine serum 
albumin (BSA) and 59.1 ml Tris buffered saline were mixed together and 
the pH adjusted to 7.6. 
 
 Proteinase K (pH 7.5) 
 
Ready-to-use, diluted in 0.05 mol/L Tris-HCl, 0.015 mol.l-1 sodium azide 
 
 Tris buffer (2 M, pH 7.6) 
Trizma base (42.26 g) was added to 758 ml of distilled water 
 
 Sodium chloride solution (3 M) 
Sodium chloride (175.32 g) was added to 1 L of distilled water 
 
 Tris buffered saline (TBS) 
Tris solution (25 ml; 2 M) was added to 50 ml 3 M sodium chloride 
solution, 925 ml of distilled water was added to the solution and the pH 
adjusted to 7.6. Solutions were placed in an autoclave for 20 minutes at 
121 oC at a pressure of 103 kPa. Items were stored for up to one month 
at room temperature. 
 
 TBS containing 0.05% (w/v) Tween 20 
Tween 20 (500 µl) was mixed with 1000 ml of autoclaved TBS and 
adjusted to a pH of 7.6. Solutions were used on the day. 
 
The antibodies and isotype controls used for immunohistochemical analysis 
are listed in Table 2.7 
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Table 2.7 – Antibodies and isotype control antibodies with their 
corresponding working concentrations  
Antibody Supplier Isotype 
Working 
dilution 
Working 
concentration 
Isotype 
dilution 
Positive 
control 
tissue 
Detection 
system 
Collagen 
I 
Millipore 
(MAB339
1) 
Mouse 
IgG1 
(Dako 
X0931) 
1:100 10 mg.L-1 1:10 Porcine 
common 
carotid 
artery 
Ultra 
vision: 
human 
Envision: 
Porcine 
tissue  
Collagen 
II 
Millipore 
(MAB888
7) 
Mouse 
IgG1 
(Dako 
X0931) 
1:200 1 mg.L-1 1:100 Porcine 
articular 
cartilage 
Envision: 
all 
Collagen 
III 
Abcam 
(AB7778) 
Rabbit 
IgG 
(GeneT
ex GTX 
35035) 
1:1000 1 mg.L-1 1:1000 Porcine 
common 
carotid 
artery 
Ultra 
Vision: all 
Collagen 
IV 
Dako 
(M0785) 
Mouse 
IgG1 
(Dako 
X0931) 
1:50 1.57 mg.L-1 1:63 Porcine 
common 
carotid 
artery 
Ultra 
Vision: 
all 
Collagen 
VI 
Millipore 
(MAB330
3) 
Mouse 
IgG1 
(Dako 
X0931) 
1:800 2.5 mg.L-1 1:400 Porcine 
articular 
cartilage 
Ultra 
Vision: all 
Fibronect
-in 
Dako 
(A0245) 
Rabbit 
immuno
1:1000 4.9 mg.L-1 1:3000 Porcine 
common 
Envision: 
all 
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globu-lin 
fraction 
IgG 
(Dako 
X0936) 
carotid 
artery 
Laminin 
Sigma 
(L8271) 
Mouse 
IgG1 
(Dako 
X0931) 
1:4558 1.57 mg.L-1 1:63 Porcine 
common 
carotid 
artery 
Ultra 
Vision: all 
 
Method: 
For assessment of the expression of each antigen of interest in the mitral 
valve annulus tissue, three sections of the tissue and one section of the 
relevant control tissue were used.  The first section of the mitral valve tissue 
served as a negative control (antibody diluent). The second section of the 
mitral valve tissue served as the isotype control (isotype control antibody in 
antibody diluent). The third section of the mitral valve tissue was the test 
section which was incubated with the primary test antibody in antibody 
diluent. The appropriate section of control tissue (known to express the 
antigen of interest) was also incubated with the primary test antibody in 
antibody diluent. The antibody staining protocol used the Ultra Vision One 
detection system unless there was background staining when Envision 
Detection system was used. 
The Ultravision protocol was as follows: 
Sections were dewaxed as described in Section 2.2.3.4. After the final 
ethanol step, sections were placed under running tap water for three 
minutes. An antigen retrieval step was carried out using proteinase K, this 
was placed dropwise onto all sections and incubated at room temperature 
for 20 minutes. The sections were then circled with a hydrophobic marker 
and then placed in 3 % (v/v) hydrogen peroxide solution for ten minutes and 
washed under running tap water for three minutes. Each of the slides was 
then washed in TBS for ten minutes and the excess solution blotted. Dual 
endogenous enzyme block (25 µl) was added to each section and incubated 
for ten minutes and washed twice using TBS for ten minutes each time. The 
diluted antibody was applied to the section of interest and the positive 
controls. The isotype control antibody was added to designated sections and 
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the negative control sections received only antibody diluent.  The slides were 
then incubated in a moist atmosphere with TBS soaked tissue paper for 60 
minutes. Following this the slides were washed twice in TBS-T for ten 
minutes each time and then washed twice in TBS for ten minutes each time. 
Labelled polymer-HRP (50 µl) was applied to the sections and incubated for 
30 minutes in the dark. This was washed with TBS-T twice for ten minutes 
each time followed by two washes in TBS for ten minutes with any excess 
tapped off. Substrate chromagen (50 µl) was added to each section and 
incubated for ten minutes. Slides were then washed four times in distilled 
water. Following this step the slides were placed into heamatoxylin for ten 
seconds before being dehydrated and mounted (Section 2.2.3.5). 
 
The Envision+ protocol was as follows: 
Sections were dewaxed as described in Section 2.2.3.4. After the final 
ethanol step, sections were placed under running tap water for three 
minutes. Sections were washed with TBS on a shaker and then circled with 
a hydrophobic marker. An antigen retrieval step was carried out using 
proteinase K, this was placed dropwise onto all sections and incubated at 
room temperature for 20 minutes. Following this step sections were rinsed 
with TBS. Dual endogenous enzyme block was added to each section and 
incubated for ten minutes. Sections were then washed for five minutes in 
TBS on a shaker and repeated three times. Primary antibody (50 µl) was 
added to the section of interest and the positive controls. The isotype control 
antibody was added to designated sections and the negative control 
sections received only antibody diluent. The slides were then incubated for 
30 minutes. Sections were then washed for five minutes in TBS on a shaker 
and repeated three times. Substrate chromagen (50 µl) was added to each 
section and incubated for ten minutes. Slides were then washed four times 
in distilled water. Following this step the slides were placed into 
haematoxylin for ten seconds before being dehydrated and mounted 
(Section 2.2.3.5). 
 
2.2.4.7 Labelling the alpha-gal epitope using biotinylated GSL-1 lectin 
GSL-1 lectin binds specifically to galactosyl residues and can be used for 
labelling of α-gal epitopes in tissue sections. In the assessment of α-gal 
epitopes in tissue sections, two controls were utilized:  α galactosidase 
treated tissue sections (negative control) and galactose-blocked lectin 
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controls (negative control) to determine the specificity of the lectin binding to 
the α-gal epitope. 
Reagents: 
 
 Ammonium formate buffer (50 mM) 
Ammonium formate (315 mg) was dissolved in 50 ml distilled water using 
a magnetic stirrer and adjusted to pH 6.0 
 
 Alpha galactosidase digestion solution 
Ten units of α-galactosidase were dissolved in 2 ml of 50 mM ammonium 
formate solution, mixing by inversion and used immediately. 
 
 Antigen unmasking solution 
Antigen unmasking solution (2 ml) was mixed in 214 ml distilled water. 
 
 Galactose blocking solution (200 mM galactose, 0.1 % sodium azide) 
Galactose powder (360 mg) was reconstituted in 9 ml TBS and mixed 
with 1 ml 1 % (w/v) sodium azide. 
 
 CarboFree blocking solution (1 %) 
Stock CarboFree blocking solution (500 µl; 10x) was added to 4.5 ml 
dH2O and used immediately.  
 
The staining procedure utilized the ImmPACT DAB Peroxidase (HRP) 
Substrate kit and the Streptavidin/Biotin blocking kit.  
Sections were dewaxed as described in Section 2.3.3.4. After the ethanol 
step, sections were placed under running tap water for five minutes. 
Samples were blotted and circled with an ImmEdge pen.  
Digestion solution (20 l) was added to the control (α-galactosidase treated) 
sections and  20 l 50 mM ammonium formate buffer added to the test and 
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other negative control sections. Sections were incubated at 37 oC overnight 
in a moist environment. Each of the slides were then washed twice in TBS-T 
for ten minutes and then TBS twice. All sections were immersed in 
preheated antigen unmasking solution at 95 oC for 25 minutes followed by 
immersion in PBS for three minutes at room temperature. Sections were 
then immersed in 3 % (v/v) hydrogen peroxide in PBS for ten minutes and 
washed for three minutes with running tap water. Each section was blotted 
and covered with Streptavidin blocking solution dropwise, for 15 minutes.  
The sections were rinsed with TBS and then covered with Biotin blocking 
solution dropwise for 15 minutes, followed by a further rinse with TBS. 
CarboFree blocking solution was applied for 30 minutes to prevent non-
specific binding. Lectin was diluted in TBS to 5 µg. ml-1 and added dropwise 
to the test and galactosidase treated sections. Lectin was also diluted in 
galactose blocking solution to 5 µg. ml-1 and incubated for 30-60 minutes 
prior to use.  Lectin blocked with galactose was added to the galactose-
blocked lectin control sections.   
Sections were washed twice with TBS-T for 10 minutes each followed by 
washes in TBS twice for 10 minutes each. Streptavidin, Horseradish 
Peroxidase, R.T.U was added to each section and incubated for 30 minutes. 
Sections were washed twice with TBS-T for 10 minutes each followed by 
washes in TBS twice for 10 minutes each. ImmPACT DAB working solution 
was prepared by adding 30 µl of Chromagen to 1 ml of diluent and mixed. 
Each section was blotted and 50 µl ImmPACT DAB working solution was 
added to cover each section which were incubated for five minutes until the 
tissue was stained.  Slides were then washed four times in distilled water. 
Following this step the slides were placed into heamatoxylin for 30 seconds 
before being dehydrated and mounted (Section 2.2.3.5). 
 
2.2.5 Cell Culture techniques 
Reagents: 
 BHK cell culture medium 
Glasgow’s minimal essential media (GMEM) was used with 5 % (v/v) 
foetal bovine serum (FBS), 10 % (v/v) tryptone phosphate broth, 2 mM L-
glutamine and  100 U.ml-1  penicillin and 100 U.ml-1 streptomycin. 
 
 L929 cell culture medium 
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Dulbecco’s modified Eagle’s medium (DMEM) was used with 10 % (v/v) 
FBS, 2 mM L-glutamine, 100 U.ml-1 penicillin and 100 U.ml-1 
streptomycin. 
Cells were cultured in the appropriate cell culture medium, aseptically in a 
class II safety cabinet. The cultures were incubated in 5 % CO2 (v/v) in air at 
37 °C and split when 70-80% confluent. Before use all culture media and 
solutions were equilibrated to 37 °C. 
 
2.2.5.1 Resurrection and maintenance of primary cells and cell lines 
Cells were removed from liquid nitrogen storage and thawed in a water bath 
at 37 oC and transferred to a plastic universal, 10 ml of the appropriate cell 
culture medium was added to a the universal drop-wise. The cell suspension 
was centrifuged at 150 g for 10 minutes and the supernatant removed, the 
cell pellet was resuspended in 1 ml of fresh culture medium and added to 10 
ml of culture medium in a T 75 cell culture flask. Flasks were incubated in 5 
% CO2 (v/v) in air at 37 °C. Cell culture medium was changed every two to 
three days and cells passaged when they were approximately 70 - 80 % 
confluent. 
 
2.2.5.2 Cell passaging 
Cell culture medium was aspirated from the flask and washed with 10 ml 
PBS without calcium or magnesium and removed. Trypsin/EDTA solution (3 
ml) was added to the flask and incubated at 37 °C in 5 % CO2 (v/v) for 
between two and five minutes. Flasks were tapped gently to dislodge the 
cells and checked for detachment under an inverted microscope. Fresh 
culture medium (10 ml) was added to the flask and then removed to a 
universal container. The medium was centrifuged at 150 g for ten minutes 
and the supernatant removed, the cell pellet was resuspended in 1 ml of 
fresh culture medium and added to 10 ml of culture medium in a T 75 cell 
culture flask. 
 
2.2.5.3 Cell viability assay 
The trypan blue dye exclusion method works on the notion that the cell 
membranes of dead cells are permeable to the dye and will appear blue. 
The membrane of viable cells are intact and therefore do not permit the dye 
to enter the cells which will leave them unstained.  
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A 50 µl volume of cell suspension was thoroughly mixed with 50 µl of the dye 
in a 2 ml Eppendorf. The combined cell suspension was transferred into a 
Neubauer counting chamber which had a volume of 0.1 µl per square and a 
cell count performed under an upright microscope observing the number of 
viable cells in a 5 x 5 matrix. The number of cells counted could be 
converted into the number of cells per ml by using the following equation: 
 
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑐𝑒𝑙𝑙𝑠. 𝑚𝑙−1 = 𝑀𝑒𝑎𝑛 𝑐𝑒𝑙𝑙 𝑐𝑜𝑢𝑛𝑡 ×  104  × 𝐷𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟 (2) (2.1) 
 
Where the dilution factor of two was used due to the dilution of the cell 
suspension in trypan blue dye. 
 
2.2.6 Biomechanical testing 
The biomechanical properties of porcine mitral annuli were investigated 
using low strain-rate to failure uniaxial tensile testing in an Instron 3365 test 
rig. Native and decellularised annulus samples (n=12) were compared in the 
study.  
2.2.6.1 Preparation of the tissue samples 
The mitral valve was removed from the porcine heart and the annulus was 
isolated following the procedure in Section 2.2.2.3. The annulus (Fig 2.3) 
was cut into four regions along its long axis, these regions were identified as 
the posterior R1 (between P2 segment of mitral leaflet), anterior R3 (left 
commissure to right commissure), right commissure R2 (P3 segment of 
mitral leaflet to right commissure) and left commissure R4 (P1 segment of 
mitral leaflet to left commissure) regions. Twelve samples were tested for 
each region.  Each region was cut into 20 mm long sections in a 
circumferential orientation. 
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Fig 2.3 – Mitral annulus and leaflets. The annulus was split into four 20 
mm circumferential regions. These were; R1: posterior (between P2 
segment of mitral leaflet), R3: anterior (left commissure to right 
commissure), R2: right commissure (P3 segment of mitral leaflet to 
right commissure) and R4: left commissure (P1 segment of mitral 
leaflet to left commissure) regions.  
Each region, 20 mm in length, was cut using a custom made cutter to a 
width of 5 mm. The cutter comprised of two parallel Stanley knife blades set 
at a width of 5 mm apart. The thickness of the tissue was measured by using 
Mitutoyo digital callipers at six points along the tissue strip and the average 
taken. The test specimens (Fig 2.4) were maintained moist throughout the 
procedure by irrigating with PBS solution. Custom made grips were used to 
secure the tissue into place to prevent slippage. A 10 mm gauge length was 
used for the tissue, this was set using a 10 mm spacer in the grips. 
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Fig 2.4 – Tissue specimen dimensions. Tissue length: 20mm, gauge 
length: 10mm, width: 5mm, thickness approximately: 3mm.   
 
 
Fig 2.5 – Equipment used for tensile testing of native and 
decellularised porcine annuli. Instron 3365 test rig with Instron 
Biobath set at 37 oC.   
The tissue specimens were tested using the Instron 3365 materials testing 
machine with 500 N load cell and an Instron 3130-100 Biopuls bath set at    
37 oC (Fig 2.5).  
Dell personal 
computer 
Instron 3365 
tensile testing 
machine 
500 N load cell 
Biobath Puls 
Heat control unit 
Custom made 
grip holder 
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Fig 2.6 – Instron 3365 test rig with Instron Biobath set at 37 oC with 
tissue clamped in custom made grips undergoing the test 
procedure. 
 
The grips were mounted into the tensile testing rig and the spacer assembly 
was removed, the bio-bath was moved into position surrounding the tissue, 
ensuring that it was at the correct temperature (Fig 2.6).  
 
2.2.6.2 Test procedure 
The cross sectional area of the annulus was assumed to be rectangular for 
data calculation. Data regarding the width, depth, length and annulus 
specimen number were entered into the Instron program. Once the data had 
been entered and program setup had been completed the strain and load 
measurement were reset to zero. Initial length was classified as 10 mm 
gauge length. Testing data was recorded as the change in length of the 
tissue and the force detected on the load cell, data was stored in Excel and 
.dat formats. Slow strain rate loading to failure testing was completed on the 
tissue, a strain rate of 10 mm.min-1 was used for the test, with no preloading. 
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The data was converted to engineering stress and strains, from this the 
elastin phase slope, collagen phase slope, ultimate tensile stress, ultimate 
tensile strain, transition strain and stress values were obtained. The 
engineering stress was calculated using the formula: 
 
𝛿 =
𝐹
𝐴1
      (2.2) 
Where: F = force (N), A1 = cross sectional area (m
2), δ = stress (Pa). The 
cross sectional area was calculated as w x t, where w was the width of the 
sample and t was the average thickness. 
 
The engineering strain was calculating using the formula: 
 
𝜀 =
∆𝑙
𝐿𝑜
          (2.3) 
Where: ε = strain, Δl =change in length (m) and Lo = original length (m). 
 
 
Fig 2.7 – Typical stress-strain curve of mitral valve annuli tissue 
subjected to uniaxial tensile loading to failure. 
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The stress-strain data was plotted using Microsoft Excel 2007 to attain the 
elastin phase (El-E) and collagen phase (Coll-E) slopes along with the 
transition stress (σt), transition strain (εt), ultimate tensile stress (σs) and 
ultimate tensile strain (εs). A typical stress-strain curve of mitral valve annuli 
tissue is illustrated in Fig 2.7, demonstrating how the parameters from the 
uniaxial tensile testing were derived. The data was processed for each 
region with 12 replicates from 12 different pigs. Each parameter was 
averaged for the number of specimens in each region and data were 
presented as the mean and 95 % confidence intervals.  
 
2.2.7 Statistical analysis 
2.2.7.1 Confidence limits 
Analysis was carried out in Microsoft Excel 2007 and numerical data 
presented as means ± 95 % confidence intervals. The 95 % confidence 
intervals were calculated using Microsoft Excel data analysis package.  
2.2.7.2 Statistical analysis 
Groups of two means were compared using the student's t-test whilst groups 
of more than two means were compared using one-way analysis of variance 
(ANOVA). Post-hoc analysis was used to compare individual differences 
between groups by calculating the minimum significant difference (MSD) at p 
= 0.05 using the T-method, or T'-method for unequal group sample sizes. 
The Q value was obtained from a table of significant values. 
𝑀𝑆𝐷 = 𝑄 × 𝑆𝐸 
𝑆𝐸 =  √
𝑀𝑆
𝑛
 
 
Where SE is the standard error, MS is the mean square within groups and n 
is the number of replicates. 
 
For data that is presented as a proportion Arcsin transformation was applied 
so that data met the assumption of standard distribution for ANOVA and 
allowed accurate calculation of the 95 % CI and statistical analysis. After 
statistical analysis had been undertaken values were back transformed so 
data could be reported as a proportion. 
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Chapter 3 
Characterisation of human and porcine mitral valve annulus 
3.1 Introduction  
To understand the requirements for atrioventricular repair using a biological 
annuloplasty ring it was necessary to characterise the human mitral valve 
annulus. The reasons behind this were two-fold; to identify the structure and 
composition of the native human annulus and to establish if the human mitral 
valve annulus would be suitable for use as the starting material for the 
development of an acellular annuloplasty ring. The structure and 
composition of the human mitral valve annulus was compared to that of the 
porcine mitral valve annulus, in order to determine the utility of utilising the 
porcine tissue as an alternative, a more readily available source material.  
The function of the annulus is to provide a foundation for the mitral valve 
leaflets, ensure complete leaflet competence during the systolic phase of the 
cardiac cycle whilst optimising stress reduction in the leaflets (Salgo, 2002).  
The anatomical structure of both the human and porcine mitral valve annulus 
has been previously described (Kunzelman et al., 1994). The total annular 
length was similar between species, albeit in both groups the excised 
annulus was significantly longer in the anterior region compared to the 
annulus in situ within the heart. The increase in length was attributed to 
redundancy existing in the posterior leaflet. The need for this redundancy 
arises from the adjustment of the valve to varying loading conditions during 
the cardiac cycle to ensure that the posterior and anterior leaflets remain 
opposed to each other when the valve closed. 
The anterior and posterior regions of the human mitral valve annulus have 
contrasting architecture. Using histology it has been established that the 
anterior region comprises of the left and right fibrous trigones, with the 
anterior mitral leaflet forming a continuum into the aortic root between the 
trigones. In the posterior region the fibrosa layer of the posterior leaflet forms 
into a thin collagenous layer of the posterior annulus, separating the atrial 
and ventricular muscle (Walmsley, 1978; Angelini et al., 1988; Berdajs et al., 
2007). No histological characterisation has been undertaken on the porcine 
mitral valve annulus previously.  
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The distribution of collagen types of the human mitral valve annulus has not 
been investigated. Collagen has an important structural role in tissue and 
understanding the distribution of collagen types in the annulus will provide 
an insight into the properties of the mitral valve annulus. The orientation of 
collagens within the mitral valve complex has been reported for the anterior 
and posterior mitral valve leaflets (Kunzelman et al., 1993; Morticelli et al., 
2013) and the chordae (Cochran et al., 1991; Kunzelman & Cochran, 1992) 
but has so far been unreported for the mitral valve annulus. Similarly the 
spatial distribution of glycosaminoglycans (GAGs) in the annulus has yet to 
be reported, GAGs are distributed in the spongiosa of the mitral valve 
leaflets which may extend into the mitral valve annulus. GAGs hold water 
within tissue which helps to resists compression during  biomechanical 
loading (Grande-Allen et al., 2004). Identifying the GAG distribution will 
provide an insight into the regions of the annulus which may aid in resisting 
compression during the cardiac cycle.  
The porcine mitral valve annulus may be a suitable animal tissue for use in 
decellularisation due to its anatomical similarities to the human mitral valve 
annulus. It is important that the biomaterial should resemble the properties of 
the native tissue so that it can provide similar biomechanical and biological 
functions. Whilst the anatomical features have been studied between 
species and basic histological features identified in the human mitral valve 
annulus, an in depth analysis of the microstructure has not and this requires 
further investigation.  
It is hypothesised that the use of the annulus as an acellular biomaterial will 
provide sufficient support for the repair of the regurgitant mitral valve, whilst 
retaining the dynamic properties of the native annulus. Prior to developing 
an acellular material the biological characteristics of the human and porcine 
mitral valve annulus were characterised in order to (a) determine whether 
the porcine mitral valve annulus and human mitral valve annulus exhibited 
similar biological characteristics and (b) determine any effects of 
decellularisation treatments on the properties of the porcine mitral valve 
annulus  
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3.1.1 Aims and objectives 
The aims of the research presented in this chapter were to characterise, 
compare and contrast the human and porcine mitral valve annuli using 
histological and immunohistochemical techniques in order to (a) assess the 
suitability of using donor human tissue as the starting material for the 
development of an acellular mitral valve repair device and (b) determine 
whether the porcine mitral valve annulus offered an alternative, readily 
available alternative source material.    
The objectives were divided into two Parts  
Part (1) Characterisation of the human mitral valve annulus  
 To characterise the human mitral valve annulus using histological 
techniques (staining of sections using; haematoxylin and eosin, alcian 
blue to detect GAGs, Sirius red Miller's to assess the orientation and 
localisation of collagen fibres) 
 To assess the presence and distribution of collagen I, III, IV, VI in 
sections of the human mitral valve annulus using 
immunohistochemistry 
 To assess the presence of calcification and ossification in sections of 
human mitral valve annulus tissue using Von Kossa staining and 
presence of collagen II. 
Part (2) Characterisation of the porcine mitral valve annulus tissue using 
histological and immunohistochemical techniques:  
 To characterise the porcine mitral valve annulus using histological 
techniques (haematoxylin and eosin, alcian blue, Sirius red Miller’s 
staining of tissue sections) 
 To assess the presence and distribution of collagen I, II, III, IV, VI in 
sections of the porcine mitral valve annulus using 
immunohistochemistry 
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3.2 Material and methods 
3.2.1 Histological evaluation of the human and porcine mitral 
valve annulus  
In order to characterise the human and porcine mitral valve annulus, in 
terms of histioarchitecture and to establish how closely the porcine mitral 
valve annulus resembled the native human annulus, the human and porcine 
tissue was evaluated using a range of histochemical methods. Three human 
mitral valve annuli, obtained from donors aged 84, 57 and 67 years old and 
labelled annulus 1, 2 and 3 respectively, were split into eleven regions. Mitral 
valve annuli (n=5), obtained from pigs aged 24-26 weeks old and labelled 
one to five, were each split into eleven regions.  
The tissue specimens were fixed in zinc for 24 hours and processed for 
standard histology as described in Section 2.2. Sections from each of the 
eleven regions were stained with H&E (Fig 2.2; Chapter 2) in order to obtain 
a detailed analysis of the whole annulus.  
 
 
Fig 3.1 – Mitral annulus split into segments Regions S1-S11 were 
analysed using H&E stained tissue sections. Highlighted regions S1, 
S3, S5, S8 and S10 were selected for histochemical investigation of 
tissue sections using Sirius red Miller's, alcian blue, Von Kossa and 
immunohistochemistry. Anterior left trigone (S1), Posterior left (S3), 
Posterior right (S5), Anterior right trigone (S8), Anterior (S10). 
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Histochemical analysis of five regions of the native human and porcine mitral 
valve tissue (Fig 3.1) was undertaken using Sirius red Miller’s (Section 
2.2.4.2) and alcian blue (Section 2.2.4.3) stains. In addition, Von Kossa stain 
was used for the human tissue (Section 2.2.4.4).  
3.2.2 Immunohistochemical analysis of the human and porcine 
mitral valve annulus  
To assess the extracellular matrix of the tissue, immunohistochemical 
analysis was undertaken using tissue sections and antibodies to collagens I, 
II, III, IV and VI along with fibronectin and laminin. The positive control 
sample for collagens I, III, IV, fibronectin and laminin was porcine common 
carotid artery whilst for collagens II and VI it was porcine articular cartilage. 
Samples were split into regions S1, S3, S5, S8 and S10 as shown in Fig 3.1. 
The methods used for this part of the study have been described in Section 
2.2.4.  
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3.3 Results 
Part (1) Characterisation of the native human mitral annulus 
  
3.3.1 Histological and histochemical characterisation of the native 
human mitral annulus 
Sections of tissue from the eleven regions of the human mitral valve annulus 
were stained with H&E to determine the overall tissue structure. Images 
representative of the different regions are presented in Fig 3.2a and Fig 
3.2b. Sections of the human mitral valve annulus stained with H&E exhibited 
a heterogeneous structure with varying characteristics in the anterior 
trigones, the mitral to aortic continuum and posterior region. Due to the age 
and health of the human tissue signs of calcification were present in the 
mitral valve of all three hearts. Calcification, indicated by violet staining in 
H&E sections was present in both the anterior region (Fig 3.2a; S1, Fig 3.2b; 
S8, S9, S10) and the posterior region (Fig 3.2a; S2, S4, Fig 3.2b; S7).  
The anterior region comprised of the mitral to aortic continuum (Fig 3.2b; 
S10) and the left (Fig 3.2a; S1, Fig 3.2b; S11) and right trigonal regions (Fig 
3.2b; S8, S9). The posterior annulus (Fig 3.2a; S2-S6, Fig 3.2b; S7) was 
more uniform in nature and comprised of thin collagenous region where the 
posterior mitral valve leaflet inserted. The thickness of the annulus at the 
junction where the leaflet inserted into the annulus was between 500 µm and 
3000 µm in all samples. In the whole of the posterior region the atrial 
myocardium was isolated to the endocardial side of the mitral valve where 
adipose tissue comprised the majority of the atrial side of the valve from the 
atrial muscle to the epicardium. The atrial myocardium was approximately 
500 - 1500 µm in width in both the posterior and anterior regions. The 
ventricular myocardial fibres close to the annulus were circumferential in 
orientation, whilst the atrial fibres were predominantly circumferential with 
some longitudinal fibres close the endocardium. The atrial myocardium also 
appeared to integrate into the atrial side of the anterior leaflet in some 
regions, on the atrial side of the annulus (Fig 3.2a; S1, Fig 3.2b; S8, S11). 
Section 1 (Fig 3.2a; S1) formed part of the left trigone. It showed a heavily 
calcified fibrosa, but the calcification did not continue into the annulus. From 
the fibrosa, the annulus formed into a thickened zone of the trigone, this 
zone was defined by a dense collagenous-connective tissue at the junction 
of the anterior leaflet. Longitudinal fibrous extensions formed from the 
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trigones into the ventricular myocardium. Calcification was present in the 
region where the annulus joined the endocardium. Section 2 (Fig 3.2a S2) 
was part of the posterior annulus close to the left commissure, the annulus 
consisted of less collagenous-connective tissue and was heavily calcified, 
this calcification did not develop into the adjoining endocardium of the left 
ventricle. The annulus extended into the ventricular myocardium with 
longitudinal collagenous fibres which were separated by areas of ventricular 
myocardium. The ventricular myocardium extended from the annulus and 
ranged from the endocardium to the epicardium with a thickness of 3500 to 
4000 µm at the annulus. In section 3 (Fig 3.2a; S3) the annulus was free 
from calcification, it had a cross section which was 900 µm to 1200 µm in 
diameter. The annulus integrated into the ventricular myocardium with 
longitudinal fibrous extensions. The ventricular myocardium was 
approximately 3000 µm thick close to the annulus and encompassed the 
region between the endocardium and epicardium. The annulus in section 4 
(Fig 3.2a; S4) comprised of collagenous connective tissue approximately 
1000 µm thick and double the width of the leaflet inserting into it. There were 
signs of calcification at the leaflet fibrosa close to the junction of the leaflet 
and annulus. The annulus formed into both the ventricular and atrial side of 
the valve. In section 5 (Fig 3.2a; S5) the mitral annulus had a cross section, 
500 µm to 1000 µm in diameter with the appearance of circumferentially 
orientated collagen. The annulus formed into the ventricular myocardium 
with longitudinal collagen extensions which were separated by regions of 
ventricular myocardium. The ventricular myocardium encompassed the 
whole region between the endocardium and epicardium. The atrial muscle 
was separated from the annulus in this region. In section 6 (Fig 3.2a; S6) the 
annulus appeared free from calcification. The annulus was 1500 µm thick at 
the junction and elongated from the leaflet into the ventricular myocardium 
with collagen extensions, it had the appearance of collagen orientated 
circumferentially. The ventricular myocardium encompassed the whole 
region between the endocardium and epicardium.  
Heavy calcification was present in the annulus and leaflet of section 7 (Fig 
3.2b; S7a), the ventricularis and atrialis surfaces were the only regions free 
from calcification. Calcification was also present in the annulus close to the 
atrial muscle but there was no calcification bordering the ventricular muscle. 
Cells close to the areas of calcification (Fig 3.2b; S7b) had the appearance 
of osteochondral-like cells within lacunae, suggesting that ossification may 
have been present in this region. The annulus formed into the ventricular 
myocardium with longitudinal collagen extensions which were separated by 
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regions of ventricular myocardium. The atrial muscle was approximately 
1500 µm in thickness and replaced by adipose tissue towards the 
epicardium whilst the ventricular myocardium traversed the whole region 
between the endocardium and epicardium. The right trigone (Fig 3.2b; S8) 
was part of the fibrous skeleton of the heart, calcification was present in the 
fibrosa and continued into the annulus. The atrial myocardium inserted into 
the atrial side of the trigone and was a similar thickness to the atrial 
myocardium in the posterior region with a width of approximately 1000 µm. 
The muscle was interspersed with loose connective tissue, adipose cells and 
blood vessels. Section 9 (Fig 3.2b; S9) formed part of the right trigone. The 
leaflet at the insertion into the annulus was approximately 1500 µm thick with 
the annulus forming into the left ventricle on the endocardial side of the 
valve. Calcification was present in the valve leaflet with some further 
calcification observed in the mitral annulus. Section 10 (Fig 3.2b; S10) 
formed part of the mitral to aortic continuum, composed of mitral valve 
leaflet, aortic wall and aortic valve leaflet. No ventricular myocardium was 
present. The maximum thickness was at the junction of the aortic valve 
leaflet of 500 µm, the minimum thickness was approximately 250 µm. 
Calcification was present in the aortic valve leaflet with some further 
calcification observed in the mitral leaflet and aortic wall. Section 11 (Fig 
3.2b; S11) formed the left trigone, atrial myocardium was isolated to the 
atrial side of the anterior leaflet with a diameter of approximately 1000 µm 
which appeared to occupy part of the atrial side of the leaflet. Longitudinal 
collagen fibres extended from the annulus into the ventricular myocardium. 
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Fig 3.2a – Images of H&E stained sections from different segments of 
the native human mitral valve annulus. Representative images from 
three human annuli are shown.  Section 1. Annulus 3 (S1), Section 2. Annulus 
3 (S2), Section 3. Annulus 3 (S3), Section 4. Annulus 3 (S4), Section 5. 
Annulus 2 (S5), Section 6. Annulus 3 (S6). A: Annulus; T: Trigone; AM: Atrial 
Muscle; AV: Aortic Valve; AVL: Aortic Valve Leaflet; VM: Ventricular Muscle; 
L: Leaflet, MA: Mitral - Aortic continuum. Magnification x 20. 
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Fig 3.2b – Images of H&E stained sections from different segments of 
the native human mitral valve annulus. Section 7. Annulus 3 (S7a), 
Section 7. Annulus 3 x 100 magnification (S7b) Section 8. Annulus 3 (S8), 
Section 9. Annulus 1 (S9), Section 10. Annulus 3 (S10), Section 11. Annulus 
2 (S11).  A: Annulus; T: Trigone; AM: Atrial Muscle; AV: Aortic Valve; AVL: 
Aortic Valve Leaflet; VM: Ventricular Muscle; L: Leaflet, MA: Mitral - Aortic 
continuum. Magnification x 20 unless stated otherwise. 
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In selected segments (S1, S3, S5, S8 and S10) of the human mitral valve 
annulus, sections were stained with alcian blue to determine the presence 
and abundance of GAGs. GAGs were stained blue and were observed at the 
hinge point of both the anterior (Fig 3.3; S1) and posterior (Fig 3.3; S3 & S5) 
annulus where the leaflets inserted. In the atrial to mitral continuum GAGs 
were present in the spongiosa of the leaflet (Fig 3.3; S10). 
 S10)  S8) 
  S5) 
 S1)  S3) 
Fig 3.3 – Images of alcian blue stained sections from different segments of 
the native human mitral valve annulus. Representative images from three 
human annuli are shown. Blue regions highlight GAG content, red arrows 
indicate regions of GAGs. Section 1. Annulus 3 (S1), Section 3. Annulus 1 
(S3), Section 5. Annulus 2 (S5), Section 8. Annulus 1 (S8), Section 10. 
Annulus 1 (S10). A: Annulus; T: Trigone; AM: Atrial Muscle; AV: Aortic Valve; 
AVL: Aortic Valve Leaflet; VM: Ventricular Muscle; L: Leaflet, MA: Mitral - 
Aortic continuum. Magnification x 20. 
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Sirius red Miller's stain was used to highlight the collagen within sections of 
the human mitral valve annulus. When viewed under polarised light the 
Sirius red gave an indication of the collagen orientation. When viewed under 
bright field microscopy the elastin fibres stained blue and collagen fibres 
stained red. The anterior and posterior leaflets forming into the annulus 
comprised of four layers; the atrialis, spongiosa, fibrosa and ventricularis. 
The atrialis of both the anterior and posterior leaflets was composed of 
densely packed elastin fibres (Fig 3.4a, 3.4b). The spongiosa was composed 
of a fine network of elastin fibres and collagen fibres, the spongiosa formed 
into the upper region of the annular junction and continued up towards the 
atrial myocardium. Densely packed collagen fibres were observed in the 
fibrosa which formed into the lower region of the annulus. The ventricularis 
was composed of a thin network of collagen and elastin which formed into 
the ventricular endocardium.  
Under polarised light the fibrosa appeared densest in, or close to, the right 
and left trigones, with a thickness of approximately 1000 µm (Fig 3.4a; S1 b, 
Fig 3.4b; S8 b). Some of the central fibres appeared radially aligned under 
polarised light but most of the dense collagen observed in bright field 
microscopy (Fig 3.4a; S1 b, Fig 3.4b; S8 b) was weakly birefringent under 
polarised light, with no discernible collagen orientation (Fig 3.4a; S1 a, Fig 
3.4b; S8 a). The mitral to aortic continuum (Fig 3.4b; S10) was defined by 
the layers of the mitral valve leaflet, the ventricularis which comprised a thin 
but dense elastin and collagen network, the fibrosa was comprised of 
prominent collagen approximately 500 µm thick, whilst a loose collagen and 
elastin network was present in the spongiosa and the atrialis comprised of 
dense elastin. There were some radially aligned collagen fibres running in 
parallel with the continuum but under polarised light, the collagen orientation 
appeared to be isotropic.  
The posterior region (Fig 3.4a; S3, S5) was weakly birefringent in the 
fibrosa, suggestive of fewer radially aligned collagen bundles. This layer was 
thinner than in the anterior, with a fibrosa thickness of approximately 500 
µm, and formed of loose bundles of collagen that formed into the lower 
region of the annulus. The lower region of the annulus continued down into 
the left ventricular myocardium. The spongiosa, characterised by loose 
elastin and collagen fibres formed into the upper half of the annulus and 
here it was thicker compared to the anterior annulus.  
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S5 a) S5 b) 
Fig 3.4a – Images of Sirius red Miller's stained sections from different 
segments of the native human mitral valve annulus viewed under 
(a) polarised light and (b) bright field microscopy. Representative 
images from three human annuli are shown. Section 1. Annulus 3 (S1 
a), Section 1. Annulus 3 (S1 b), Section 3 Annulus 1 (S3 a), Section 3. 
Annulus 1 (S3 b), Section 5. Annulus 1 (S5 a), Section 5. Annulus 1 
(S5 b).  
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S8 a)  S8 b) 
 
S10 a) S10 b) 
Fig 3.4b – Images of Sirius red Miller's stained sections from different 
segments of the native human mitral valve annulus viewed under 
(a) polarised light and (b) bright field microscopy. Collagen fibres 
are stained red, elastin fibres are stained blue. Section 8. Annulus 1 
(S8 a), Section 8. Annulus 1 (S8 b), Section 10. Annulus 2 (S10 a), 
Section 10. Annulus 2 (S10 b). A: Annulus; T: Trigone; AM: Atrial 
Muscle; AV: Aortic Valve; AVL: Aortic Valve Leaflet; VM: Ventricular 
Muscle; L: Leaflet, MA: Mitral - Aortic continuum. Magnification x 20. 
The Von Kossa stain was used to visualise calcium deposits within sections 
of the human mitral valve annulus and the surrounding tissue (Fig 3.5). 
Under bright field illumination calcium deposits appeared brown to black and 
the eosin counter stain stained basic components pink. Calcium deposits 
highlighted by brown staining were prominent along the endocardium and 
atrial and ventricular leaflet surface in every section of the tissue. The fibrosa 
of the leaflets in sections S1, S5 and S10 stained black and continued into 
the annulus, illustrating the deposition of calcium deeper within the annulus 
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region. Heavy calcification was identified in every layer of the posterior 
leaflet in section S8 with the calcification continuing into the annulus, as 
shown by the black staining. 
 
Fig 3.5 – Images of Von Kossa stained sections from different 
segments of the native human mitral valve annulus. Representative 
images from three human annuli are shown Areas with apparent 
calcium deposits are stained brown to black. Section 1. Annulus 1 (S1), 
Section 3. Annulus 2 (S3), Section 5. Annulus 3 (S5), Section 8. 
Annulus 1 (S8), Section 10. Annulus 3 (S10). A: Annulus; T: Trigone; 
AM: Atrial Muscle; AV: Aortic Valve; AVL: Aortic Valve Leaflet; VM: 
Ventricular Muscle; L: Leaflet. Magnification x 20. 
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3.3.2 Distribution of proteins in the extracellular matrix of the 
human mitral annulus 
The distribution of different structural proteins of the extracellular matrix of 
the human mitral valve annulus was investigated using 
immunohistochemistry.  
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3.3.2.1 Collagen I 
Sections of the mitral valve annulus, described in Section 3.2.1, were 
labelled with antibodies to collagen I, indicated by brown staining in the 
images in Fig 3.6a. Positive staining was identified in the anterior regions of 
the trigones and mitral to aortic continuum as well as the posterior region 
(Fig 3.6a; S1-S10). Staining was more prominent in the fibrosa which 
integrated into the annulus, as well as the annulus, compared to the 
surrounding tissue such as the atrial and ventricular myocardium. Limited 
background staining was observed in the control sections labelled with the 
isotype control antibody (Fig 3.6b; a) and diluent alone (Fig 3.6b; b). 
  
- 101 - 
 
 S10) 
 
 
 
 
 
 
 S8) 
  S5) 
 S1)  S3) 
Fig 3.6a – Sections of human mitral valve annulus stained with 
antibody to collagen I. Representative images from three human 
annuli are shown. Sections labelled with antibodies to collagen I 
stained brown. Section 1. Annulus 2 (S1), Section 3. Annulus 2 (S3), 
Section 5. Annulus 2 (S5), Section 8. Annulus 3 (S8), Section 10. 
Annulus 1 (S10). A: Annulus; T: Trigone; AM: Atrial Muscle; AV: Aortic 
Valve; AVL: Aortic Valve Leaflet; VM: Ventricular Muscle; L: Leaflet, 
MA: Mitral-Aortic continuum. Magnification x 20 
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 a)  b) 
 c)  
Fig 3.6b – Sections of human mitral valve annulus stained with antibody to 
collagen I. Representative images from three human annuli are shown. 
Sections labelled with antibodies to collagen I stained brown. Isotype control 
(a). Diluent control (b). Porcine common carotid artery positive control (c). A: 
Annulus; T: Trigone; AM: Atrial Muscle; AV: Aortic Valve; AVL: Aortic Valve 
Leaflet; VM: Ventricular Muscle; L: Leaflet, MA: Mitral-Aortic continuum. 
Magnification x 20. 
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3.3.2.2 Collagen II 
Images of sections of the anterior and posterior regions (Fig. 3.7a) of the 
mitral valve annulus labelled with antibody to collagen II showed positive 
staining in the anterior region (Fig 3.7a; S8, S10), indicated by a dark brown 
colour. In the region that was positively stained for collagen II, lacunae type 
structures were visible (Fig 3.7a; S10b). Staining was not visible in the 
muscle surrounding the annulus. No staining was observed in the control 
sections stained with the isotype control antibody (Fig 3.7b; a) or diluent 
alone (Fig 3.7b; b). 
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S1) S3) 
S5)  S8) 
S10a)  S10b) 
Fig 3.7a – Sections of human mitral valve annulus stained with antibody to 
collagen II. Representative images from three human annuli are shown. 
Sections labelled with antibodies to collagen II stained brown. Section 1. 
Annulus 1 (S1), Section 3. Annulus 2 (S3), Section 5. Annulus 3 (S5), Section 
8. Annulus 1 (S8), Section 10. Annulus 1 (S10a). Section 10. Annulus 1 x 400 
magnification (S10b). A: Annulus; T: Trigone; AM: Atrial Muscle; AV: Aortic 
Valve; AVL: Aortic Valve Leaflet; VM: Ventricular Muscle; L: Leaflet, MA: 
Mitral - Aortic continuum. Magnification x 20 unless stated otherwise. 
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a) b) 
c)  
Fig 3.7b – Sections of human mitral valve annulus stained with antibody to 
collagen II. Sections labelled with antibodies to collagen II stained brown. 
Isotype control (a). Diluent control (b). Porcine articular cartilage control (c). A: 
Annulus; T: Trigone; AM: Atrial Muscle; AV: Aortic Valve; AVL: Aortic Valve 
Leaflet; VM: Ventricular Muscle; L: Leaflet, MA: Mitral - Aortic continuum. 
Magnification x 20 unless stated otherwise. 
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3.3.2.3 Collagen III 
Images of sections of the anterior and posterior regions (Fig. 3.8a) of the 
human mitral annulus labelled with antibody to collagen III revealed that all 
regions stained positively. Collagen III staining was darker in the 
endocardium and at the surfaces of the leaflets. Positive staining was also 
observed in the annulus and atrial and ventricular myocardium in both the 
anterior and posterior regions. No staining was observed in sections stained 
with the antibody isotype control (Fig 3.8b; a) or diluent alone (Fig 3.8b; b). 
Fig 3.8a – Sections of human mitral valve annulus stained with antibody to 
collagen III. Representative images from three human annuli are shown. 
Sections labelled with antibodies to collagen III stained brown. Section 1. 
Annulus 3 (S1), Section 3. Annulus 1 (S3), Section 5. Annulus 2 (S5), Section 
8. Annulus 1 (S8), Section 10. Annulus 1(S10). A: Annulus; T: Trigone; AM: 
Atrial Muscle; AV: Aortic Valve; AVL: Aortic Valve Leaflet; VM: Ventricular 
Muscle; L: Leaflet, MA: Mitral - Aortic continuum. Magnification x 20. 
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Fig 3.8b – Sections of human mitral valve annulus stained with antibody to 
collagen III. Sections labelled with antibodies to collagen III stained brown. 
Isotype control (a). Diluent control (b). Porcine common carotid artery positive 
control (c). A: Annulus; T: Trigone; AM: Atrial Muscle; AV: Aortic Valve; AVL: 
Aortic Valve Leaflet; VM: Ventricular Muscle; L: Leaflet, MA: Mitral - Aortic 
continuum. Magnification x 20. 
3.3.2.4 Collagen IV 
The anterior and posterior regions (Fig 3.9a) of the human mitral valve 
annulus were labelled with antibodies to collagen IV. Positive staining was 
observed in the annulus, atrial and ventricular myocardium in both the 
anterior and posterior regions. Staining was more prominent in the 
myocardium, endocardium and blood vessels compared to the annulus. In 
the annulus, staining was observed in the collagen fibres (Fig 3.9a; S8) and 
surrounding lacunae type regions in the mitral to aortic continuum (Fig 3.9a; 
S10 a, S10 b) which appeared to have ossified. No staining was observed in 
sections stained with the antibody isotype control (Fig 3.9b; a) or diluent 
alone (Fig 3.9b; b).  
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 S10 a)  S10 b)  
  S8) S5 b) 
  S5 a) 
 S1)  S3) 
Fig 3.9a – Sections of human mitral valve annulus stained with antibody to 
collagen IV. Representative images from three human annuli are shown. 
Sections labelled with antibodies to collagen IV stained brown. Section 1. 
Annulus 3 (S1), Section 3. Annulus 1 (S3), Section 5. Annulus 1 (S5 a), 
Section 5 x 100 magnification (S5 b), Section 8. Annulus 1 (S8), Section 10. 
Annulus 2 (S10a), Section 10 x100 magnification (S10b). A: Annulus; T: 
Trigone; AM: Atrial Muscle; AV: Aortic Valve; AVL: Aortic Valve Leaflet; VM: 
Ventricular Muscle; L: Leaflet, LA: Lacunae, MA: Mitral - Aortic continuum. 
Magnification x 20 unless stated otherwise. 
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S10 b)  a) 
b)  
Fig 3.9b – Sections of human mitral valve annulus stained with antibody to 
collagen IV. Representative images from three human annuli are shown. 
Sections labelled with antibodies to collagen IV stained brown.  Section 1. 
Annulus 3 (S1), Section 3. Annulus 1 (S3), Section 5. Annulus 1 (S5 a), 
Section 5 x 100 magnification (S5 b), Section 8. Annulus 1 (S8), Section 10. 
Annulus 2 (S10a), Section 10 x100 magnification (S10b). Isotype control (a). 
Diluent control (b). Porcine common carotid artery positive control (c). A: 
Annulus; T: Trigone; AM: Atrial Muscle; AV: Aortic Valve; AVL: Aortic Valve 
Leaflet; VM: Ventricular Muscle; L: Leaflet, LA: Lacunae, MA: Mitral - Aortic 
continuum. Magnification x 20 unless stated otherwise. 
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3.3.2.5 Collagen VI 
Sections of human mitral valve annulus in both the anterior and posterior 
regions were stained with antibody to collagen VI (Fig 3.10a). Positive 
staining was observed in the annulus, atrial and ventricular myocardium in 
all regions. Staining was slightly more prominent in the endocardium. No 
staining was observed in the sections stained with the antibody isotype 
control (Fig 3.10b; a) or diluent alone (Fig 3.10b; b). 
 S10)   S8) 
  S5)  
 S1)  S3) 
Fig 3.10a – Sections of human mitral valve annulus stained with antibody to 
collagen VI. Representative images from three human annuli (1-3) are 
shown. Sections labelled with antibodies to collagen VI stained brown.  
Section 1. Annulus 3 (S1), Section 3. Annulus 1 (S3), Section 5. Annulus 1 
(S5), Section 8. Annulus 1 (S8), Section 10. Annulus 2 (S10). A: Annulus; T: 
Trigone; AM: Atrial Muscle; AV: Aortic Valve; AVL: Aortic Valve Leaflet; VM: 
Ventricular Muscle; L: Leaflet. Magnification x 20. 
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 a)  b) 
 c)  
Fig 3.10b – Sections of human mitral valve annulus stained with antibody to 
collagen VI. Isotype control (a). Diluent control (b). Porcine articular cartilage 
positive control (c). A: Annulus; T: Trigone; AM: Atrial Muscle; AV: Aortic 
Valve; AVL: Aortic Valve Leaflet; VM: Ventricular Muscle; L: Leaflet. 
Magnification x 20. 
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3.3.2.6 Fibronectin 
Sections of the human mitral annulus from the anterior and posterior regions 
(Fig 3.11a) were labelled with antibody to fibronectin. The results showed 
that both regions were stained positive. Staining was most prominent in the 
endocardium, leaflet surfaces and myocardium compared to the annulus but 
the annulus was also stained positive. No staining was observed in the 
sections stained with the antibody isotype control (Fig 3.11b; a) or diluent 
alone (Fig 3.11b; b)  
Fig 3.11a – Sections of human mitral valve annulus stained with antibody to 
fibronectin. Representative images from three human annuli are shown. 
Sections labelled with antibodies to fibronectin stained brown.  Section 1. 
Annulus 2 (S1), Section 3. Annulus 2 (S3), Section 5. Annulus 2 (S5), Section 
8. Annulus 3 (S8), Section 10. Annulus 1 (S10). A: Annulus; T: Trigone; AM: 
Atrial Muscle; AV: Aortic Valve; AVL: Aortic Valve Leaflet; VM: Ventricular 
Muscle; L: Leaflet, Mitral-Aortic continuum. Magnification x 20. 
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Fig 3.11b – Sections of human mitral valve annulus stained with antibody to 
fibronectin. Sections labelled with antibodies to fibronectin stained brown.  
Isotype control (a). Diluent control (b). Porcine common carotid artery positive 
control (c). A: Annulus; T: Trigone; AM: Atrial Muscle; AV: Aortic Valve; AVL: 
Aortic Valve Leaflet; VM: Ventricular Muscle; L: Leaflet, Mitral-Aortic 
continuum. Magnification x 20. 
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3.3.2.7 Laminin 
The antibody to laminin was used to label sections of the anterior and 
posterior mitral valve annulus (Fig 3.12a). Positive staining was observed in 
the atrial and ventricular myocardium in all regions whilst the annulus 
stained weakly. Staining was more prominent in the muscle surrounding the 
annulus, endocardium and blood vessels. No staining was observed in 
sections stained with the isotype control antibody (Fig 3.12b; a) or diluent 
alone (Fig 3.12b; b).  
 S10)   S8) 
  S5) 
 S1)   S3)  
Fig 3.12a – Sections of human mitral valve annulus stained with antibody to 
laminin. Sections labelled with antibodies to laminin stained brown.  Section 
1. Annulus 3 (S1), Section 3. Annulus 2 (S3), Section 5. Annulus 1 (S5), 
Section 8. Annulus 2 (S8), Section 10. Annulus 2 (S10). A: Annulus; T: 
Trigone; AM: Atrial Muscle; AV: Aortic Valve; AVL: Aortic Valve Leaflet; VM: 
Ventricular Muscle; L: Leaflet. Magnification x 20. 
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 a)  b) 
 c)  
Fig 3.12b – Sections of human mitral valve annulus stained with antibody to 
laminin. Sections labelled with antibodies to laminin stained brown. Isotype 
control x 100 magnification (a). Diluent control x 100 magnification (b) Porcine 
common carotid artery positive control (c). A: Annulus; T: Trigone; AM: Atrial 
Muscle; AV: Aortic Valve; AVL: Aortic Valve Leaflet; VM: Ventricular Muscle; 
L: Leaflet. Magnification x 20. 
 
3.3.3 Deposition of calcium in the extracellular matrix of the 
human mitral annulus 
Upon excision of each of the human mitral valve annuli from donor hearts 
heavy calcification was apparent. In order to identify the presence and 
abundance of the calcification in the annulus, sections of the anterior and 
posterior regions of the human mitral annulus were stained with H&E (Fig 
3.13; a, d), labelled with antibodies to collagen II (Fig 3.13; b, e) and stained 
with Von Kossa (Fig 3.13; c, f) to show regions where calcification was 
prominent and ossification might have been present. Regions of calcification 
stained deep purple in sections stained by H&E, regions with signs of 
cartilage development labelled with antibodies to collagen II and stained 
brown whilst regions of calcification stained dark brown to black when 
sections were stained by Von Kossa. Staining was most prominent in the 
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posterior annulus for both calcification (Fig 3.13; d, f) and signs of 
ossification (Fig 3.13; e) compared to the anterior annulus (Fig 3.13; a, b, c). 
The anterior annulus had signs of calcification (Fig 3.1; c) but ossification 
was not visible and did not stain positive for collagen II (Fig 3.13; b). The 
results indicate the overlap between the calcium deposition and collagen II 
present in the samples. 
Fig 3.13 – Sections of native human mitral valve annulus stained with H&E, 
Von Kossa and labelled with antibodies to collagen II. Representative 
images from three human annuli (1-3) are shown. Anterior: H&E (a), collagen 
II (b), Von Kossa (c), Posterior: H&E (d), collagen II (e), Von Kossa (f). A: 
Annulus; T: Trigone; AM: Atrial Muscle; AV: Aortic Valve; AVL: Aortic Valve 
Leaflet; VM: Ventricular Muscle; L: Leaflet. Magnification x 20. 
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Part 2 Characterisation of the native porcine mitral annulus  
3.3.4 Histological and histochemical characterisation of the native 
porcine mitral valve annulus 
Sections of tissue from the eleven regions of the porcine mitral valve 
annulus (n=5; labelled annulus 1 to 5) were stained with H&E to determine 
the overall tissue structure. Images representative of the different regions 
are presented in Fig 3.14a and Fig 3.14b. The native porcine mitral annulus 
exhibited a diverse structure between the anterior and posterior annulus.  
Connective tissue density appeared greatest in the anterior of the annulus 
(Fig 3.14a; S1, Fig 3.14b; S8-S11) or close to the anterior (Fig 3.14a; S2, Fig 
3.14a; S7) where the annulus was thickest, ranging between 1000 µm close 
to the commissures and 5200 µm in thickness at the trigones, the connective 
tissue in this region also extended further towards the epicardial side of the 
heart compared to the posterior. The anterior comprised of the highly fibrous 
trigonal regions (Fig 3.14a; S1, Fig 3.14b; S8, S11) and the mitral to aortic 
continuum (Fig 3.14b; S9-S10). Cells within the trigones resembled 
chondrocytes located within lacunae (Fig 3.14b; S11b). The mitral to aortic 
continuum (Fig 3.14b; S10) appeared as a dense collagenous-connective 
membrane that formed the core of the tissue in this region and lacked the 
spongiosa that was visible in the posterior mitral leaflets. 
The collagenous fibrosa of the mitral leaflets appeared to form into the mitral 
annulus in the posterior region and up to the trigones in the anterior (Fig 
3.14a; S1-S6, Fig 3.14b; S7-S8), although the spongiosa appeared to form 
into the annulus in Section 4 (Fig 3.14a; S4). The fibrosa was defined by the 
densely packed collagenous connective tissue compared to the other layers 
of the mitral valve leaflets, the spongiosa, ventricularis and atrialis. The 
posterior mitral valve region (Fig 3.14a; S2-S6, Fig 3.14b; S7) consisted 
primarily of collagenous-connective tissue of the mitral valve annulus and of 
adipose cells, surrounded by myocardium. The posterior connective tissue 
ranged in thickness between 500 µm and 1100 µm. The atrial and ventricular 
myocardium were separated by the annulus or adipose tissue. Adipose 
tissue replaced the collagenous connective tissue towards the epicardium, 
separating the ventricular and atrial myocardium. 
The muscle fibres close to the annulus were circumferential in orientation. 
The atrial myocardium also appeared to integrate into the atrial side of the 
posterior leaflet, above the annulus (Fig 3.14a; S3, S5, Fig 3.4b; S7).  
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Fig 3.14a – Images of H&E stained sections from different segments of the 
porcine mitral valve annulus. Representative images from three porcine 
annuli are shown. Section 1. Annulus 3 (S1), Section 2. Annulus 2 (S2), 
Section 3. Annulus 3 (S3), Section 4. Annulus 3 (S4), Section 5. Annulus 1 
(S5), Section 6. Annulus 1 (S6). A: Annulus; T: Trigone; AM: Atrial Muscle; 
AV: Aortic Valve; AVL: Aortic Valve Leaflet; VM: Ventricular Muscle; L: 
Leaflet. Magnification x 20.  
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Fig 3.14b – Images of H&E stained sections from different segments of the 
porcine mitral valve annulus. Representative images from three porcine 
annuli are shown. Section 7. Annulus 3 (S7), Section 8. Annulus 3 (S8), 
Section 9. Annulus 1 (S9), Section 10. Annulus 3 (S10), Section 11. Annulus 
1 (S11a), Section 11, Section 11.  Annulus 1x 400 magnification (S11b). 
Magnification x20 unless stated otherwise.    
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Selected segments of the porcine mitral valve annulus were sectioned and 
stained with alcian blue to determine the presence and abundance of GAGs. 
GAGs were observed at the hinge point of both the anterior (Fig 3.15; S1, S8 
a, S8 b) and posterior (Fig 3.15 S3, S5) annulus, where the leaflets inserted. 
The trigonal region had a high concentration of GAGs (Fig 3.15; S8, S10) in 
the irregularly arranged tissue which had chondrocyte-like cells residing in 
lacunae (Fig 3.15; S8 b). GAGs were also present within the spongiosa of 
the mitral valve leaflet (Fig 3.15 S1, S3, S5, S10).  
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Fig 3.15 – Images of alcian blue stained sections from different segments of 
the native porcine mitral valve annulus. Representative images from three 
porcine annuli are shown. Black arrows represent GAGs within the spongiosa, 
red arrows represent GAGs present within the annular junction. Section 1. 
Annulus 3 (S1), Section 3. Annulus 3 (S3), Section 5. Annulus 3 (S5), Section 
8. Annulus 5 (S8 a), Section 8 x100 magnification (S8 b), Section 10. Annulus 
1 (S10). Chondron-like regions formed in an area high in GAGs (S8 b) 
magnification x 100.  A: Annulus; T: Trigone; AM: Atrial Muscle; AV: Aortic 
Valve; AVL: Aortic Valve Leaflet; VM: Ventricular Muscle; L: Leaflet. LA: 
Lacunae. Magnification x 20 unless stated otherwise. 
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Sirius red Miller's staining of tissue sections from various regions of the 
porcine mitral valve annulus showed red/orange stained collagen fibres, 
when viewed under polarised light (Fig 3.16a; a, Fig 3.16b; a, Fig 3.17) and 
purple stained elastin fibres when viewed by bright field microscopy (Fig 
3.16a; b, Fig 3.16b; b). Collagen concentration was highest in the trigones 
(Fig 3.16a; S1 a, Fig 3.16b; S8), the mitral to aortic continuum (Fig 3.16b; 
S10) and the fibrosa of the mitral leaflet (Fig 3.16a; S3, S5), which formed 
into the mitral annulus. The fibrosa of the anterior leaflet was thinnest in the 
posterior, between 250 and 370 µm thick and thickest in the anterior, 
between 500 and 620 µm. Elastin was concentrated around structures which 
closely resembled chondrons in the trigones and was suggestive of elastic 
cartilage (Fig 3.16a; S1 b, S1 c, Fig 3.16b;  S8 b). Regions of lacunae 
appeared orange under polarised light and weakly birefringent, with denser 
collagenous regions appearing red surrounding them (Fig 3.16a; S1 a, Fig 
3.16b; S8 a). Elastin was also present in the atrialis in both the posterior and 
anterior regions which integrated into the endocardium, high concentrations 
of elastin were present in the anterior regions in the wall of the aorta in the 
anterior (Fig 3.16a; S1 b, Fig 3.16b; S8 b) and the mitral to aortic continuum 
(Fig 3.16b; S10 b).  
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 S5 a)  S5 b) 
  S3 a)  S3 b) 
 S1 c)  
 S1 a)  S1 b) 
Fig 3.16a – Images of Sirius red Miller's stained sections from selected 
segments of the native porcine mitral valve annulus viewed under (a) 
polarised light and (b) bright field microscopy. Representative images 
from three porcine annuli are shown. Elastin fibres are stained dark blue, 
collagen fibres are stained red. Images are shown in pairs; polarised light 
images followed by bright field images. Section 1 (S1 a. Annulus 5, S1 b. 
Annulus 5), Section 1 x 400 magnification (S1 c. Annulus 5), Section 3 (S3 a. 
Annulus 5, S3 b. Annulus 5), Section 5 (S5 a. Annulus 3, S5 b. Annulus 3).  A: 
Annulus; T: Trigone; AM: Atrial Muscle; AV: Aortic Valve; AVL: Aortic Valve 
Leaflet; VM: Ventricular Muscle; L: Leaflet. LA: Lacunae. Magnification x 20 
unless stated otherwise. 
LA 
T 
AM 
AV 
L 
1000 µm 
20 µm 
A 
L 
AM 
VM 
A 
L 
AM 
VM 
1000 µm 1000 µm 
L 
A 
AM 
VM L 
A 
AM 
VM 
1000 µm 1000 µm 
T 
AM 
AV 
L 
1000 µm 
- 124 - 
 
 
 S8 a)  S8 b) 
 
 S10 a)  S10 b)  
Fig 3.16b – Images of Sirius red Miller's stained sections from selected 
segments of the native porcine mitral valve annulus viewed under (a) 
polarised light and (b) bright field microscopy. Representative images 
from three porcine annuli are shown. Elastin fibres are stained dark blue, 
collagen fibres are stained red. Images are shown in pairs; polarised light 
images followed by bright field images. Section 8 (S8 a. Annulus 5, S8 b. 
Annulus 5), Section 10 (S10 a. Annulus 1, S10 b. Annulus 1).  A: Annulus; T: 
Trigone; AM: Atrial Muscle; AV: Aortic Valve; AVL: Aortic Valve Leaflet; VM: 
Ventricular Muscle; L: Leaflet. LA: Lacunae. Magnification x 20 unless stated 
otherwise. 
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Magnified regions of Sirius red Miller's stained tissue sections shown in Fig 
3.16 were viewed under polarised light at x100 or x200 magnification (Fig 
3.17). Collagen fibres were aligned radially from the fibrosa in the posterior 
leaflet into the posterior annulus (Fig. 3.17; S3, S5), fibres were only weakly 
birefringent in Segment 5 suggesting that the majority of collagens were not 
orientated radially in this region. In the anterior region the collagen appeared 
isotropic in the trigones (Fig. 3.17; S1, S8) whilst in the mitral to aortic 
continuum fibres were aligned radially at the outer regions of the fibrosa and 
were isotropic towards the centre (Fig. 3.17 S10). 
 S10)  S8)  
  S5) 
 S1)  S3) 
Fig 3.17 – Images of Sirius red Miller's stained sections from selected 
segments of the native porcine mitral valve annulus viewed under 
polarised light microscopy. Representative images from three porcine 
annuli are shown. Section 1 had isotropic fibres x 100 magnification (S1), 
Section 3 had radially aligned fibres x 50 magnification (S3), Section 5 had 
radially aligned fibres x 50 magnification (S5), Section 8 had isotropic fibres x 
100 magnification (S8), Section 10 had isotropic fibres surrounded by radial 
fibres x 100 magnification (S10).  A: Annulus; AM: Atrial Muscle; VM: 
Ventricular Muscle; L: Leaflet. 
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3.3.5 Distribution of proteins in the extracellular matrix of the 
porcine mitral annulus 
The distribution of different structural proteins of the extracellular matrix of 
the porcine mitral valve annulus was investigated using 
immunohistochemistry  
 
3.3.5.1 Collagen I 
The anterior and posterior regions (Fig.3.18a) of the porcine mitral annulus 
were labelled with collagen I antibody. Images of annulus sections showed 
that both regions stained positive. Staining was observed in the fibrosa of 
the anterior and posterior mitral valve leaflets (Fig 3.18a; S5, S8, S10) and 
became more prominent in the annulus (Fig 3.18a; S1, S3, S5, S8, S10). In 
the trigonal region (Fig 3.18a; S1) collagen I intensity was greatest at the 
outer edges and diminished in regions where lacunae-like structures were 
apparent towards the centre. No staining was observed in the sections 
stained with the antibody isotype control (Fig 3.18b; a) or diluent alone (Fig. 
3.18b; b). 
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 S10)   S8) 
  S5) 
 S1)  S3) 
Fig 3.18a – Sections of porcine mitral valve annulus stained with 
antibody to collagen I. Representative images from three porcine 
annuli are shown. Anterior region with collagen I prominent in the outer 
layers of the thick trigones, (S1. Annulus 4, S3. Annulus 3, S8. Annulus 
4, S10. Annulus 1). Posterior region (S3. Annulus 3, S5. Annulus 4). A: 
Annulus; T: Trigone; AM: Atrial Muscle; AV: Aortic Valve; AVL: Aortic 
Valve Leaflet; VM: Ventricular Muscle; L: Leaflet. Magnification x 20 
unless stated otherwise. 
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 a)  b) 
 c)   
Fig 3.18b – Sections of porcine mitral valve annulus stained with 
antibody to collagen I. Representative images from three porcine 
annuli are shown. Isotype control (a). Diluent control (b). Porcine 
common carotid artery positive control x 50 magnification (c). A: 
Annulus; T: Trigone; AM: Atrial Muscle; AV: Aortic Valve; AVL: Aortic 
Valve Leaflet; VM: Ventricular Muscle; L: Leaflet. Magnification x 20 
unless stated otherwise. 
 
3.3.5.2 Collagen II 
Images of sections of the anterior and posterior regions (Fig. 3.19a) of the 
porcine mitral annulus labelled with antibody to collagen II showed positive 
staining in the anterior region. Positive staining was observed in the anterior 
annulus in the dense cartilage-like regions (Fig 3.19a; S1, S8, S10). Staining 
was not seen in the muscle surrounding the annulus and it gradually 
decreased in the posterior region (Fig 3.19a; S3). There was no positive 
staining in the posterior annulus region (Fig 3.19a; S5). Structures 
resembling chondrons were apparent in the anterior region surrounded by 
collagen II stained tissue (Fig. 3.19a; S10 b). No staining was observed in 
the sections stained with the antibody isotype control (Fig 3.19b; a) or diluent 
alone (Fig. 3.19b; b). 
1000 µm 
200 µm 
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 S10a)  S10b) 
  
 
 S8)  
 S5) 
 S1) S1sd  S3) 
Fig 3.19a – Sections of porcine mitral valve annulus stained with antibody to 
collagen II. Representative images from three porcine annuli are shown. 
Anterior region with collagen II prominent in the inner regions of the trigones 
(in contrast to collagen I in the outer layers), (S1. Annulus 4, S8. Annulus 3, 
S10 a. Annulus 1). Posterior region showed little evidence of collagen II, 
magnification (S3. Annulus 4, S5. Annulus 1). Anterior region showing 
chondron-like regions enclosed by collagen II (S10 b. Annulus 1). A: Annulus; 
T: Trigone; AM: Atrial Muscle; AV: Aortic Valve; AVL: Aortic Valve Leaflet; 
VM: Ventricular Muscle; L: Leaflet. Magnification x 20 unless stated otherwise. 
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 a)  b) 
 c)  
Fig 3.19b – Sections of porcine mitral valve annulus stained with antibody to 
collagen II. Representative images from three porcine annuli are shown. 
Isotype control (a). Diluent control (b). Porcine articular cartilage positive 
control (c). A: Annulus; T: Trigone; AM: Atrial Muscle; AV: Aortic Valve; AVL: 
Aortic Valve Leaflet; VM: Ventricular Muscle; L: Leaflet. Magnification x 20 
unless stated otherwise. 
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3.3.5.3 Collagen III 
Positive staining was observed in the anterior and posterior regions in 
images of sections of the porcine mitral valve annulus (Fig. 3.20a) labelled 
with antibody to collagen III. Staining was prominent in both the annulus and 
the surrounding muscle in all regions. Staining was more prominent in the 
endocardium and surfaces of the leaflets (Fig 3.20a; S1, S3, S8, S10). No 
staining was observed in the sections stained with the antibody isotype 
control (Fig 3.20b; a) or diluent alone (Fig. 3.20b; b). 
 S10)   S8) 
   S5) 
 S1)  S3) 
Fig 3.20a – Sections of porcine mitral valve annulus stained with antibodies 
to collagen III. Representative images from three porcine annuli are shown.  
Anterior region with collagen III, (S1. Annulus 4, S8. Annulus 4, S10. Annulus 
4). Posterior region with collagen III, (S3. Annulus 3, S5. Annulus 1). A: 
Annulus; T: Trigone; AM: Atrial Muscle; AV: Aortic Valve; AVL: Aortic Valve 
Leaflet; VM: Ventricular Muscle; L: Leaflet. Magnification x 20 unless stated 
otherwise. 
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 a)  b) 
 c)   
Fig 3.20b – Sections of porcine mitral valve annulus stained with antibodies 
to collagen III. Representative images from three porcine annuli are shown.  
Isotype control (a). Diluent control (b). Porcine common carotid artery positive 
control x 50 magnification (c). A: Annulus; T: Trigone; AM: Atrial Muscle; AV: 
Aortic Valve; AVL: Aortic Valve Leaflet; VM: Ventricular Muscle; L: Leaflet. 
Magnification x 20 unless stated otherwise. 
 
3.3.5.4 Collagen IV 
The images of the anterior and posterior regions (Fig 3.21a) of the porcine 
mitral annulus labelled with antibody to collagen IV revealed positive staining 
for both regions. Positive staining was observed primarily in the fibrosa of 
the leaflet and myocardium, staining was less prominent in the mitral 
annulus (Fig 3.21a; S1, S3, S5, S8). In the trigones collagen IV was 
identified in structures that resembled chondrons (Fig 3.21a; S1, S10 a, S10 
b). No staining was observed in the sections stained with the antibody 
isotype control (Fig 3.20b; a) or diluent alone (Fig 3.20b; b). 
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Fig 3.21a – Sections of porcine mitral valve annulus stained with antibody to 
collagen IV. Representative images from three porcine annuli are shown. 
Anterior region showing collagen IV (S1. Annulus 3, S8. Annulus 1, S10 a. 
Annulus 3). Brown staining observed around lacunae of anterior x 200 
magnification (S10 b. Annulus 3). Posterior region showing collagen IV (S3. 
Annulus 4, S5. Annulus 3). A: Annulus; T: Trigone; AM: Atrial Muscle; AV: 
Aortic Valve; AVL: Aortic Valve Leaflet; VM: Ventricular Muscle; L: Leaflet; LA: 
Lacunae. Magnification x 20 unless stated otherwise. 
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 a)   b)  
 c)   
Fig 3.21b – Sections of porcine mitral valve annulus stained with antibody to 
collagen IV. Representative images from three porcine annuli are shown. 
Isotype control (a). Diluent control (b). Porcine common carotid artery positive 
control (c). A: Annulus; T: Trigone; AM: Atrial Muscle; AV: Aortic Valve; AVL: 
Aortic Valve Leaflet; VM: Ventricular Muscle; L: Leaflet; LA: Lacunae. 
Magnification x 20 unless stated otherwise. 
 
3.3.5.5 Collagen VI  
Images of sections of the anterior and posterior regions (Fig 3.22a) of the 
porcine mitral annulus labelled with antibody to collagen VI showed positive 
staining in both regions. Positive staining more prominent in the muscle 
surrounding the annulus in all regions (Fig 3.22a; S1-S10) and within the 
trigones of the annulus (Fig 3.22a; S1, S8) and the mitral to atrial continuum 
(Fig 3.22a; S10). No staining was observed in the sections stained with the 
antibody isotype control (Fig 3.22b; a) or diluent alone (Fig. 3.22b; b). 
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Fig 3.22a – Sections of porcine mitral valve annulus stained with antibody to 
collagen VI. Representative images from three porcine annuli are shown. 
Anterior region showing collagen VI (S1 a. Annulus 5, S1 b. Annulus 5 x 200 
magnification, S8. Annulus 4, S10 a. Annulus 3, S10 b. Annulus 3 x100 
magnification). Posterior region showing collagen VI, (S3 a. Annulus 5, S3 b. 
Annulus 5 x100 magnification, S5. Annulus 4). A: Annulus; T: Trigone; AM: 
Atrial Muscle; AV: Aortic Valve; VM: Ventricular Muscle; L: Leaflet.  
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Fig 3.22b – Sections of porcine mitral valve annulus stained with antibody to 
collagen VI. Representative images from three porcine annuli are shown. 
Isotype control (a). Diluent control (b). Porcine articular cartilage positive 
control (c). A: Annulus; T: Trigone; AM: Atrial Muscle; AV: Aortic Valve; AVL: 
Aortic Valve Leaflet; VM: Ventricular Muscle; L: Leaflet. Magnification x 20 
unless stated otherwise. 
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3.3.5.6 Fibronectin 
Sections of the porcine mitral annulus labelled with fibronectin antibody 
stained positive in both the anterior and posterior regions (Fig 3.23a). 
Positive staining was most intense in the fibrosa leading into the annulus in 
the posterior region and in the endocardium (Fig 3.23a; S3, S5, S8). Staining 
was also visible in the trigones (Fig 3.23a; S1, S10) and myocardium in all 
regions. No staining was observed in the sections stained with the antibody 
isotype control (Fig 3.23b; a) or diluent alone (Fig. 3.23 b). 
Fig 3.23a – Sections of porcine mitral valve annulus stained with antibody to 
fibronectin. Representative images from three porcine annuli are shown. 
Anterior region showing fibronectin, (S1. Annulus, S8. Annulus 3, S10. 
Annulus 2). Posterior region showing fibronectin, (S3. Annulus 4, S5. Annulus 
3). Isotype control (a). A: Annulus; T: Trigone; AM: Atrial Muscle; AV: Aortic 
Valve; AVL: Aortic Valve Leaflet; VM: Ventricular Muscle; L: Leaflet. 
Magnification x 20 unless stated otherwise. 
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Fig 3.23b – Sections of porcine mitral valve annulus stained with antibody to 
fibronectin. Representative images from three porcine annuli are shown. 
Isotype control (a). Diluent control (b). Porcine common carotid artery positive 
control (c). A: Annulus; T: Trigone; AM: Atrial Muscle; AV: Aortic Valve; AVL: 
Aortic Valve Leaflet; VM: Ventricular Muscle; L: Leaflet. Magnification x 20 
unless stated otherwise. 
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3.3.5.7 Laminin 
Images of sections of the anterior and posterior regions (Fig 3.24a) of the 
porcine mitral annulus labelled with antibody to laminin revealed that both 
regions were stained positive. Positive staining was observed in the annulus 
and atrial and ventricular myocardium in all regions. Staining was more 
prominent in the muscle surrounding the annulus. No staining was observed 
in the sections stained with the antibody isotype control (Fig 3.24b; a) or 
diluent alone (Fig. 3.24b; b). 
 S10)  S8) 
   S5)  
 S1)  S3) 
Fig 3.24a – Sections of porcine mitral valve annulus stained with antibody to 
laminin. Representative images from three porcine annuli are shown. Anterior 
region showing laminin, (S1. Annulus 4, S8. Annulus 1, S10. Annulus 3). 
Posterior region showing laminin, (S3. Annulus 4, S5. Annulus 3). A: Annulus; 
T: Trigone; AM: Atrial Muscle; AV: Aortic Valve; AVL: Aortic Valve Leaflet; 
VM: Ventricular Muscle; L: Leaflet. Magnification x 20 unless stated otherwise. 
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 S10)  a) 
  
Fig 3.24b – Sections of porcine mitral valve annulus stained with antibody to 
laminin. Representative images from three porcine annuli are shown. 
Isotype control (a). Diluent control (b). Porcine common carotid artery 
positive control (c). A: Annulus; T: Trigone; AM: Atrial Muscle; AV: 
Aortic Valve; AVL: Aortic Valve Leaflet; VM: Ventricular Muscle; L: 
Leaflet. Magnification x 20 unless stated otherwise. 
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3.4 Discussion 
The aim of the research presented in this chapter was to characterise, 
compare and contrast the human and porcine mitral valve annulus using 
histology and immunohistochemistry. H & E stained sections were used to 
visualise the general structure of the extracellular matrix. Alcian blue stained 
sections provided information on the spatial distribution of GAGs and Sirius 
red Miller's stained sections revealed the collagen orientation and elastin 
distribution in the tissue. Immunohistochemistry was used to assess the 
spatial distribution of proteins in and around the mitral valve annulus.  
The annulus provides a foundation for the mitral valve leaflets and ensures 
complete leaflet competence during the systolic phase of the cardiac cycle. 
At the macroscopic level, the anterior region of the annulus  comprises the 
left and right fibrous trigones, with the anterior mitral leaflet forming a non-
thickened membranous septum into the aortic root between the trigones in 
human ( Walmsley, 1978; Angelini et al., 1988; Berdajs et al., 2007) and 
porcine tissue (Rijk-Zwikker et al., 1994). Observations of the histological 
sections of the annulus in the present study showed that the mitral-aortic 
continuum formed a membrane from the mitral valve anterior leaflet to the 
aortic valve. The continuum was identified in both the human and porcine 
mitral valve annulus. The major component of the continuum was the fibrosa 
which showed structural similarities between the two species. It formed a 
dense collagenous region which comprised of the central core of the human 
and porcine tissue in the mitral to aortic continuum and could be clearly 
identified in the Sirius red Miller’s stained sections. The thickness of the 
fibrosa layer in the anterior leaflet has been reported to be significantly 
greater than in the posterior region for human tissue (Kunzelman et al., 
1993) and the results of this study concurred with this for both species, albeit 
the human tissue was thicker in both anterior and posterior leaflets 
compared to the porcine mitral valve fibrosa.  
The trigones were present on either side of the mitral to aortic continuum in 
both the human and porcine annulus. Angelini et al. (1988) described the 
trigones in the human annulus as thickened well organised structures which 
were found to extend laterally around part of the annulus in some hearts. 
The results of the present work indicated a thickening of the annulus in the 
trigones of both the human and porcine annulus. In the human annulus, the 
trigonal collagenous-connective tissue extended further into the epicardial 
side of the mitral valve compared to the connective tissue in the posterior 
region, but lacked some of the features found in the porcine trigones. The 
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porcine trigones were visually more defined compared to the human 
trigones; they had the appearance of cartilage-like tissue with chondrocytes 
visible within lacunae.  
Cartilage tissue is formed, organised and maintained by chondrocytes, these 
cells are surrounded by a matrix which together form a chondron. 
Chondrons appeared to be present in the cartilage-like region in the trigones 
of the porcine annulus. This suggested that a role of the trigones may be to 
resist compression in a manner similar to cartilage. In cartilage, the 
chondron also behaves as a compression resistant membrane acting to 
protect the chondrocyte (Broom & Myers, 1980).  The presence of collagen II 
and GAGs in the trigonal tissue of the porcine annulus confirmed the 
cartilage-like properties of this region. Collagen II is a fibril forming collagen 
and the primary collagen present in articular cartilage (Gelse et al., 2003). It 
has biomechanical properties which are similar to type I collagen (Bruckner 
& van der Rest, 1994). In the trigones of the porcine annulus, collagen II was 
the primary collagen with collagen I present only in the outer regions. The 
presence of abundant GAGs in this region was also indicative of 
cartilaginous tissue. In the extracellular matrix, GAGs are found associated 
with proteoglycans. Proteoglycans consist of a protein core with numerous 
attached GAG chains. GAGs contain negatively charged groups that are 
responsible for swelling of tissue; this is what provides compressive 
stiffness. The presence of collagen II in the trigones of the porcine annulus 
may indicate why there was an abundance of GAGs. Collagen II contains 
more hydroxylysine and glucosyl and galactosyl residues than collagen I; 
these permit interaction with proteoglycans, signifying the hydrating role that 
GAGs have in cartilage (Mayne, 1989).  
Using computational modelling it has been found that the trigones undergo 
large peak stresses at peak pressure compared to other regions of the mitral 
valve annulus (Lim et al., 2005). It has been hypothesised that the function 
of cartilage found in the aortic and pulmonary valves of hamsters, birds and 
terrapins (Sans-Coma et al., 1994; López et al., 2000, 2001, 2003) is to act 
as a pivot and resist the high mechanical loads. This could also explain the 
function of cartilage-like tissue in the trigones of the porcine annulus, and 
why this region consists of a large accumulation of GAGs compared to other 
regions in the mitral valve. The cartilage-like tissue in the trigones of the 
porcine annulus may act as a structural component helping to resist 
compressive forces whilst maintaining the structure of the mitral valve under 
load. This region extended laterally towards the commissures of each leaflet 
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and gradually reduced in size until it was not visible in the posterior most 
part of the annulus.  
The lack of similar cartilage-like regions in the trigones of the human annulus 
may indicate either a difference between species or differences due to age 
of the tissue donors. Whilst collagen II was present in the human mitral valve 
annulus, the presence appeared to be due to disease rather than part of 
normal heart development. The collagen II in the human tissue was 
accompanied by calcification and signs of ossification, not just in the anterior 
region but also the posterior region. The porcine annulus was from animals 
aged 24-26 weeks old and the human tissue was from donors with a mean 
age of 69 years. It is possible that the trigones of the annulus of older pigs 
may also be absent of cartilage-like tissue. In human foetal hearts cartilage 
has been reported to be expressed during heart development in the 
endocardial cushions (Combs & Yutzey, 2009) but the presence of cartilage 
in fully developed human hearts has only been reported in diseased tissue in 
which calcification and ossification are apparent (Caira et al., 2006).  
Sirius red Miller's stained sections also revealed differences in the trigones 
between the species, there was a distribution of thick radially aligned fibres 
in the human trigones compared to the porcine trigones which appeared to 
show the presence of largely isotropic fibre distributions and high levels of 
elastin. The elastin in the porcine trigones surrounded the chondron-like 
regions which was suggestive of elastic cartilage. The high level of elastic 
fibres within the cartilage-like regions might endow the tissue with flexibility 
enabling it to withstand repeated bending whilst maintaining shape. These 
high levels of elastin were not found in the human annulus trigones but have 
been reported in cartilage foci in the aortic valve of Syrian hamsters, close to 
the attachment of the dorsal leaflet (Sans-Coma et al., 1994). Sirius red 
Millers staining provided an insight into the isotropic orientation of the 
cartilage-like tissue in this region of the porcine annulus and supports the 
theory that the proteoglycans may influence the orientation of the collagens. 
The isotropic nature of the cartilage-like tissue in the porcine annulus 
trigones may be due to osmotic forces. Osmotic forces in cartilage cause the 
proteoglycans to expand, a hydrostatic pressure of 0.35 MNm-2 acts 
isotropically leading to a predominantly isotropic structure in the collagen 
network (Ottani et al., 2001).  
The thickened fibrosa in the anterior compared to the posterior region, along 
with the trigones in both species, indicated the important structural role this 
region has in the mitral valve. This region is often attributed to the cardiac 
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skeleton in human valves (Fedak et al., 2008) where it acts to anchor the 
valve and surrounding heart tissue during the cardiac cycle. The posterior 
region of the porcine and human mitral valve annulus at the microscopic 
level consisted of a thin collagenous band of fibres which separated the 
atrial and ventricular muscle and provided insertion for the posterior leaflet.  
Compared to the differing characteristics of the trigones in the anterior 
region between species, the posterior region shared a similar morphology. 
The fibrosa is the load bearing element of the mitral valve leaflets (McCarthy 
et al., 2010) that provides effective valve closure without causing prolapse 
(Rabkin-Aikawa et al., 2004). The fibrosa layer of the leaflet of both the 
human and porcine specimens showed some radially aligned fibres that 
formed into a thin collagenous layer of the posterior annulus, with most 
fibres weakly birefringent under polarised light. The load bearing properties 
of the fibrosa appeared to continue into the posterior annulus of both species 
for anchoring the leaflets and providing effective stress distribution in the 
mitral valve during the cardiac cycle. As for the anterior region, the fibrosa of 
the posterior region was thicker in the human tissue specimens compared to 
the porcine tissue. The presence of a thicker fibrosa in the human hearts 
may be the product of age; porcine hearts tend to resemble younger human 
hearts whilst canine hearts have been found to resemble older human heart 
tissue, which are more likely to show signs of heart disease (Hearse & 
Sutherland, 2000) and an increase in the thickness of the mitral valves along 
with other heart related changes (Kitzman & Edwards, 1990) . 
 
In the posterior region of the annulus in both species an area high in GAGs 
was identified in the hinge point of the annulus where the posterior leaflet 
inserted. The presence of GAGs at the hinge of the mitral leaflet suggests 
that their role could be to resist compression in regions of tensile and 
compressive loading as the leaflets open and close, as found in the leaflets 
and chordae of the human mitral valve (Grande-Allen et al., 2004).The 
spongiosa is clearly integrated into the annulus in the human tissue in the 
posterior annulus, the spongiosa consisted of loose collagen and elastin 
fibres interspersed with GAGs. In contrast, the spongiosa of the porcine 
leaflet was not integrated into the atrial side of the mitral valve, where only 
the fibrosa of the mitral valve leaflet formed into the annulus region. 
The posterior part of the human valve comprised a high proportion of 
adipose tissue that was visible close to the epicardial side of the atrial and 
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ventricle myocardium. This adipose tissue appeared to support the coronary 
artery. In contrast to the human mitral valve the adipose tissue in the porcine 
valves was less prominent, separating the atrial and ventricular muscle only 
at the epicardial side of the valve. This adipose tissue has been suggested 
to provide a mechanical supportive structure for the vessels in the heart 
(Iozzo, 2011) and also act as an energy source for the heart and as a buffer 
against toxicity (Marchington et al., 1989). Adipose tissue is an electrical 
insulator (Petrofsky, 2008), preventing electrical impulses travelling between 
the ventricular myocardium and atrial myocardium. The increase in adipose 
tissue in the human heart is likely a feature of age (Kitzman & Edwards, 
1990). 
The presence of atrial myocardium in the annulus and basal region of the 
mitral leaflets was a feature of both species. In both species atrial muscle 
appeared circumferential in orientation close to the annulus, with the 
presence of a thin band of longitudinal fibres in the human tissue in the 
posterior region, in a layer closest to the endocardium. The circumferential 
orientation in both species suggested that the function of this muscle was to 
contract to reduce the annular area during systole and assist in valve closure 
(Boucek et al., 1978; Timek et al., 2003), this is in agreement with another 
study by Berdajs et al. (2007) who found the same arrangement in human 
tissue. The wall of the left ventricle in human hearts has been analysed by 
Ho (2009) who observed that the myocardium of the left ventricle comprised 
of three layers; the superficial, middle and deep. Ho (2002) found that the 
middle layers of the human myocardium encircled the valve and were 
thickest close to the mitral valve, in the present study it was found that the 
middle layers of the myocardium  of both the human and porcine valves 
contained fibres that ran circumferentially and were numerous and close to 
the annulus. The circumferential orientation of the muscle close to the 
annular region may explain how the human annulus undergoes a reduction 
in annular area of approximately 25% during systole (Ormiston et al., 1981; 
Flachskampf et al., 2000).  
 
There was a similar distribution of proteins present in the ECM of the 
anterior and posterior regions of the mitral valve for both species. 
Immunohistochemistry staining was used to determine the spatial 
distribution of extracellular matrix proteins in the mitral annulus and 
surrounding regions. Positive staining for collagen I, III, IV, VI, fibronectin 
and laminin was observed in all regions of the annulus, for both the human 
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and porcine annulus and surrounding regions. Collagen I and III are closely 
linked primarily structural proteins, known to be fibril forming, and confer 
mechanical strength to the tissue with their highly orientated structure (Gelse 
et al., 2003). Collagen I is the major collagen of bone, tendon and ligament 
along with other connective tissues and was distributed around the whole of 
the annulus. Collagen I has been shown to co-localise with collagen III. In 
the mitral valve annulus of both species there was evidence of the collagen I 
and collagen III network, although collagen I was more prominent in the 
fibrosa whilst collagen III was more prominent in the myocardium, adipose 
tissue and endocardium. 
There was a high concentration of collagen IV in the myocardium, on the 
leaflet surfaces and the endocardium of the mitral valve annulus and 
surrounding tissue in both the species. Collagen IV forms collagen networks 
in the basement membrane, these interlink with the laminins and 
fibronectins, to form a structure important for cell adhesion, migration and 
differentiation (Charonis et al., 1985; Khoshnoodi et al., 2008) as well as 
providing mechanical stability (Aumailley & Timpl, 1986). Collagen IV is 
prominent in the basement membrane of the myocardium and acts as an 
anchoring site for the collagen fibrils (McLeod et al., 2015). The annulus was 
largely devoid of collagen IV in both species. It was principally found 
surrounding the chondron-like regions in the trigones of the porcine tissue 
and in the mitral to aortic continuum of the porcine and human annulus.  
Collagen VI was present in both the annulus and surrounding myocardium in 
the mitral valve annulus region of both species. Collagen VI is a beaded-
filament-forming collagen that forms structural links with cells (Kadler et al., 
2007). It is found in the majority of interstitial tissues where it forms a 
network that attaches large interstitial structures such as blood vessels and 
collagen fibres to adjacent connective tissues (Keene et al., 1988). In the 
porcine annulus, collagen VI also appeared close to the chondron-like 
regions in the trigones. In cartilage, collagen VI is present in the pericellular 
matrix; its role may be to help with anchoring of chondrocytes and cell 
signalling between the cells and the extracellular matrix of the cartilage 
(Poole et al., 1992) as well as controlling the interactions within the chondron 
matrix. A similar role might occur in the porcine mitral valve annulus. 
Previous studies have shown that the collagen VI in myocardium is prevalent 
in the endomysium which distributes the loads and stresses from the 
muscle, these forces are then distributed to collagen III and then collagen I 
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(Bashey et al., 1992). It is also thought to play a role in cardiac remodelling 
by enabling myofibroblast differentiation (Naugle et al., 2006). 
One major difference between species was the heavy calcification present in 
the human mitral valve. It was important to establish the extent of 
calcification in the annulus and determine whether this posed problems for 
decellularising the human mitral valve annulus. Calcification was visible in 
the human mitral valve during excision and the subsequent analysis showed 
that in some regions collagen II had formed. Calcium forms in the heart as 
people age (Carpentier et al., 1996; Allison et al., 2006), bone formation is 
also a feature in some diseased hearts, with heterotopic ossification 
occurring quite commonly in end stage valvular heart disease (Mohler et al., 
2001). This is thought to occur due to calcium formation in the process to 
repair damaged valves; as the calcium deposits fracture, ossification of the 
tissue is stimulated and bone formation can occur in the tissue. Mohler et al. 
(2001) found that of 347 aortic and mitral valves explanted from diseased 
human heart 83 % had calcium deposits and 13 % had evidence of bone 
formation. Calcification in the valves is a passive process which is part of the 
degeneration of connective tissues whilst ossification is more of an active 
process observed in abnormal tissue repair. Cartilage development has 
been reported in diseased mitral valve lesions, following a similar path to 
that of normal skeletal bone growth that forms from a cartilaginous 
phenotype that mineralises into calcified bone (Caira et al., 2006). There are 
two possible pathways for calcification and ossification to occur in the 
diseased valves. Osteogenic cells derived from the bone marrow may enter 
the valves from the circulation to repair endothelial injury and cause 
heterotopic ossification (Egan et al., 2011). Alternatively valve interstitial 
cells can differentiate into bone cells caused by abnormal biomechanical 
stress, reactive oxygen species, inflammation and disease (Rajamannan et 
al., 2011). Calcium formation was confined in the posterior annulus in a 
study by Carpentier et al. (1996) which is in contrast to the data from the 
present study in which calcification was widespread and visible in both the 
anterior and posterior regions. A secondary limitation of using human heart 
tissue is its availability. In the UK there were 262 people on the heart 
transplant waiting list at the end of March 2015 but only 180 heart 
transplants during April 2014 to March 2015 (NHS Blood and Transplant, 
2015). Donated human hearts can be used for heart transplantation or tissue 
can be harvested from the hearts to be used for homograft replacement or 
aortic valve and pulmonary valve replacements, where the tissue has been 
subjected to decellularisation treatment. If the decellularised annuloplasty 
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ring, using human tissue as the base material, was successfully taken to 
clinic the availability of human tissue would therefore also be a limiting factor 
in its use.  Only when tissue is not suitable for clinical use is the heart tissue 
then used for research, which reduces the amount of tissue available. The 
close proximity of the aortic valve to the mitral valve means only one set of 
valves can be removed for research as the other valve will be damaged in 
the process, further reducing the number of mitral valves that can be utilised. 
Porcine tissue as an alternative is readily available and available at a low 
cost, which is a major advantage for this study.  
3.5 Conclusion 
One of the major aims of this part of the study was to determine whether 
human donor mitral valve annuli were suitable as a starting material for 
producing an acellular biological annulus for mitral valve annulus repair. The 
evidence of extensive calcification in the human donor mitral valves 
indicated that this was not a suitable way forward. Even if it was possible to 
decalcify the annuli prior to decellularisation processes, the evidence 
presented indicated that this would result in damaged tissue where the 
calcium deposits were present. The availability of the tissue is an additional 
limiting factor for human tissue use, which highlights the advantage that 
porcine tissue may have for this study.  
Based on the comparison of the human and porcine mitral valve annuli it 
was considered that the porcine mitral valve annulus may be suited for 
development as an acellular biological annuloplasty ring. Whilst there were 
many similarities between species, there were some differences. The fibrosa 
of the human mitral valve was thicker, which may influence the 
biomechanical properties of the tissue and the trigones in the human 
annulus did not contain cartilage-like tissue, with a high GAG content, as 
found in the porcine trigones. The atrial side of the annulus in human tissue 
contained a larger proportion of adipose tissue compared to the porcine 
mitral valve which contained a larger proportion of atrial myocardium. The 
younger age of the porcine tissue and the older age of the human tissue 
may have contributed to some of the differences between species due to 
age related changes. The similarities between species included the 
anatomical size, posterior region and mitral-aortic continuum. Both species 
had a muscular posterior region, separated by a thin band of collagen 
formed from the fibrosa of the posterior leaflet, the anterior contained a 
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thicker band of collagen in the left and right trigones separated by the mitral 
to aortic continuum formed of a central core of dense fibrosa.  
Due to the many similarities the porcine mitral valve annulus was found to 
share with the human mitral valve annulus the porcine annulus was used as 
the starting material for investigating decellularisation protocols developed at 
the University of Leeds, as the first step in creating an acellular biological 
annuloplasty ring device for mitral valve repair. 
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Chapter 4 
Development of a decellularised porcine mitral valve annulus 
4.1 Introduction 
Protocols have been developed for the decellularisation of a range of tissues 
that have established that the natural structure of the ECM can be retained 
in order to provide a suitable environment for cellular adhesion and 
regeneration (Wilcox et al., 2005; Mirsadraee et al., 2006; Paniagua 
Gutierrez et al., 2015). The mitral valve is inherently a complex structure, the 
leaflets are of different sizes, the chordae are numerous and have different 
mechanical characteristics (Ritchie et al., 2005) and the annulus has 
heterogeneous properties (Walmsley, 1978, Angelini et al., 1988; Berdajs et 
al., 2007; McCarthy et al., 2010). To date, attention has mainly centred on 
the development of tissue engineered chordae using directed collagen gel 
shrinkage (Shi & Vesely, 2004) and the use of pericardium for leaflet and 
annuloplasty repair, including autologous, glutaraldehyde treated human 
tissue (Chauvaud et al., 1991; Muehrcke et al., 1997; Ng et al., 2001), 
glutataldehyde treated bovine pericardium for closing perforations 
(Muehrcke et al., 1997) and decellularised porcine tissue (Morticelli et al., 
2013). Recently a preliminary study has been undertaken for the 
decellularisation of the whole mitral valve complex in sheep (Iablonskii et al., 
2015). There have been no reports of research into annuloplasty repair 
using tissue engineered devices.  
This study focuses on the decellularisation of the porcine mitral valve 
annulus with a view to clinical translation as an acellular biological 
annuloplasty ring replacement device. The porcine mitral valve has many 
similarities to the human mitral valve including anatomical dimensions and 
structure (Kunzelman et al., 1994) albeit in the pig, the extent of the mitral to 
aortic continuity is reduced (Crick et al., 1998). The major requirements of a 
successful decellularisation process for the porcine mitral valve annulus 
were that the ECM composition of tissue was retained and that the process 
had minimal effects on the biological, biochemical and biomechanical 
properties of the tissue whilst effectively removing the cells. It is 
hypothesised that if the acellular porcine annuloplasty ring was implanted 
into the heart, it would integrate into the surrounding tissue with cells 
penetrating the ring to provide remodelling and potential for repair.  
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Previous studies that have attempted to define an acellular tissue by 
quantifying the extent of decellularisation required to avoid adverse 
inflammatory reactions in-vivo whilst enabling constructive remodelling have 
led to the general acceptance of the following criteria: 
 
 DNA content of less than 50 ng. mg-1 dry weight (Crapo et al., 2011). 
 DNA fragment length of less than 180 base pairs for degradation in 
the lysosomes of macrophages (Nagata et al., 2010). 
 Nuclear material lacking in DAPI and H&E stained tissue sections 
(Crapo et al., 2011). 
 
The potential clinical use of decellularised porcine tissue may also carry the 
risk of disease transmission due to the presence of porcine endogenous 
retrovirus (PERV). It has been reported that the risk of transmission is 
removed if the DNA content post decellularisation is less than 2 % of native 
DNA per weight unit in porcine pulmonary artery scaffolds (Kallenbach et al., 
2004). 
Decellularisation of tissues can be achieved using a range of chemical and 
mechanical processes. The majority of processes use a combination of 
methods to achieve successful decellularisation of tissue. Chemical 
processes include washing the tissue in non-ionic, ionic or zwitterionic 
detergents, enzymatic digestion using proteases and nucleases and 
washing using hypertonic and hypotonic buffers. Physical methods can 
include freeze thaw, sonification, agitation or direct pressure. The type and 
concentration of detergent used, process time, tissue type and age of the 
tissue are all factors that have been shown to be important considerations in 
the removal of cellular material, damage caused to the ECM (Cartmell & 
Dunn, 2000; Booth et al., 2002; Schenke-Layland et al., 2003; Woods & 
Gratzer, 2005; Gilbert et al., 2006) and the remodelling response when 
implanted in vivo (Badylak, 2014). Previous studies have illustrated that 
successful decellularisation protocols hinge on many factors such as; the 
species from which the tissue is obtained, the age of the animal and the 
composition and density of the ECM. It will therefore be necessary to 
optimise the decellularisation protocol using chemical and physical methods 
for effective cell removal from the porcine mitral valve annulus. 
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4.1.1 Chemical methods used in tissue decellularisation  
4.1.1.1 Biological agents 
Nucleases are used to remove nuclear material from the tissues. Nucleases 
cleave the bonds of the subunits of DNA and RNA. DNase and RNase are 
endonucleases that cleave double and single stranded DNA and single 
stranded RNA but may cause an adverse immune reaction if they are from a 
bovine source (Gilbert et al., 2006). Endonucleases, such as Benzonase 
have been reported to be more effective in removing DNA as they cause 
more efficient fragmentation of DNA material. Benzonase digests all nucleic 
acids into oligonucleotides of less than ten base pairs in length (Nestle & 
Roberts, 1969; Janning et al., 1994) and rapidly hydrolyses DNA and RNA 
(Nestle & Roberts, 1969). Nucleases are used after the cell and nuclear 
membranes in tissues have been disrupted to ensure effective removal of 
nuclear material. 
EDTA is a chelating agent, which is often incorporated into decellularisation 
processes. EDTA chelates calcium and magnesium ions which disrupts the 
cell-matrix interactions. By disrupting the attachment of cells to the ECM the 
level of cell removal can be improved (Klebe, 1974; Gailit & Ruoslahti, 
1988). 
Protease inhibitors such as aprotinin, phenylmethylsulfonyl fluoride and 
leupeptin have been used during decellularisation processes to prevent 
proteinases released from lysed cells degrading the proteins of the ECM. 
They have been reported to be useful in preventing damage to the ECM 
caused by proteases released by cells during the decellularisation process  
(Gilbert et al., 2006). 
The epitope α-gal is expressed widely on the cell surface glycoproteins and 
glycolipids of mammals except for humans, old world monkeys and apes. 
The presence of this epitope in implanted xenogeneic tissue causes 
hyperacute rejection and failure of the graft (Konakci et al., 2005).  
Decellularisation processes may remove most of the α-gal epitopes but 
tissue can also be treated with α-galactosidase to reduce the content of the 
α-gal epitope within the decellularised tissue (Choi et al., 2012). 
4.1.1.2 Detergents 
There are three types of detergent used for the decellularisation of tissue; 
non-ionic, ionic and zwitterionic. These operate by solubilising cell 
membranes and causing DNA dissociation from proteins (Crapo et al., 
2011). Detergents are often used near the start of the process to initiate the 
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disruption of the cell membranes but have been reported to cause 
ultrastructural damage to the ECM and growth factor removal (Booth et al., 
2002; Reing et al., 2010).  
Non-ionic detergents such as Triton X-100 disrupt lipid-lipid and lipid-protein 
interactions of the cells, caused by the uncharged hydrophilic head group on 
the detergents. Due to the disruption of the cell membranes, cell lysis is 
facilitated. The non-ionic detergents interact with the cell membrane and 
form micelles by penetrating between membrane bilayers when used at a 
suitable detergent concentration. They are advantageous for 
decellularisation due to their limited capacity for disrupting protein-protein 
interactions in the ECM. Non-ionic detergents, however have been reported 
to disrupt the basement membrane (Nakayama et al., 2010), reduce GAG 
content (Vavken et al., 2009) and change the ultrastructure of the tissue 
(Grauss et al., 2005; Hyoungshin Park et al., 2011) whilst complete 
decellularisation is not always achieved (Lumpkins et al., 2008; Nakayama 
et al., 2010).  
Ionic detergents such as sodium dodecyl sulphate (SDS), sodium 
deoxycholate and Triton X-200 have hydrophobic head elements that 
solubilise and denature the membranes of the cells and nucleus. Such 
detergents have been shown to be successful in removing cell and nuclear 
elements from tissue but at certain concentrations have been found to 
remove essential ECM components such as collagen fibres, GAGs and 
growth factors (Gilbert et al., 2006; Lumpkins et al., 2008; Nakayama et al., 
2010; Stapleton et al., 2008). Concentrations of SDS of 0.1% (w/v) facilitated 
the removal of cellular material without causing substantial damage to the 
ECM (Booth et al., 2002). Concentrations of SDS of 1% (w/v) and higher 
have been found to change the biomechanical properties of tissues in some 
studies (Nakayama et al., 2010) but have been reported to have no effect on 
the biomechanical properties of tissue in others (Lumpkins et al., 2008).  
Zwitterionic detergents, such as 3-[(3-cholamidopropyl)dimethylammonio]-1-
propanesulfonate (CHAPS), combine the properties of non-ionic and ionic 
detergents, having both positive and negatively charged groups with an 
overall net charge of zero. Using CHAPS, Dahl at al. (2003) removed cells 
from the ECM of arteries but altered the biomechanical properties of the 
tissue. 
It is important to include multiple wash cycles post detergent washes in the 
decellularisation process to remove any residual detergent. Detergents can 
be cytotoxic and prevent cells from integrating back into the ECM once 
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implanted (Booth et al., 2002). This can be counteracted by introducing 
multiple wash cycles (Cebotari et al., 2010).  
4.1.1.3 Hypotonic/hypertonic buffers 
Use of hypotonic and hypertonic buffers disrupts the osmotic balance of the 
cells. Exposure of cells to hypotonic solutions causes cell lysis by the 
movement of water into the cell and causes the cell to swell and burst. 
Hypertonic solutions help to dissociate DNA from proteins (Cox & Emili, 
2006). These solutions are both commonly used during the decellularisation 
process and can be used to wash any cell debris out of the tissue. 
4.1.1.4 Acids 
Acids, such as peracetic acid (PAA), are often used at the end of the 
decellularisation process to disinfect the tissue whilst also aiding in the 
decellularisation process by removing nucleic acids. They play a role in 
decellularisation by helping to solubilise cellular components by hydrolytic 
degradation. Compared to gamma irradiation and ethylene oxide sterilisation 
methods, the use of PAA has been reported to give rise to improved cell 
attachment and increased matrix porosity without negatively affecting the 
mechanical properties of decellularised tissue (Woon et al., 2011; Matuska & 
McFetridge, 2015). 
4.1.2 Physical methods 
Physical methods can be used to implement cell lysis and increase the 
permeability of tissue to allow chemical methods to work more effectively. 
Freeze thaw cycles can be used at the start of the decellularisation process 
to increase permeability of the ECM and cause cell lysis. Freeze/thaw cycles 
facilitate cell lysis and ECM permeability by the formation of ice crystals 
within the tissue and cells. Freeze/thaw cycles can have a negative effect on 
the ECM due to the ice crystal formation which may damage the matrix.   
Another method that disrupts cells is sonification. Sonification generates 
ultrasound waves that cause disruption to the cell by cavitation. Bubbles 
form in the liquid which is subject to sonification which compress and 
decompress at high frequencies causing shock waves to the cell membrane, 
leading to cell lysis. Sonification has been used to create a more porous 
ECM in decellularised anterior cruciate ligament so that cells extrinsic to the 
tissue could migrate into the scaffold (Ingram et al., 2007). 
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Abrasion is an alternative method that encourages the removal of cells by 
the application of direct force on the ECM but has been found to have a 
negative effect on the ECM (Hopkinson et al., 2008). 
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4.2 Aims 
The aim of this chapter was to optimise the decellularisation protocols 
developed by Booth et al. (2002) and Stapleton et al. (2008) for 
decellularisation of porcine aortic valves and menisci and adapt the 
approaches for porcine mitral annuli. The acellularity of the tissue during the 
development of the process was assessed, initially using histology and DNA 
content analysis. The process involved the optimisation of proprietary 
protocols previously developed at the University of Leeds using repeated 
cycles of low concentration SDS in the presence of proteinase inhibitors and 
hypotonic buffer. 
4.3 Objectives 
 To develop a decellularisation protocol to remove the cells and cell 
debris from the porcine mitral valve annulus without damaging the 
underlying the histioarchitecture  
 
 Characterise the decellularised porcine mitral valve annulus and 
compare it to native porcine mitral annulus using the following 
techniques: 
 
o Histological characterisation looking at H&E, Sirius Red Millers 
and Alcian Blue staining and DAPI 
o Immunohistochemistry  
o DNA quantification 
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4.4 Methods 
4.4.1 Decellularisation solutions 
4.4.1.1 EDTA solution (10% w/v EDTA) 
EDTA (10 g) was dissolved in 90 ml of distilled water with two sodium 
hydroxide pellets whilst being stirred and then the pH was adjusted to 8.0. 
The solution was topped up to 100 ml with distilled water and then 
autoclaved at 121oC. The solution was stored at room temperature for up to 
one month.  
4.4.1.2 SDS solution (10%; w/v SDS) 
Sodium dodecyl sulphate (10 g) was dissolved in 100 ml of distilled water 
using a magnetic stirrer. The solution was passed through a 0.2 µm filter into 
a sterile container in a class II safety cabinet and stored at room temperature 
for up to one month.  
4.4.1.3 BSA solution (5 mg.ml-1 BSA) 
Bovine serum albumin (250 mg) was dissolved into 50 ml of distilled water 
using a magnetic stirrer. The solution was passed through a 0.2 µm filter into 
a sterile container in class II safety cabinet and used immediately or stored 
at -20oC for up to six months. 
4.4.1.4 Magnesium Chloride (1M) 
Magnesium chloride (2.03 g) was dissolved in 10 ml distilled water using a 
magnetic stirrer and then autoclaved at 121oC and stored at room 
temperature for up to one week. 
4.4.1.5 Magnesium Chloride (10M) 
Magnesium chloride (20.3 g) was dissolved in 10 ml distilled water using a 
magnetic stirrer and then autoclaved at 121oC and stored at room 
temperature for up to one week. 
4.4.1.6 Hypertonic solution (50 mM tris, 1.5 M sodium chloride) 
Sodium chloride (87.66 g) and 6.06 g of Tris was dissolved into 900 ml of 
distilled water and the pH was adjusted to 7.5 – 7.7. The volume was made 
up to 1000 ml using distilled water and autoclaved at 121oC and stored at 
room temperature for up to one week. 
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4.4.1.7 Hypotonic buffer (10 mM tris, 2.7 mM EDTA, 10 KIU.ml-1 
aprotinin) 
Trizma base (1.21 g) and 1 g EDTA were dissolved into 450 ml of distilled 
water and the pH was adjusted to 8.0 – 8.2 using 6 M NaOH or 6 M HCL. 
The solution was made up to 1000 ml and autoclaved at 121 oC and stored 
at room temperature for up to one week. Prior to use 1 ml of aprotinin 
(10,000 KIU.ml-1) was added aseptically. 
4.4.1.8 SDS hypotonic buffer (0.1 %; w/v SDS, 2.7 mM EDTA, 10 KIU.ml-1 
aprotinin) 
On the day of use, 5 ml of SDS solution was added to 495 ml of hypotonic 
buffer. Prior to use 0.5 ml of aprotinin (10,000 KIU.ml-1) was added 
aseptically. 
4.4.1.9 Nuclease solution 1 (50 mM Tris, 10 mM MgCl2, 50 U.ml
-1 DNase, 
1 U.ml-1 RNase) 
Trizma base (3.05 g) and 1.0 g of magnesium chloride were dissolved in 40 
ml of distilled water and adjusted to pH 7.5 – 7.7 using 6 M NaOH or 6 M 
HCL. The solution was made up to 500 ml with distilled water and 
autoclaved at 121oC and stored at room temperature for up to one week. 
Ten minutes prior to use 1 ml of RNase stock (100U.ml-1) and 0.5 ml DNase 
stock (10,000 U.ml-1) were added aseptically. 
4.4.1.10 Nuclease solution 2 (50 mM Tris,10 mM MgCl2 , 1 U.ml
-1 
Benzonase) 
Trizma base (6.1 g) and 2 g magnesium chloride were dissolved in 80 ml 
distilled water using a magnetic stirrer and stirrer bar. The pH was adjusted 
to 7.5 - 7.7 using 6 M NaOH or 6 M HCL. The volume was made up to 1000 
ml with distilled water and autoclaved at 121 °C and stored at room 
temperature for up to one week. Prior to use 40 µl of Benzonase was added 
to 1000 ml of the buffer aseptically. 
4.4.1.11 Nuclease solution 3 (50 mM Tris,1 mM MgCl2 , 10 U.ml
-1 
Benzonase) 
Trizma base (6.1 g) and 0.2 g magnesium chloride were dissolved in 80 ml 
distilled water using a magnetic stirrer and stirrer bar. The pH was adjusted 
to 7.5 - 7.7 using 6 M NaOH or 6 M HCL. The volume was made up to 1000 
ml with distilled water and autoclaved at 121 °C and stored at room 
temperature for up to one week. Prior to use 400 µl of Benzonase was 
added to 1000 ml of the buffer aseptically. 
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Working solutions: 
4.4.1.12 PBS  
PBS was prepared in accordance with the protocol in Section 2.1.3.1 and 
stored at room temperature for up to one month.  
4.4.1.13 PBS wash buffer with aprotinin (10 KIU.ml-1 aprotinin) 
Aprotinin (0.5ml, 10,000 KIU.ml-1) was added aseptically to 499.5 ml of PBS 
and used within one hour of preparation. 
4.4.1.14 Peracetic acid (PAA) solution (0.1 %; v/v) 
PAA solution (1.57 ml) was added to 500 ml of autoclaved PBS aseptically 
and adjusted to pH 7.2 – 7.5 using 6 M NaOH or 6M HCL and used within 
one hour of preparation. 
4.4.1.15 PBS wash buffer with EDTA, Aprotinin 
EDTA (10%, 5ml) produced as described in Section 4.4.1.1 and 0.5 ml 
aprotinin (10,000 KIU.ml-1) were aseptically added to 494.5 ml of PBS and 
used within one of preparation. 
 
4.4.2. Decellularisation of the porcine mitral annulus 
Several methods were tested for effectively removing cells and DNA from 
the porcine mitral valve annulus, as described below (Methods 1-8). For the 
application of each method, native porcine mitral annuli (n=3) were thawed 
from frozen storage at -200C and each annulus initially placed into a 150 ml 
plastic pot after which 80 ml of solution was added and the pots were laid 
horizontally. Each wash was carried out at 240 rpm at 42 oC apart from the 
nuclease step which was carried out at 80 rpm at 37 oC and the post PAA 
(0.1 % w/v) washes which were carried out at 240 rpm at 4 oC. All wash 
solutions used were sterile as indicated above and pre-warmed to the 
correct temperature prior to use. All decellularisation methods were carried 
out aseptically with solution changes carried out in a class II safety cabinet.  
4.4.2.1 Method 1 - 1 cycle SDS 
Porcine mitral valve annuli were removed from porcine hearts and stored at -
20oC on filter paper soaked in PBS until required, using the method 
described in Section 2.2.2.3. Each annulus was thawed for three hours at 
room temperature and placed into sterile 150 ml pots with 80 ml of hypotonic 
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Tris buffer (10 mM) at 42oC for 21 hours. The annuli were washed for a 
further 21 hours with SDS hypotonic buffer (0.1 % w/v SDS) at 42oC. 
Following this the annuli were washed thrice using PBS wash buffer with 
aprotinin for 30 minutes each at 42oC and then a further wash at 42oC for 66 
hours. The annuli were then washed thrice using PBS wash buffer with 
aprotinin for 20 minutes each at 42oC and then a further wash for 24 hours. 
The annuli were washed in nuclease solution with magnesium chloride (10 
mM) and Benzonase (1 U.ml-1), twice for 2.5 hours at 37oC. They were then 
washed twice using PBS wash buffer for 20 minutes at 42oC and washed for 
a further 21 hours in PBS at 42oC. Following this the annuli were washed in 
hypertonic buffer for 21 hours at 42oC. The tissue was then washed twice in 
PBS for 15 minutes each at 42oC. The annuli were then disinfected using 
peracetic acid (0.1% v/v) solution for four hours at room temperature and 
washed three times using PBS for 30 minutes each at 42 oC and then 
washed for 66 hours at 42 oC. The annuli were stored in PBS without 
calcium and magnesium at 4oC for up to one week or used immediately for 
analysis as described in Section 4.4.3. 
 
4.4.2.2 Method 2 – 2 cycles SDS 
The process described in Method 1 was amended to include one extra cycle 
of hypotonic and SDS hypotonic buffer washes for 24 hours each, taking 
place directly after the first cycle. 
 
4.4.2.3 Method 3 – 3 cycles SDS 
The process in described in Method 1 was amended to include two extra 
cycles of hypotonic and SDS hypotonic buffer washes for 24 hours each, 
taking place directly after the first cycle. 
 
4.4.2.4 Method 4 – RNase and DNase 
The process described in Method 2 was altered by changing the Benzonase 
for RNase (1 U.ml-1) and DNase (50 U.ml-1) (Section 4.4.1.9) for the 
nuclease digestion step.  
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4.4.2.5 Method 5 - 2 cycles of SDS with freeze thaws  
Extra steps of muscle removal were incorporated into the dissection process 
so that approximately 2-5 mm of muscle remained. The mitral annuli were 
thawed at 37oC for two hours and frozen at -20oC overnight, the tissue was 
then thawed at room temperature for three hours and then frozen at -20oC in 
hypotonic buffer overnight. The annuli were then subject to the process 
described in Method 2.  
4.4.2.6 Method 6- Increased Benzonase and reduced magnesium 
chloride concentration  
Method 5 was used with the exception being that the Benzonase 
concentration was increased to 10 U.ml-1and the magnesium chloride 
concentration was reduced to 1 mM. In addition, the decellularisation 
process was carried out in 250 ml pots with 150 ml of solutions throughout.  
 
4.4.2.7 Method 7 - 6 x freeze thaw  
Method 6 was applied following the addition of further cycles of freeze thaw. 
After the initial freeze thaw cycle the tissue was frozen at -20oC overnight, 
thawed at room temperature for three hours and then frozen at -20oC in 
hypotonic buffer overnight and thawed at room temperature, this was 
repeated for two more cycles. There were six freeze thaw cycles in total. 
 
4.4.2.8 Method 8 - Multiple wash cycles 
Method 6 was applied with the addition of further washes after the PAA step 
and 66 hour PBS wash. The annuli were washed thrice in PBS for 30 
minutes each at 4 oC and washed for 24 hours in PBS, the tissue was 
washed thrice again in PBS at 4 oC for 30 minutes each and washed for 24 
hours in PBS. Following this the annuli were subject to a final wash cycle of 
three PBS washes at 4 oC for 30 minutes each and one for 24 hours. The 
annuli were stored in PBS without calcium and magnesium at 4 oC and used 
for analysis as described in Section 4.4.3. 
 
4.4.3 Determination of the effectiveness of the decellularisation 
methods (Methods 1-8) 
In order to determine the effectiveness of each of the decellularisation 
protocols applied to the mitral annulus, following the application of each 
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method (Methods 1-8), porcine mitral valve annuli (n=3) were evaluated 
using histology to assess the extent of cell removal and any damage to the 
histioarchitecture. The total DNA content of the annuli (n=3) was also 
determined and compared to the total DNA content of native porcine mitral 
annuli to determine the extent of DNA removal. 
The annuli were analysed in the two main regions, the anterior and posterior. 
For H&E and DAPI staining the two regions analysed were the left anterior 
trigone (Fig 4.1 S1) and posterior annulus (Fig 4.1 S2). For DNA 
quantification the annuli were split into the right anterior trigone (Fig 4.1 
Adna) and the posterior annulus (Fig 4.1 Pdna) using the same tissue 
samples.  
 
Fig 4.1 – Mitral valve annulus, following application of various 
decellularisation methods split into segments Regions selected for 
histological l investigation of tissue sections using H&E, DAPI and DNA 
quantification. Histology: Anterior left trigone (S1. Yellow segment), 
Posterior right (S5. Yellow segment). DNA quantification: Posterior left 
(Pdna. S3-S4. Blue segment), Anterior right trigone (Adna. S8-S9. Blue 
segment).  
 
4.4.3.1 Histological evaluation of the porcine mitral valve annuli 
following application of various decellularisation methods 
The tissue specimens (n=3) were fixed in zinc for 24 hours and processed 
for standard histology as described in Section 2.2. Sections from the anterior 
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and posterior regions (Fig 4.1) were stained with H&E (Section 2.2.4.1) and 
DAPI (Section 2.2.4.4). 
4.4.3.2 DNA quantification of the porcine mitral valve annuli following 
application of various decellularisation methods 
Samples were processed for total DNA extraction by the DNaesy Blood & 
Tissue Kit (Qiagen, Texas, USA). Approximately 25 mg of native tissue (n=3) 
and 250 mg of processed tissue (n=3) was macerated and placed into sterile 
2 ml microcentrifuge tubes. Proteinase K (20 µl) and 180 µl of Buffer ATL 
were added to each tube of fresh tissue and 40 µl of proteinase K and 360 µl 
of Buffer ATL was added to each tube of decellularised tissue. Samples 
were mixed by vortexing and incubated overnight at 56 oC in a water bath 
and vortexed to disperse the sample. Buffer AL (200 µl) and ethanol (200 µl) 
were mixed and added to the fresh samples and 400 µl of Buffer AL and 400 
µl ethanol were mixed and added to the decellularised samples and then 
vortexed. From each sample, 600 µl was transferred to a DNeasy Mini spin 
column which was placed within a 2 ml collection tube and centrifuged at 
6000 x g for one minute. The flow through was discarded and the process 
was repeated until no sample remained in the microcentrifuge tubes. The 
spin columns were placed into new 2 ml collection tubes and 500 µl of buffer 
AW1 was added to each sample and centrifuged at 6000 x g for one minute, 
discarding the flow through and collection tube. Each spin column was 
placed into a new collection tube and 500 µl of Buffer AW2 was added to 
each sample and centrifuged at 20000 x g for three minutes which dried the 
spin column membrane. The spin columns were placed into 2 ml 
microcentrifuge tubes and 200 µl of buffer AE was placed onto the spin 
column membrane and left to incubate at room temperature for one minute. 
The tubes were then centrifuged at 6000 x g for one minute to elute the 
substances from the membrane. The DNA samples were stored temporarily 
at 4oC and then quantified using a nanodrop spectrophotometer and 
checking for absorbance at 260 nm. Buffer AE was used as a blank.  
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4.5 Results 
The extent of decellularisation for each method of decellularisation was 
examined by H&E for Method 1, H&E and DAPI for Methods 2-4 and H&E, 
DAPI and DNA quantification for Methods 5-8, with comparisons made to 
native porcine mitral valve annuli. The initial results of decellularisation using 
a single cycle of SDS followed by hypotonic SDS wash did not yield tissue 
void of cellular material. The protocol was altered in attempts to increase the 
removal of cells and nuclear material, as visualised in histological tissue 
sections stained with H&E. Once initial progress had been made subsequent 
tissues were analysed using DAPI stained histology sections for visual 
assessment of dsDNA remaining within the tissue. DNA quantification was 
then utilised once it was apparent that dsDNA was not visible with DAPI 
staining. 
 
4.5.1 Method 1: One cycle of SDS 
H&E stained sections of the tissue that had been subject to decellularisation 
Method 1 (Fig 4.2a; a, b) revealed the presence of cells and nuclear material 
in both the annulus and surrounding muscular tissue in all regions. Cells 
within the posterior region were elongated and had the appearance of 
fibroblasts elongated in the direction of collagen fibres. Cardiomyocytes 
were present in tissue surrounding the annulus with cell nuclei clearly visible. 
Cells appeared to be absent in the loose connective tissue bordering the 
myocardium. The general structure of the tissue was well maintained with no 
obvious signs of damage. No further analysis of the tissue was undertaken 
due to the failure to remove cellular material with this protocol. 
4.5.2 Method 2: Two cycles of SDS 
Following the addition of an extra cycle of hypotonic SDS washes the 
content of cellular material present had visibly reduced in the H&E stained 
tissue sections. Cellular material was present within the lacunae of the 
trigonal region (Fig 4.2a; c) which had the appearance of chondrocytes. H&E 
stained sections showed purple haematoxylin staining of the chondrocyte-
like nuclear membrane with pink eosin staining within the nucleus, the 
cytoplasm appeared to have been removed. In the posterior region 
decellularisation appeared to be successful with no visible cell nuclei (Fig 
4.2a; d) or fibroblasts. Observations of DAPI stained tissue sections 
revealed remnants of dsDNA, predominantly in the anterior annulus in the 
trigones (Fig 4.3 a).  
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4.5.3 Method 3: Three cycles of SDS 
Following the addition of an extra two cycles of SDS washes to the 
decellularisation process the content of cellular material present within the 
tissue had reduced in H&E stained tissue sections compared Method 1.  
There was no visible difference in the results obtained using two SDS wash 
cycles (Fig 4.2b; e, f) compared to three SDS wash cycles. Interrogation of 
DAPI stained sections revealed staining for nuclear material in the anterior 
region in the trigones (Fig 4.3 b).  
4.5.4 Method 4: RNase and DNase 
Benzonase was replaced by RNase and DNase to establish if DNase was 
more effective at cleaving nuclear material from the lacunae present in the 
trigonal region. In H&E stained sections, cell nuclei were visible in both the 
anterior region (Fig 4.2b; g) within the lacunae and in the posterior region 
(Fig 4.2b; h) with the presence of fibroblast nuclei. Observations of DAPI 
stained sections showed an apparent lack of dsDNA in the tissues (Fig 4.3 
c). Benzonase was retained for the nuclease step due to DNase and RNase 
offering no improvement in the removal of cellular material compared to the 
Benzonase. In H&E stained sections for the RNase and DNase treated 
tissue there was some nuclei visible in the posterior region which were 
absent with the Benzonase treated H&E stained sections. 
4.5.5 Method 5: Two freeze thaw cycles 
An extra freeze thaw cycle was added to the start of the decellularisation 
process in an attempt to open up the tissue structure and allow better 
diffusion of decellularisation solutions. Freeze thaw cycles might also 
increase damage inflicted on the cells prior to chemical decellularisation. 
Damage to the ECM ultrastructure was shown to be minimal in H&E stained 
tissue sections (Fig 4.2b; i, j) but nuclear debris remained within lacunae (Fig 
4.2b; i). There was no visible positive staining with DAPI in tissue sections 
(Fig 4.3 d). DNA quantification revealed that there was 5.7 ± 2.21 ng.mg-1of 
DNA per wet weight of tissue remaining in the anterior region, representing 
94.6% removal of DNA compared to native tissue with 105.32 ± 1.88 ng.mg-1 
of DNA per wet weight of tissue (p < 0.05) and 4.46 ± 2.85 ng.mg-1 per wet 
weight of tissue remaining in the posterior region equating to 97.5% removal 
of DNA compared to native tissue with 179.07 ± 10.922 ng.mg-1 of DNA per 
wet weight of tissue (p < 0.05) (Fig 4.4).  
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4.5.6 Method 6: Increased Benzonase and reduced magnesium 
chloride concentration 
Method 5 was altered by changing the nuclease and magnesium 
concentrations in the nuclease treatment step in order to optimise the 
performance of the Benzonase enzyme and increasing the wash volumes to 
remove potentially toxic SDS remnants and enhance removal of cellular 
material. There were no visible nuclei in H&E stained sections of the 
posterior region (Fig 4.2c; l) but the lacunae in the anterior region (Fig 4.2c; 
k) had cellular debris remaining. There was no visible damage to the tissue 
structure and observations of DAPI stained sections showed no positive 
staining for dsDNA (Fig 4.3 e). DNA quantification revealed 1.05 ± 1.06 
ng.mg-1 of DNA remaining per wet weight of tissue in the anterior region, 
representing 99.14% removal of DNA with 122.42 ± 54.39 ng.mg-1 of DNA 
per wet weight of tissue (p < 0.05) and 3.79 ± 1.2 ng.mg-1 per wet weight of 
tissue remaining in the posterior region equating to 98.99% removal of DNA 
(p < 0.05) compared to native tissue with 374.21 ± 183.43 ng.mg-1 of DNA 
per wet weight of tissue (Fig 4.4). 
4.5.7 Method 7: Multiple freeze thaw cycles 
Multiple freeze thaw cycles were added to the start of the decellularisation 
process. Multiple freeze thaw cycles might increase cell lysis and disrupt the 
ECM enabling solutions to diffuse into the tissue with greater effectiveness. 
Observations of H&E stained tissue sections revealed the presence of 
apparent cell debris remaining the lacunae of the anterior region of the 
annulus (Fig 4.2c; m). The morphology of the tissue appeared damaged 
compared to native tissue and all previous decellularisation methods. The 
muscular region (Fig 4.2c; n) and lacunae were visibly dilated with holes in 
the structure. Observations of DAPI stained sections of the processed tissue 
revealed the presence of dsDNA in the trigonal region where the lacunae 
resided (Fig 4.3 f). DNA quantification revealed 1.75 ± 1.46 ng.mg-1 of DNA 
remaining in the anterior region per wet weight of tissue, representing 
98.57% (p < 0.05) removal of DNA with 122.42 ± 54.39 ng.mg-1 of DNA per 
wet weight of tissue and 3.18 ± 1.25 ng.mg-1 per wet weight of tissue 
remaining in the posterior region equating to a 99.15 % removal of DNA (p < 
0.05) compared to native tissue with 374.21 ± 183.43 ng.mg-1 of DNA per 
wet weight of tissue (Fig 4.4). 
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4.5.8 Method 8: Multiple wash cycles post PAA sterilisation 
In Method 8 multiple wash cycles were added to the process described as 
Method 6, after the PAA sterilisation step. Examination of H&E stained 
tissue samples revealed the tissue to be predominantly free of cellular 
material with improved removal of cellular debris from the lacunae region 
(Fig 4.2c; o) and no visible cells remaining in the posterior region (Fig 4.2c; 
p). Evaluation of DAPI stained sections did not reveal the presence of ds 
DNA (Fig 4.3 g). DNA quantification revealed 2.56 ± 0.73 ng.mg-1 of DNA 
remaining per wet weight of tissue in the anterior region, 97.83 % removal of 
DNA with 155.76 ± 61.63 ng.mg-1 of DNA per wet weight of tissue (p < 0.05) 
and 2.92 ± 2.11 ng.mg-1 per wet weight of tissue remaining in the posterior 
region equating to a 99.07 % removal of DNA compared to the native tissue 
with 304.44 ± 164.72 ng.mg-1 of DNA per wet weight of tissue (p < 0.05) (Fig 
4.4).  
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Anterior (S1) Posterior (S5) 
a) b) 
c) d) 
Fig 4.2a – Images of H&E stained sections from anterior and posterior 
segments of the porcine mitral valve annulus decellularised using 
different methods. Method 1 - Images of H&E stained sections of 
decellularised porcine mitral annulus using one cycle of SDS. Anterior 
region of annulus (a), Posterior part of the annulus (b). Method 2 - Two 
cycles of SDS. Anterior region of annulus (c), Posterior part of the 
annulus (d). Magnification x 200 unless stated otherwise. Images are 
representative of the results obtained from n = 3 annuli. 
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Anterior (S1) Posterior (S5) 
e) f) 
g) h) 
i) j) 
Fig 4.2b – Images of H&E stained sections from anterior and posterior 
segments of the porcine mitral valve annulus decellularised using 
different methods. Method 3 - Three cycles of SDS. Anterior region of 
annulus magnification x 100 (e), Posterior part of the annulus 
magnification x 400 (f). Method 4 - RNase and DNase. Anterior region 
of annulus (g), Posterior part of the annulus magnification x 100 (h). 
Method 5 -Two freeze thaw cycles and increased muscle removal. 
Anterior region of annulus (i), Posterior part of the annulus (j). 
Magnification x 200 unless stated otherwise. Images are representative 
of the results obtained from n = 3 annuli. 
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Anterior (S1) Posterior (S5) 
k) l) 
m) n) 
o)  p)  
Fig 4.2c – Images of H&E stained sections from anterior and posterior 
segments of the porcine mitral valve annulus decellularised using 
different methods. Method 6 - Optimised nuclease concentration. 
Anterior region of annulus magnification x 400 (k), Posterior part of the 
annulus magnification x 400 (l). Method 7 - Six times freeze thaw 
cycles. Anterior region of annulus magnification x 400 (m), Posterior 
part of the annulus magnification x 400 (n). Method 8 - Final wash with 
multiple post PAA washes. Anterior region of annulus magnification x 
400 (o), Posterior part of the annulus (p). Magnification x 200 unless 
stated otherwise. Images are representative of the results obtained 
from n = 3 annuli. 
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a)  b)  
c)  d)  
e)  f)  
g)  h)  
Fig 4.3 – Images of DAPI stained sections from segments of the porcine mitral 
valve annulus decellularised using alternative methods. Images of DAPI 
stained sections of decellularised porcine mitral valve annulus. Method 2 - 
Two cycles of SDS (a). Method 3 - Three cycles of SDS (b). Method 4 - 
RNase and DNase magnification x 20 (c). Method 5 -Two freeze thaw cycles 
and increased muscle removal (d). Method 6 - Optimised nuclease 
concentration (e). Method 7 - Six times freeze thaw cycles (f). Method 8 - 
Final wash with multiple post PAA washes (g). Fresh native control tissue (h). 
Magnification x50 unless stated otherwise. Images are representative of the 
results obtained from n = 3 annuli. 
200 µm 200 µm 
200 µm 
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Fig 4.4 – DNA content of native and decellularised mitral valve annulus 
decellularised using Methods 5 to 8. Data is presented as the mean 
(n=3) ± 95% C.I and was analysed by unpaired student`s t-test (native 
vs dCELL for each method) that showed significant differences 
between all native and dCELL groups (p < 0.05*). 
 
4.6 Discussion 
The aim of the research presented in this chapter was to develop a 
decellularisation method to remove the cell nuclei and cellular debris from 
the porcine mitral annulus, leaving only the ECM scaffold of the tissue and 
create a material free from the major immunogenic components.  
Extracellular matrix proteins that are conserved across higher mammalian 
species, such as collagens should not invoke an immune response in man 
since they would not be recognised as foreign. This initial protocol was 
based upon work previously completed by Booth et al. (2002) and Stapleton 
et al. (2008) for decellularisation of porcine aortic valves and menisci. Low 
concentrations of SDS were used to avoid possibly toxic levels that would 
prevent cell integration when used in vivo. Concentrations of SDS, when 
used in decellularisation protocols, of 1 % and above have been found to 
result in tissues which are toxic to cells and damage the collagen in the ECM 
(Booth et al., 2002). The protease inhibitor aprotinin was included in the 
early stages of the decellularisation procedure to prevent breakdown of the 
ECM caused by release of proteases by the cells when being lysed. 
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The initial process using one cycle of SDS with hypotonic buffer was 
performed to establish if cells could be removed with minimal processing 
and damage to the ECM. Histological analysis of processed tissue revealed 
that the extent of cell removal when compared to native porcine mitral valve 
annuli was negligible, with visible cell nuclei remaining in both the annulus 
and muscle surrounding it. Increasing the number of SDS and hypotonic 
buffer cycles during tissue processing had a notable effect on cell removal 
with a decrease in visible cell nuclei in the annulus and myocardium 
although cell debris was still visible in the trigones whilst retaining the overall 
tissue structure. The use of two and three cycles of SDS washes in the 
decellularisation process were compared to ascertain the optimal number of 
cycles for cell removal. Histological evaluation of processed tissues revealed 
similar results using both methods with residual material present in the 
trigones and some evidence of cell nuclei in the myocardium. Further 
analysis was undertaken of DAPI stained tissue sections to visualise any 
remaining dsDNA in the decellularised tissue which showed no difference 
between methods. The lack of complete decellularisation suggested that 
increasing the number of SDS wash cycles alone was insufficient for 
complete removal of cellular material. Increased numbers of SDS washes 
also had the potential to increase damage to the ECM and cause cytotoxicity 
(Booth et al., 2002; Elder et al., 2009; Gilbert et al., 2006; Hudson et al.; 
Lumpkins et al., 2008; Nakayama et al., 2010) so it was decided to use two 
cycles of SDS to reduce any potentially damaging effects it may cause.  
The protocol was adjusted to use RNase and DNase in place of Benzonase 
in the nuclease digestion step to elucidate if the removal of cellular material 
could be improved. No improvement was seen between the use of 
Benzonase and RNase and DNase. The protocol was improved by 
increasing the number of freeze thaw cycles from one cycle to two cycles in 
hypotonic buffer. These freeze thaw cycles were used to increase the 
permeability of the tissue by the formation of ice crystals to dilate the tissue 
and damage cell membranes (Crapo et al., 2011). Adding further freeze 
thaw cycles to the decellularisation process revealed that this resulted in 
damage the underlying structure of the tissue and hence this approach was 
abandoned.  Moreover, it was clear that the addition of further freeze thaw 
cycles showed no improvement in the removal of nuclear material from the 
lacunae hence other approaches were required. It was hypothesised that 
residual SDS remaining in the tissue following the SDS washes may have 
been inhibitory to the action of the nuclease in the nuclease digestion step. 
SDS may denature enzymes such as Benzonase. The concentration of 
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Benzonase was increased to 10 U.ml-1 to compensate for any residual SDS. 
The concentration of the magnesium chloride in the nuclease digestion 
buffer was also changed from 10 to 1 mM. The magnesium chloride acts as 
a cofactor for nuclease enzymes but this is concentration dependent. The 
initial concentration of 10 mM magnesium chloride, whilst optimal for DNase 
activity was found to be above the recommended concentration for  
Benzonase (EMD Millipore Corporation, 2013), the concentration of 
magnesium chloride was reduced to 1mM to account for this. Histological 
analysis revealed that the cells were removed from the tissue in all regions 
although two regions appeared to contain residual cell debris; the 
myocardium and the cartilaginous region in the anterior part of the porcine 
mitral valve annulus. When the same regions were observed in DAPI stained 
sections there was no evidence of any positive staining for dsDNA. 
Moreover, the total DNA content of the processed tissue was below 3 ng.mg-
1 of tissue, significantly lower than the 50 ng.mg-1 suggested (Crapo et al., 
2011). The content of DNA remaining in the tissue is important because the 
any remaining nuclear material can cause calcification (Spina et al., 2003). 
Increased washes of PBS following the PAA cycles were carried out to 
improve the removal of cellular material and remove any potentially toxic 
solutions. Cell debris still remained within the lacunae even with multiple 
washes. It has been hypothesised that the cell remnants that appear in the 
anterior region could be ghost nuclei (Keller & Riley, 1976), these are the 
structural scaffold components of the nuclei without the presence of DNA.  
Further analysis of the changes to the histioarchitecture, cytotoxicity in the 
scaffold and changes to the biomechanical properties of the porcine mitral 
valve annulus, using the final decellularisation protocol, are investigated in 
the following chapter. 
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Chapter 5 
Characterisation of the decellularised porcine mitral valve 
annulus 
5.1 Introduction 
In Chapter 4, a protocol for the decellularisation of the porcine mitral valve 
annulus was developed with a view to the future production of a biological 
acellular annuloplasty ring. The aims of the work described in this chapter, 
were to characterise further the acellular tissue using immunohistochemistry 
to detect key extracellular matrix proteins, biochemical assays to determine 
the extracellular matrix composition and biomechanical testing to determine 
whether the decellularisation process had any major effects on the 
biomechanical properties of the tissue compared to native porcine mitral 
valve annuli. 
The extra cellular matrix (ECM) of a tissue is comprised of molecules that 
have been secreted by cells that reside in the tissue. These molecules form 
a large number of components which have a range of regulatory and 
structural functions. The components of the ECM can be categorised into 
three main classes: structural proteins such as collagen and elastin fibers, 
proteoglycans and specialist glycoproteins such as fibronectin and laminin. 
The molecules that assemble in the ECM are arranged in a 3D structure 
appropriate to the function of the tissue (Badylak et al., 2009). The 
phenotype of a cell and the functions required of the tissues influence the 
composition and structure of the ECM (Badylak et al., 2009). The process of 
decellularisation has been shown to deplete some structural components of 
the ECM. Studies in which  0.1 % (w/v) SDS and peracetic acid (PAA) have 
been used for effective tissue decellularisation have found depletion  of 
components of the basement membrane, including fibronectin and collagen 
IV from porcine pulmonary valves (Luo et al., 2014) and collagen IV and 
laminin from porcine bladder scaffold (Bolland et al., 2007) with PAA being 
attributed to the loss of collagen IV from the matrix (Luo et al., 2014). In the 
majority of studies that have used 0.1 % (w/v) SDS in the tissue 
decellularisation process, GAG content has been shown to be reduced in the 
decellularised scaffold compared to the fresh tissue, including in porcine 
pericardium (Morticelli et al., 2013), porcine bladder (Bolland et al., 2007), 
porcine medial meniscus (Stapleton et al., 2008) and porcine pulmonary 
- 176 - 
 
valves (Luo et al., 2014), the exception being in human pericardium 
(Mirsadraee et al., 2006). Therefore, in this study it was important to 
determine whether the developed decellularisation process had any effects 
on the structural protein, glycoprotein and GAG content of the porcine mitral 
valve annulus.  
Alpha-gal is an epitope found on cell membrane glycoproteins and 
glycolipids of all mammals excluding humans, apes and old world primates. 
The epitope is the major xenoantigen that causes hyperacute rejection in 
humans (Konakci et al., 2005). Humans produce anti-gal antibody which 
interacts with the α-gal epitope present in xenografts. Up to 1 % of IgG 
antibodies and up to 8 % of IgM antibodies in humans can interact with this 
epitope (McMorrow et al., 1997; Galili, 2001), the presence of the α-gal 
epitope in vascularised porcine tissue causes hyperacute rejection when 
implanted into humans (Kim et al., 2007). In porcine tissue high amounts of 
α-gal are expressed on  the surface of endothelial cells which promotes 
hyperacute rejection of vascularised organs (Sandrin & Mckenzie, 1994). 
Other antigens may also lead to hyperacute rejection, including 
Hanganutziu–Deicher and Forssman antigens (Cooper, 1998). It was 
therefore important to determine if decellularisation of the porcine mitral 
valve annulus resulted in removal of the α-gal epitope from the scaffold. 
The decellularisation process also uses chemicals that are potentially 
cytotoxic, in particular SDS (Sakai et al., 1998; Caamaño et al., 2009) and 
EDTA (Ballal et al., 2009; Marins et al., 2012), residual SDS or EDTA could 
prevent cells from attaching to and regenerating the decellularised scaffold 
both in vitro and in vivo. It was therefore important to assess the 
biocompatibility of the acellular porcine mitral valve annulus using contact 
and extract cytotoxicity assays. 
Perhaps of most importance for any future consideration of the use of the 
acellular porcine mitral valve annulus in the clinic, it was important to 
determine any effects of the decellularisation process on the biomechanical 
properties of the scaffold. It has been shown in previous studies of 
cardiovascular tissue that treatment using 0.1 % (w/v) SDS can alter the 
biomechanical properties. Significant decreases in the elastin phase slope, 
increased transition stress (Korossis et al., 2005; Luo et al., 2014) along with 
increased extensibility (Korossis et al., 2002; Mirsadraee et al., 2006) and 
greater transition stress and strains (Morticelli et al., 2013) were all found 
when compared to fresh tissue.  
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Few studies have investigated the biomechanical properties of the porcine 
mitral valve annulus. Biomechanical testing using uniaxial tensile testing was  
completed on native porcine mitral valve annuli by Gunning & Murphy 
(2014). The native porcine mitral valve annulus was split into regions, the 
anterior, left commissural, posterior and right commissural sections. The 
anterior region, defined as the mitral to aortic continuum situated between 
the trigones, was shown to have a significantly higher (p<0.05) Young’s 
modulus compared to the other regions of the porcine mitral valve annulus. 
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5.2 Aims 
The aim of this chapter was to characterise the porcine mitral valve annulus 
that had been decellularised using Method 8 (Section 4.4.2.8) as outlined in 
Chapter 4.  
5.3 Objectives 
To characterise the decellularised porcine mitral valve annulus tissue using 
histological, immunohistochemical and biomechanical techniques and carry 
out a comparison with native tissue:  
 To compare the GAG content of  native and decellularised porcine 
mitral valve annulus tissue using histology with alcian blue staining 
 To compare the orientation and localisation of collagen and elastin 
fibres of  native and decellularised porcine mitral valve annulus using 
histology with Sirius red Miller's staining 
 To compare the distribution of collagen I, II, III, IV, VI, and fibronectin, 
laminin and the α-gal epitope in sections of the native and 
decellularised porcine mitral valve annulus using 
immunohistochemistry. 
 To determine the biocompatibility of the decellularised porcine mitral 
valve tissue using extract and contact cytotoxicity assays. 
 Compare the quantitative biomechanical properties of the native and 
decellularised porcine mitral valve annulus using uniaxial tensile 
testing. 
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5.4 Methods 
The decellularisation process (Method 8; developed in Chapter 4) used to 
prepare the acellular porcine mitral valve annulus for the analyses described 
below is summarised in Fig 5.1   
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Fig 5.1 – Porcine mitral valve annulus decellularisation protocol 
x2 
x3 
x3 
x2 
x2 
x3 
x2 
x2 
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5.4.1 Analysis of the final decellularisation method (Method 8) 
In order to determine the biological and biomechanical characteristics of the 
acellular porcine mitral valve annuli and to compare with the characteristics 
of native tissue, the annuli were evaluated using histology (n=3) and 
immunohistochemistry (n=3). This analysis was used to determine the extent 
of cell removal and any changes to the histioarchitecture of the tissue, 
including distribution of collagens, fibronectin and laminin. The 
biocompatibility of the decellularised porcine mitral annulus scaffold was 
evaluated using contact (n=3) and extract (n=3) cytotoxicity assays. The 
biomechanical characteristics of the annuli (n=12) were established by 
uniaxial tensile testing and compared to the biomechanical characteristics of 
the native mitral valve annuli (n=12) to determine if decellularisation caused 
any alterations in the mechanical properties of the tissue. 
 
Fig 5.2 – Decellularised mitral valve annulus split into segments 
Regions selected for histochemical investigation of tissue sections 
using Sirius red Miller's, alcian blue, immunohistochemistry, contact 
and extract cytotoxicity assays. Histology: Anterior left trigone (S1. 
Yellow), Posterior (S5. Yellow). DNA quantification: (Completed in 
Chapter 4) Anterior right trigone (Adna. Blue), Posterior (Pdna. Blue). 
Contact cytotoxicity assay: Anterior (Acyt. Red), Posterior right (Pcyt. 
Red). Extract cytotoxicity assay: Left commissure (Extr. Green). 
The annuli were analysed in the two main regions, the anterior and posterior. 
For alcian blue and Sirius red Miller's staining and immunohistochemistry the 
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regions analysed were the anterior left trigone (Fig 5.2, S1) and the posterior 
annulus (Fig 5.2, S5). For the contact cytotoxicity assays the annuli were 
split into the anterior (Fig 5.2, Acyt S10-S11) and the posterior right annulus 
(Fig 5.2, Pcyt S6-S7) using the same tissue samples. For the extract 
cytotoxicity assays the annuli segment S2 was used (Fig 5.2, Extr S2). 
Separate annuli were used for biomechanical analysis and split four into 
regions using the protocol described in Chapter 2; Section 2.2.6.1. 
 
5.4.2 Histological evaluation of the human and porcine mitral 
valve annulus 
Tissue specimens (n = 3) were fixed in zinc for 24 hours and processed for 
standard histological treatment as described in Section 2.2. Sections from 
the anterior and posterior regions (Fig 5.2) were stained with Sirius red 
Miller’s (Section 2.2.4.2) and alcian blue (Section 2.2.4.3). 
 
5.4.3 Immunohistochemical analysis of the decellularised porcine 
valve annulus 
To assess the extracellular matrix of the decellularised porcine mitral valve 
tissue, immunohistochemical analysis was undertaken using decellularised 
tissue sections and antibodies to collagens I, II, III, IV and VI along with 
fibronectin and laminin. The positive control sample for collagens I, III, IV, 
fibronectin and laminin was porcine common carotid artery whilst for 
collagens II and VI it was porcine articular cartilage. Samples were split into 
two regions, the anterior left trigone (Fig 5.2 S1) and the posterior annulus 
regions as shown in Fig 5.2 S5. The methods used for this part of the study 
can be found in Section 2.2.4. 
 
5.4.4 Labelling the α-gal epitope using biotinylated GSL-1 lectin 
GSL-1 lectin binds specifically to galactosyl residues and were used for 
labelling of α-gal epitopes in decellularised and native porcine mitral valve 
annulus tissue sections. Two controls were utilized: galactosidase treated 
tissue sections (negative control) and galactose-blocked lectin controls 
(negative control) to determine the specificity of the lectin binding to the α-
gal epitope. Samples were split into two regions, the anterior left trigone (Fig 
5.2 S1) and the posterior annulus regions (Fig 5.2 S5).The methods used for 
this part of the study can be found in Section 2.2.4.7 
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5.4.5 Extract cytotoxicity assay of the decellularised porcine 
valve annulus 
To assess the biocompatibility of the decellularised mitral valve annuli, 
extract and contact cytotoxicity assays were undertaken to simulate what 
the direct and non-direct effects of the decellularised annuloplasty ring may 
be on cells in the body. Quantative extract cytotoxicity was used for 
analysing the potential cytotoxic effects of any solutes from the 
decellularised annuloplasty rings on the cells. This assay determined the 
effect of soluble components from the decellularised porcine mitral valve 
annuli on L929 and BHK cell lines. Relative ATP levels were determined for 
the decellularised tissue, positive control and negative control. The relative 
ATP levels of cells following culture with tissue extracts were prepared from 
the decellularised porcine annuli taken from the left commissure (n=3) as 
shown in Fig 5.2 (S2). Cell culture medium with 40 % (v/v) DMSO was used 
as a positive control, as described in Chapter 2 Section 2.2.5 and the 
appropriate cell culture medium was used as a negative control. Baby 
hamster kidney cells (BHK) and murine adipose fibroblast cells (L929) were 
used. Samples of 300 mg tissue were macerated with a sterile scalpel blade 
and added to a bijou with 3 ml of culture medium (1 ml per 100 mg tissue 
weight). Samples were incubated at 37oC for 72 hours with agitation of 240 
rpm. The samples were checked for sterility by streaking onto agar plates 
containing nutrient agar, fresh blood agar and Sabouraud`s agar. Extracts 
were then stored for up to one month at -20oC until tested. BHK  cells were 
cultured (Section 2.2.5) and seeded at a density of 1×104 cells per well in a 
96 well plate and cultured for 24 hours at 37oC in 5 % (v/v) CO2 in air. L929 
cells were cultured (Section 2.2.5) and seeded at a density of 2.5×104 cells 
per well in a 96 well plate and cultured for 24 hours at 37oC in 5 % (v/v) CO2 
in air. Extracts were thawed at 37 oC and the culture medium from each well 
was aspirated and replaced with 100 µl of test extract and 100 µl of culture 
medium containing 20% (v/v) FBS, 200 µl of the appropriate culture medium 
was added to the controls (n = 3) and the plates incubated for a further 24 
hours under the same conditions.  
The ATPLite-M assay (Perkin Elmer) was used as a measure of cell viability 
by determination of the adenosine triphosphate (ATP) content of the cells. 
All reagents were equilibrated to room temperature before carrying out the 
assay. Substrate buffer (25 ml) was added to a vial of lyophilised substrate 
solution. The culture medium from each well of the 96-well plate was 
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aspirated and replaced with 50 µl culture medium along with 50 µl of 
mammalian cell lysis solution, the well plate was shaken at 500 rpm for five 
minutes. Substrate (50 l) was added to each well and the plate was shaken 
at 500 rpm for five minutes. Luminescence was measured using Top Count 
NXT with the ATP2007 software, data (counts per second) was recorded 
and plotted using Microsoft Excel. 
5.4.6 Contact cytotoxicity assay of the decellularised porcine 
valve annulus 
Contact cytotoxicity assays were utilised to determine the effects of direct 
contact of the decellularised annuloplasty ring on cells. Contact cytotoxicity 
testing was undertaken as a qualitative assay in order to record the cell 
growth up to the tissue and morphology of the cells upon contact with the 
tissue. Anterior (Fig 5.2 S10-S11) and posterior regions (Fig 5.2 S6-S7) of 
decellularised mitral valve annuli (n=3) were aseptically dissected into 5 mm2 
sections and attached to a six well culture plate using steri-strips. A drop of 
cyanoacrylate contact adhesive was placed into one of the wells as a 
positive control (for cytotoxicity) and steri-strip was used as a negative 
control placed into the centre of a second well. All of the wells were washed 
using DPBS without calcium and magnesium, three times for ten minutes 
each. The cells were passaged and a cell count performed whilst the 
washes were taking place. The BHK and L929 cells were re-suspended in 
medium to a concentration of approximately 250,000 cells.ml-1 of medium. 
Medium (2 ml) was added to the test and control wells, resulting in 500,000 
cells per well. The plates were incubated for 48 hours in 5 % (v/v) CO2 in air 
at 37 oC, with the plates examined at 24 hours and 48 hours. Any changes in 
the morphology, vacuolization, detachment, cell lysis and membrane 
integrity were recorded and images taken using phase contrast microscopy. 
The culture medium was aspirated from the plates and the surface gently 
washed using DPBS containing calcium and magnesium. Neutral buffered 
formalin (2 ml) was added to each well in a fume hood for ten minutes, the 
neutral buffered formalin was removed and discarded. Using a Pasteur 
pipette Giemsa stain was added onto the cell layer, ensuring that the stain 
covered the cell layer and left for five minutes before washing with tap water. 
The plates were air dried and viewed microscopically and changes to 
morphology, vacuolization, detachment, cell lysis and membrane integrity 
were recorded, images were taken using bright field microscopy. 
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5.4.7 Biomechanical testing of the native and decellularised 
porcine mitral valve annuli 
 
The biomechanical properties of the native and decellularised porcine mitral 
valve annuli were examined using low strain rate to failure tensile testing. 
Decellularised porcine mitral valve annuli (n=12) were split into four regions 
and compared against fresh porcine mitral valve annuli (n=12) split into 
identical regions and tested using the protocol in Section 2.2.6.  
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5.5 Results 
5.5.1 Histological and histochemical characterisation of 
decellularised porcine mitral valve annulus 
Sirius red Miller's stain was used to highlight the collagen within sections of 
the decellularised porcine mitral valve annulus. When viewed under 
polarised light the Sirius red gave an indication of the collagen orientation. 
When viewed under bright field microscopy the elastin fibres stained blue 
and collagen fibres stained red. There appeared to be no loss of collagen or 
elastin fibres when decellularised porcine mitral annuli were stained with 
Sirius red Miller's. Similarly to native porcine mitral valve annulus, regions 
with lacunae type zones in the anterior annulus (Fig. 5.3a; S1a) were weakly 
birefringent with collagen fibres orientated isotropically (Fig. 5.3a; S1b). 
Elastin was prominent in the trigones surrounding the lacunae (Fig 5.3a; 
S1c), retaining the elastic cartilage-like characteristics of the native porcine 
mitral annulus (Fig 5.3a; S1 N). Collagen within this elastic zone was not 
birefringent under polarised light (Fig 5.3a; S1d) similar to that in native 
tissue in the same zone (Fig 5.3a; S1N b). Collagen fibres were prominent in 
the fibrosa of the posterior mitral valve leaflet and in the posterior annulus 
(Fig 5.3b; S5a, S5b, S5c) and comparable to fibres in the native posterior 
mitral valve annulus (Fig 5.3b; S5N a). The orientation of the fibres was 
isotropic with some fibres in the fibrosa and annulus orientated radially (Fig 
5.3b; S5 c) but other fibres weakly birefringent with the orientation not 
detectable as also identified in the native posterior annulus under polarised 
light (Fig 5.3b; S5N b). Elastin, characterised by blue fibres, was visible in 
the atrialis of the leaflet and the endocardium of the mitral valve in the 
posterior annulus (Fig 5.3b; S5a).  
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Fig 5.3a – Images of Sirius red Miller's stained sections from the anterior 
segments of the decellularised porcine mitral valve annulus viewed 
under polarised light microscopy and bright light microscopy. Annulus 1 
(S1 a), Anterior polarised. Annulus 1 (S1 b), Anterior x 400 magnification (S1 
c), Anterior polarised x 400 magnification (S1 d), Native anterior. Annulus 5 
(S1N a), Native anterior polarised. Annulus 5 (S1N b). T: Trigone; LA: 
Lacunae; AV: Aortic Valve; L: Leaflet.   
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S5 a) 
S5 b) S5 c) 
S5N a) S5N b) 
Fig 5.3b – Images of Sirius red Miller's stained sections from the posterior 
segments of the decellularised porcine mitral valve annulus viewed 
under polarised light microscopy and bright light microscopy. Annulus 1 
(S5 a), posterior section polarised. Annulus 1 (S5 b), posterior section x 100 
magnification (S5 c). Native posterior. Annulus 5 (S5N a), Native posterior 
polarised. Annulus 5 (S5N b). A: Annulus; T: Trigone; AM: Atrial Muscle; AV: 
Aortic Valve; AVL: Aortic Valve Leaflet; VM: Ventricular Muscle; L: Leaflet; LA: 
Lacunae. Images are representative of the results obtained from n = 3 annuli. 
Magnification x 20 unless stated otherwise. 
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In the anterior and posterior segments (S1, S5) of the decellularised porcine 
mitral valve annulus, sections were stained with alcian blue to determine the 
presence and abundance of GAGs. Alcian blue revealed that GAG 
concentration was reduced in both the anterior and posterior region 
compared to the native mitral valve annulus in the anterior (Fig 5.4 S1N) and 
the posterior region (Fig 5.4 S5N). The GAG content was higher in the 
anterior region where the trigones retained some of the GAGs (Fig 5.4 S1a, 
b) compared to that of the posterior region where the GAGs were removed 
at the hinge point (Fig 5.4 S5a, b), in contrast to GAGs present in the hinge 
point of the native tissue (Fig 5.4 S5N). Some GAGs remained in the 
spongiosa and ventricularis in the posterior of the decellularised tissue. 
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S1 a) S5 a) 
S1 b) S5 b) 
S1N) S5N) 
Fig 5.4 – Images of alcian blue stained sections from the anterior and 
posterior segments of the decellularised porcine mitral valve annulus. 
Images of alcian blue stained decellularised porcine mitral annulus to 
visualise GAG localisation, red arrows indicate regions of GAGs. Areas with 
GAG contain are stained blue. Decellularised anterior annulus stained with 
alcian blue. Annulus 1 (S1a), Anterior x 100 magnification (S1b), 
Decellularised posterior. Annulus 1 (S5a), Posterior x 100 magnification 
(S5b), Anterior x 100 magnification (S1b), Native anterior annulus. Annulus 1 
(S1N), Native posterior annulus. Annulus 1 (S5N). A: Annulus; T: Trigone; 
AM: Atrial Muscle; AV: Aortic Valve; AVL: Aortic Valve Leaflet; VM: Ventricular 
Muscle; L: Leaflet. Images are representative of the results obtained from n = 
3 annuli. Magnification x 20 unless stated otherwise. 
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5.5.2 Distribution of proteins in the extracellular matrix of 
decellularised porcine mitral annulus 
The distribution of different structural proteins of the extracellular matrix of 
the decellularised porcine mitral valve annulus was investigated using 
immunohistochemistry.  
5.5.2.1 Collagen I 
Images of sections of the anterior and posterior regions (Fig. 5.5a) of the 
decellularised porcine mitral valve annulus labelled with the collagen I 
antibody showed that collagen I was distributed throughout the anterior (Fig 
5.5a; S1) and posterior (Fig 5.5a; S5) regions. Positive staining was 
indicated by a dark brown stain and was more prominent in the posterior 
annulus compared to the anterior annulus. The level of collagen I in the 
decellularised tissue appeared to be similar to the native porcine mitral valve 
annuli, albeit staining appeared less prominent in the anterior decellularised 
section compared to the native anterior section (Fig 5.5a; S1, S1N). Limited 
background staining was observed in the control sections labelled with the 
isotype control antibody (Fig 5.5b; a) and diluent alone (Fig 5.5b; b). 
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S1) S5) 
S1N) S5N)  
Fig 5.5a – Sections of decellularised porcine mitral valve annulus 
stained with antibodies to collagen I. Decellularised anterior region 
stained with antibodies to collagen I x 400 magnification. Annulus 3 
(S1), Native anterior annulus x 200 magnification. Annulus 4 (S1N). 
Decellularised posterior region stained with antibodies to collagen I x 
400 magnification. Annulus 1 (S5), Native posterior annulus x 400 
magnification. Annulus 1 (S5N). A: Annulus; T: Trigone; AM: Atrial 
Muscle; AV: Aortic Valve; AVL: Aortic Valve Leaflet; VM: Ventricular 
Muscle; L: Leaflet. Images are representative of the results obtained 
from n = 3 annuli. Magnification x 20 unless stated otherwise. 
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a) b) 
c)  
Fig 5.5b – Sections of decellularised porcine mitral valve annulus stained with 
antibodies to collagen I. Isotype control x 400 magnification (a). Diluent 
control x 400 magnification (b). Porcine common carotid artery positive control 
(c). A: Annulus; T: Trigone; AM: Atrial Muscle; AV: Aortic Valve; AVL: Aortic 
Valve Leaflet; VM: Ventricular Muscle; L: Leaflet. Images are representative of 
the results obtained from n = 3 annuli. Magnification x 20 unless stated 
otherwise. 
 
5.5.2.2 Collagen II 
Sections from the anterior and posterior regions (Fig 5.6a) of the 
decellularised porcine mitral valve annulus were labelled with antibodies to 
collagen II. Images of the sections showed staining in the anterior annulus 
(Fig 5.6a; S1) in the dense cartilage-like regions. Staining was not visible in 
the muscle surrounding the annulus or in the posterior annulus region (Fig 
5.6a; S5). There was no visible reduction in staining when compared to the 
native porcine mitral annulus (Fig 5.6a; S1N, S5N). No staining was 
observed in sections stained with the antibody isotype control (Fig 5.6b; a) or 
diluent alone (Fig 5.6b; b).  
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S1) S5) 
S1N) S5N) 
Fig 5.6a – Sections of decellularised porcine mitral valve annulus stained with 
antibodies to collagen II. Decellularised anterior region stained with 
antibodies to collagen II. Annulus 2 (S1), Native anterior region. Annulus 1 
(S1N). Decellularised posterior region stained with antibodies to collagen II. 
Annulus 2 (S5), Native posterior region. Annulus 3 (S5N). A: Annulus; T: 
Trigone; AM: Atrial Muscle; AV: Aortic Valve; AVL: Aortic Valve Leaflet; VM: 
Ventricular Muscle; L: Leaflet. Images are representative of the results 
obtained from n = 3 annuli. Magnification x 20 unless stated otherwise. 
  
1000 µm 500 µm 
T 
T 
A 
AM 
VM 
AM 
500 µm 
- 195 - 
 
a) b) 
c)  
Fig 5.6b – Sections of decellularised porcine mitral valve annulus stained with 
antibodies to collagen II. Isotype control (a). Diluent control (b). Porcine 
articular cartilage positive control (c). A: Annulus; T: Trigone; AM: Atrial 
Muscle; AV: Aortic Valve; AVL: Aortic Valve Leaflet; VM: Ventricular Muscle; 
L: Leaflet. Images are representative of the results obtained from n = 3 annuli. 
Magnification x 20 unless stated otherwise. 
 
5.5.2.3 Collagen III 
Sections of decellularised porcine mitral valve annulus from both the anterior 
and posterior regions were stained with antibody to collagen III (Fig 5.7a). 
Images of the sections revealed positive staining in the annulus and atrial 
and ventricular myocardium in both the anterior and posterior regions of the 
decellularised annuli (Fig 5.7a; S1, S5). Staining was more prominent in the 
myocardium, endocardium and leaflet surfaces of the decellularised tissue 
compared to the collagenous annulus tissue. Similar amounts of staining 
were observed in the native annulus regions (Fig 5.7a; S1N, S5N) compared 
to the decellularised mitral valve annulus. No staining was observed in the 
sections stained with the antibody isotype control (Fig 5.7b; a) or diluent 
alone (Fig 5.7b; b). 
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S1) S5) 
S1N) S5N)  
Fig 5.7a – Sections of decellularised porcine mitral valve annulus stained with 
antibodies to collagen III.  Decellularised anterior region stained with 
antibodies to collagen III. Annulus 2 (S1). Native anterior annulus. Annulus 1 
(S1 N). Decellularised posterior region stained with antibodies to collagen III. 
Annulus 2 (S5), Native posterior annulus. Annulus 4 (S5 N). A: Annulus; T: 
Trigone; AM: Atrial Muscle; AV: Aortic Valve; AVL: Aortic Valve Leaflet; VM: 
Ventricular Muscle; L: Leaflet. Images are representative of the results 
obtained from n = 3 annuli. Magnification x 20 unless stated otherwise. 
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a) b) 
c)  
Fig 5.7b – Sections of decellularised porcine mitral valve annulus stained with 
antibodies to collagen III.  Isotype control (a). Diluent control (b). Porcine 
common carotid artery positive control (c). A: Annulus; T: Trigone; AM: Atrial 
Muscle; AV: Aortic Valve; AVL: Aortic Valve Leaflet; VM: Ventricular Muscle; 
L: Leaflet. Images are representative of the results obtained from n = 3 annuli. 
Magnification x 20 unless stated otherwise. 
 
5.5.2.4 Collagen IV 
Images of sections from the anterior and posterior regions of the 
decellularised porcine mitral valve annulus labelled with the collagen IV 
antibody are shown in Fig 5.8a. The anterior and posterior regions of the 
decellularised tissue were stained positive in the myocardium. Staining was 
strong in the atrial and ventricular myocardium and weak in the annulus and 
mitral valve leaflets. Staining in the decellularised annulus appeared 
diminished compared to the native porcine mitral valve annulus for both 
anterior (Fig 5.8a; S1N) and posterior (Fig 5.8a; S5 N) regions. There was 
some background staining observed in the sections stained with the 
antibody isotype control (Fig 5.8b; a) or diluent alone (Fig 5.8b; b) 
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S1) S5) 
S1N)  S5N) 
Fig 5.8a – Sections of decellularised porcine mitral valve annulus stained with 
antibodies to collagen IV. Decellularised anterior region. Annulus 1 (S1), 
Native anterior annulus. Annulus 4 (S1 N). Decellularised posterior region. 
Annulus 1 (S5), Native posterior annulus. Annulus 3 (S5 N). A: Annulus; T: 
Trigone; AM: Atrial Muscle; AV: Aortic Valve; AVL: Aortic Valve Leaflet; VM: 
Ventricular Muscle; L: Leaflet. Images are representative of the results 
obtained from n = 3 annuli. Magnification x 20 unless stated otherwise. 
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a) b) 
c)  
Fig 5.8b – Sections of decellularised porcine mitral valve annulus stained with 
antibodies to collagen IV. Isotype control (a). Diluent control (b). Porcine 
common carotid artery positive control (c). A: Annulus; T: Trigone; AM: Atrial 
Muscle; AV: Aortic Valve; AVL: Aortic Valve Leaflet; VM: Ventricular Muscle; 
L: Leaflet. Images are representative of the results obtained from n = 3 annuli. 
Magnification x 20 unless stated otherwise. 
 
5.5.2.5 Collagen VI 
Sections of the decellularised porcine mitral annulus from the anterior and 
posterior regions (Fig 5.9a) were labelled with antibody to collagen VI. 
Strong staining was observed primarily in the anterior annulus in the same 
region where the lacunae reside (Fig 5.9a; S1a, S1b). In the posterior region 
collagen VI was more prominent in the endocardium than the annulus (Fig 
5.9a; S5). Compared to the native porcine mitral valve annulus in the 
anterior region, staining in the trigonal region was comparable (Fig 5.9a; 
S1N). In the posterior region staining appeared almost completely removed 
from the myocardium (Fig 5.9a; S5) compared to the native porcine mitral 
valve annulus in the same region (Fig 5.9a; S5N). No staining was observed 
in the sections stained with the antibody isotype control (Fig 5.9b; a) or 
diluent alone (Fig 5.9b; b). 
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S1 a) S5) 
S1 b)  
S1N)  S5N)  
Fig 5.9a – Sections of decellularised porcine mitral valve annulus stained with 
antibodies to collagen VI. Decellularised anterior region stained with 
antibodies to collagen VI. Annulus 1 (S1 a), anterior region x 400 
magnification. Annulus 1 (S1 b), Native anterior annulus x 200 magnification. 
Annulus 4 (S1 N). Decellularised posterior region stained with antibodies to 
collagen VI. Annulus 1 (S5), Native posterior annulus x 50 magnification. 
Annulus 4 (S5 N). A: Annulus; T: Trigone; AM: Atrial Muscle; AV: Aortic Valve; 
AVL: Aortic Valve Leaflet; VM: Ventricular Muscle; L: Leaflet; LA: Lacunae.  
Images are representative of the results obtained from n = 3 annuli. 
Magnification x 20 unless stated otherwise. 
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a) b) 
c)  
Fig 5.9b – Sections of decellularised porcine mitral valve annulus stained with 
antibodies to collagen VI. Isotype control (a). Diluent control (b). Porcine 
articular cartilage positive control (c). A: Annulus; T: Trigone; AM: Atrial 
Muscle; AV: Aortic Valve; AVL: Aortic Valve Leaflet; VM: Ventricular Muscle; 
L: Leaflet; LA: Lacunae.  Images are representative of the results obtained 
from n = 3 annuli. Magnification x 20 unless stated otherwise. 
5.5.2.6 Fibronectin 
Images of sections of the anterior and posterior regions (Fig 5.10a, Fig 
5.10b) of the decellularised porcine mitral annulus labelled with the 
fibronectin antibody show both regions were stained positive. Positive 
staining was indicated by a dark brown stain and was observed in the 
annulus and atrial and ventricular myocardium in all regions. Staining was 
more prominent in the myocardium compared to the annulus, endocardium 
and leaflet surfaces. Compared to the native porcine mitral valve annulus 
(Fig 5.10b; S1N, S5N) staining was weaker in both the anterior (Fig 5.10a; 
S1 a) and posterior (Fig 5.10a; S5 a) regions in the connective tissue of the 
annulus. Myocardium surrounding the annulus (Fig 5.10a; S5a) appeared 
the same as native (Fig 5.10b; S5N b) porcine mitral valve tissue. Limited 
background staining was observed in sections stained with the isotype 
control antibody (Fig 5.10c; a) or diluent alone (Fig 5.10c; b) 
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S1 a) S5 a) 
S1b) S5b) 
Fig 5.10a – Sections of decellularised porcine mitral valve annulus stained 
with antibodies to fibronectin. Decellularised anterior region stained with 
antibodies to fibronectin. Annulus 1 (S1 a), decellularised anterior region x 
400 magnification (S1 b). Decellularised posterior region stained with 
antibodies to fibronectin. Annulus 1 (S5 a), decellularised posterior region x 
400 magnification (S5 b). Native posterior annulus x 200 magnification. A: 
Annulus; T: Trigone; AM: Atrial Muscle; AV: Aortic Valve; AVL: Aortic Valve 
Leaflet; VM: Ventricular Muscle; L: Leaflet. Images are representative of the 
results obtained from n = 3 annuli. Magnification x 20 unless stated otherwise. 
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S1N)  S5N a)  
 S5N b) 
Fig 5.10b – Sections of decellularised porcine mitral valve annulus stained 
with antibodies to fibronectin. Decellularised anterior region stained with 
antibodies to fibronectin. Native anterior region x 200 magnification, Annulus 4 
(S1 N). Decellularised posterior region stained with antibodies to fibronectin. 
Native posterior annulus x 200 magnification, Annulus 4 (S5N a). Native 
posterior region atrial myocardium x 200 magnification (S5N b). A: Annulus; T: 
Trigone; AM: Atrial Muscle; AV: Aortic Valve; AVL: Aortic Valve Leaflet; VM: 
Ventricular Muscle; L: Leaflet. Images are representative of the results 
obtained from n = 3 annuli. Magnification x 20 unless stated otherwise. 
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a) b) 
c)  
Fig 5.10c – Sections of decellularised porcine mitral valve annulus stained 
with antibodies to fibronectin. Isotype control (a). Diluent control (b). 
Porcine common carotid artery positive control (c). A: Annulus; T: Trigone; 
AM: Atrial Muscle; AV: Aortic Valve; AVL: Aortic Valve Leaflet; VM: Ventricular 
Muscle; L: Leaflet. Images are representative of the results obtained from n = 
3 annuli. Magnification x 20 unless stated otherwise. 
 
5.5.2.7 Laminin 
Anterior and posterior sections of the decellularised porcine mitral valve 
annulus were labelled with antibodies to laminin. Images (Fig 5.11a; S1, S5) 
of the laminin labelled sections revealed absence of any staining. The 
decellularisation process appeared to have removed all laminin from the 
tissue which was prominent in the native porcine mitral valve annulus (Fig 
5.11a; S1N, S5N). No staining was observed in the control sections labelled 
with the isotype control antibody (Fig 5.11b; a) and diluent alone (Fig 5.11b; 
b). 
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S1) S5) 
S1N)  S5N) 
Fig 5.11a – Sections of decellularised porcine mitral valve annulus stained 
with antibodies to laminin. Decellularised anterior region stained with 
antibodies to laminin. Annulus 1 (S1), Native anterior region. Annulus 3 (S1N). 
Decellularised posterior region stained with laminin x 100 magnification. 
Annulus 3 (S5), Native posterior region. Annulus 3 x 100 magnification (S5N). 
A: Annulus; T: Trigone; AM: Atrial Muscle; AV: Aortic Valve; AVL: Aortic Valve 
Leaflet; VM: Ventricular Muscle; L: Leaflet. Images are representative of the 
results obtained from n = 3 annuli.  Magnification x 20 unless stated 
otherwise. 
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a) b) 
c)  
Fig 5.11b – Sections of decellularised porcine mitral valve annulus stained 
with antibodies to laminin. Decellularised anterior region stained with 
antibodies to laminin. Annulus 1 (S1), Native anterior region. Annulus 3 (S1N). 
Decellularised posterior region stained with laminin x 100 magnification. 
Annulus 3 (S5), Native posterior region. Annulus 3 x 100 magnification (S5N). 
Isotype control (a). Diluent control (b). Porcine common carotid artery positive 
control (c). A: Annulus; T: Trigone; AM: Atrial Muscle; AV: Aortic Valve; AVL: 
Aortic Valve Leaflet; VM: Ventricular Muscle; L: Leaflet. Images are 
representative of the results obtained from n = 3 annuli.  Magnification x 20 
unless stated otherwise. 
5.5.2.8 Alpha-gal localisation using lectin 
Images of sections of the anterior (Fig 5.12a; S1) and posterior regions (Fig 
5.12a; S5) of the decellularised mitral valve annulus labelled with the lectin 
showed  both regions stained positive for the α-gal epitope. Positive staining 
was indicated by a dark brown stain and was seen in the anterior annulus 
(Fig 5.12a; S1 a, S1 b) and myocardium (Fig 5.12a; S1 a, S1 c) and the 
posterior myocardium (Fig 5.12a; S5 a, S5 c). Staining was more prominent 
in the vasculature and muscle surrounding the annulus. Blood vessels and 
some of the cellular remnants in the anterior region stained positive. No 
staining was observed in the two control sections of galactosidase treated 
tissue (Fig 5.12b; a) and tissue stained with galactose-blocked lectin (Fig 
5.12b; b) indicating specific staining. Lectin staining was noticeably reduced 
when compared to the native tissue, where staining was stronger in both the 
anterior (5.12b; c) and posterior (5.12b; d) annulus and surrounding 
myocardium. 
500 µm 500 µm 
500 µm 
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S1 a) S5 a) 
S1 b) S5 b)  
S1 c) S5 c) 
Fig 5.12a – Sections of decellularised porcine mitral valve annulus labelled 
with lectin. Sections labelled with lectin to identify α-gal epitopes. 
Decellularised anterior annulus region. Annulus 1 (S1a), decellularised 
anterior annulus x 200 magnification (S1b), decellularised anterior 
myocardium x 400 magnification (S1c). Decellularised posterior annulus 
region. Annulus 3 (S5a), decellularised posterior annulus x 200 magnification 
(S5b), decellularised posterior myocardium x 200 magnification (S5c). A: 
Annulus; T: Trigone; AM: Atrial Muscle; AV: Aortic Valve; M: Myocardium; VM: 
Ventricular Muscle; L: Leaflet. Images are representative of the results 
obtained from n = 3 annuli. Magnification x 20 unless stated otherwise. 
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a) b) 
c) d) 
Fig 5.12b – Sections of decellularised porcine mitral valve annulus 
labelled with lectin. Galactosidase treated annulus section x 200 
magnification (a), Galactose blocked lectin x 200 magnification (b), 
Native anterior porcine mitral valve annulus x 200 magnification (c), 
Native posterior porcine mitral valve annulus (d). A: Annulus; T: 
Trigone; AM: Atrial Muscle; AV: Aortic Valve; M: Myocardium; VM: 
Ventricular Muscle; L: Leaflet. Images are representative of the results 
obtained from n = 3 annuli. Magnification x 20 unless stated otherwise. 
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5.5.3 Extract cytotoxicity assays of decellularised porcine mitral 
valve annuli 
The levels of ATP present in BHK and L929 cells following incubation with 
extracts of the decellularised annulus are illustrated in Fig 5.13 and Fig 5.14 
respectively. There was no significant difference in the ATP levels of BHK 
cells incubated with the three decellularised annulus extracts compared to 
the negative control. BHK cells incubated with extract 3 had significantly 
lower levels of ATP compared to BHK cells incubated with extract 2 (p< 
0.05; ANOVA). There was no significant difference in the ATP levels of L929 
cells incubated with all three of the decellularised annulus extracts compared 
to the negative control. The ATP content of the L929 cells incubated with 
DMSO (positive control) was significantly lower than the extracts and the 
control (p < 0.05; ANOVA).  
  
 
Fig 5.13 – ATP content of BHKs incubated with decellularised annulus 
extracts.  Data is presented as the mean (n = 3) ± 95 % CI. Data was 
analysed by one way ANOVA followed by calculation of MSD using the 
T-test. A1-A3 tissues extracts; Neg; Culture medium only; Pos; DMSO 
(40% v/v). Results showed a significant difference between extract A2 
and extract A3 and between all tests and the positive control (p<0.05*) 
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Fig 5.14 – ATP content of L929s incubated with acellular annulus 
extracts. Data is presented as the mean (n = 3) ± 95 % CI. Data was 
analysed by one way ANOVA followed by calculation of MSD using the 
T-test. A1-A3 tissues extracts; Neg; Culture medium only; Pos; DMSO 
(40% v/v) Results showed a significant difference between the positive 
control and the extracts and the negative control (p<0.05*). 
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5.5.4 Contact cytotoxicity assays of decellularised porcine mitral 
valve annuli 
The contact cytotoxicity results are shown in Fig 5.15 and Fig 5.16. 
Microscopic analysis of the contact cytotoxicity plates showed attachment 
and growth of both the BHK and L929 cells up to and onto the decellularised 
porcine mitral valve annulus tissues. There were no observed changes to 
the cell morphology of the BHK or L929 cells in the presence of tissues from 
the anterior (Fig 5.15c; Fig 5.16c) or posterior region (Fig 5.15d; Fig 5.16d) 
of the annulus or in the presence of the steri-strips used as negative controls 
(Fig 5.15b, Fig 5.16b). The scaffold appeared to be non-cytotoxic from these 
studies, the cyanoacrylate glue used as a positive control was cytotoxic to 
the cells (Fig 5.15a, Fig 5.16a).  
   
a) b) 
c) d) 
Fig 5.15 – Contact cytotoxicity of decellularised porcine mitral valve 
annulus tissues cultured with BHK cells.  Images of BHK cells 
incubated with controls and decellularised porcine mitral annulus. 
Cyanoacrylate control x4 magnification (a), Steri-strip control (b), 
Anterior annulus 1 (c), Posterior annulus 1 (d). Images are 
representative of the results obtained from n = 3 annuli. Magnification x 
20 unless stated otherwise. 
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a) b) 
c) d) 
Fig 5.16 – Contact cytotoxicity of decellularised porcine mitral valve 
annuli cultured with L929 cells. Images of L929 cells incubated with 
controls and decellularised porcine mitral annulus. Cyanoacrylate 
control x 40 magnification (a), Steri-strip control x 40 magnification (b), 
Anterior annulus 1 x 40 magnification (c), Posterior annulus 1 x 40 
magnification (d). Images are representative of the results obtained 
from n = 3 annuli. Magnification x 20 unless stated otherwise. 
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5.5.5 Biomechanical characterisation of native and decellularised 
porcine mitral valve annuli 
For biomechanical testing the native and decellularised annuli (n=12) were 
split into four regions, these regions were identified as, R1: the posterior 
(between P2 segment of mitral leaflet), R3: anterior (left commissure to right 
commissure), R2: right commissure (P3 segment of mitral leaflet to right 
commissure) of the posterior annulus and R4: left commissure (P1 segment 
of mitral leaflet to left commissure) of the posterior annulus.  
The stress-strain curves for the decellularised and native porcine mitral valve 
annuli for regions 1 to 4 are shown in Fig 5.17 to Fig 5.20. The stress strain 
curves for all the decellularised tissues from the four regions appeared to 
have larger variability compared to the native tissues. Comparing the slopes 
between regions for both the decellularised and native tissues it was 
apparent that region 3 had much greater ultimate tensile stresses and lower 
ultimate tensile strains compared to regions 1, 2 and 4.  
 
Fig 5.17 – Stress/strain curves for native and decellularised porcine 
mitral valve annuli in region 1 (posterior region). a) Native porcine 
mitral valve annulus region 1, b) Decellularised porcine mitral valve 
annulus region 1.  
  
a) b) 
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Fig 5.18 – Stress/strain curves for native and decellularised porcine 
mitral valve annuli in region 2 (right commissural region). a) Native 
porcine mitral valve annulus region 2, b) Decellularised porcine mitral 
valve annulus region 2.  
 
Fig 5.19 – Stress/strain curves for native and decellularised porcine 
mitral valve annuli in region 3 (anterior region). a) Native porcine 
mitral valve annulus region 3, b) Decellularised porcine mitral valve 
annulus region 3.  
 
Fig 5.20 – Stress/strain curves for native and decellularised porcine 
mitral valve annuli in region 4 (left commissural region). a) Native 
porcine mitral valve annulus region 4, b) Decellularised porcine mitral 
valve annulus region 4.  
  
a) b) 
a) b) 
a) b) 
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The various biomechanical parameters (elastic phase modulus, collagen 
phase modulus, ultimate tensile stress, ultimate tensile strain, transition 
stress and transition strain) for the decellularised and native porcine mitral 
valve annulus tissues from regions 1 to 4 were extracted from the stress 
strain curves as described in Chapter 2, Section 2.2.6 and the mean (n=12) 
values are shown in Fig 5.21 to Fig 5.26.  
The Young`s modulus in the elastic region of the stress strain curves 
showed a high level of variation between the regions of the annulus in the 
native tissue, with a modulus of 0.83 MPa in region 3 compared to 0.05 MPa 
in region 1, 0.07 MPa in region 2 and 0.05 MPa in region 4. The Youngs 
modulus in the elastic region of the stress strain curves for the decellularised 
tissues revealed that the modulus in region 3 was reduced to 0.12 MPa 
compared to native tissue with little effect of the decellularisation treatment 
on the elastic modulus in regions 1, 2 and 4. The data was analysed by two-
way analysis of variance which revealed that the effect of decellularisation 
on Young's Modulus in the elastic phase of the stress-strain curve was 
dependent upon the region of the annulus (Fig 5.21). There was a significant 
interaction between the type of tissue (native versus decellularised) and the 
region of interest. This was the result of the differences in the Young's 
modulus in region 3 between the native and decellularised tissue but not for 
regions 1, 2 and 4. The Young’s modulus for the native tissue in region 3 
was significantly higher compared to native tissue in the other regions, whilst 
in the decellularised group there were no differences between regions. 
These results would seem to suggest that for region 3, decellularisation 
caused a reduction in Young's modulus in the elastic phase compared to the 
native tissue group.  
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Fig 5.21 – The Young's Modulus in the elastic phase of each region of 
the native and decellularised porcine mitral valve annulus. Data is 
presented as the mean (n = 12) ± 95 % CI. Data was analysed by two 
way ANOVA with replication that showed significant interaction 
between regions and the tissue, on the elastic phase modulus 
(p<0.05*). Perusal of the data revealed that this was due to a reduction 
in the modulus in region R3 following decellularisation. R1 = Posterior 
annulus, R2 = Right commissure, R3 = Anterior annulus, R4 = Left 
commissure. 
The Young`s modulus in the collagen region of the stress strain curves also 
showed a high level of variation between the regions of the annulus in the 
native tissue, with a modulus of 7.33 MPa in region 3 compared to 1.27 MPa 
in region 1, 2.17 MPa in region 2 and 1.23 MPa in region 4. The data for the 
Youngs modulus in the collagen region of the stress strain curves for the 
decellularised tissues was similar to that of the native tissue in all four 
regions. The data was analysed by two-way analysis of variance which 
revealed that there was no effect of decellularisation on Young's modulus in 
the collagen phase of the stress-strain curve when compared to native tissue 
for the same mitral valve annulus region (Fig 5.22). Analysis of Young’s 
modulus between regions showed that for both the decellularised and native 
porcine mitral valve annuli there were significant differences between region 
3 and the other regions. Evaluation of the data revealed that the Young’s 
modulus in the collagen phase for the native annuli was significantly higher 
in region 3 (p<0.05; MSD = 2.32) compared to region 1, region 2 and region 
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4 and significantly higher for the decellularised mitral valve annuli in region 3 
(p<0.05; MSD=2.82) compared to region 1, region 2, and region 4.  
 
 
Fig 5.22 – The Young's Modulus in the collagen phase of each region of 
the native and decellularised porcine mitral valve annulus. Data is 
presented as the mean (n = 12) ± 95 % CI. Data was analysed by two 
way ANOVA with replication followed by calculation of MSD using the 
T-test. Results showed significant differences between region 3 and the 
other regions for both native (p<0.05*; MSD = 2.32) and decellularised 
tissue ((p<0.05*; MSD=2.82) but not between the tissue types in the 
same region. R1 = Posterior annulus, R2 = Right commissure, R3 = 
Anterior annulus, R4 = Left commissure. 
 
The data for the ultimate tensile stress of native and decellularised annuli in 
the four regions tested is presented in Fig 5.23. The ultimate tensile stress 
showed a high level of variation between the regions of the annulus in the 
native tissue, with a value of 2.55 MPa in region 3 compared to 0.63 MPa in 
region 1, 0.67 MPa in region 2 and 0.54 MPa in region 4. The data was 
analysed by two way analysis of variance. This revealed that there was no 
significant variation in the ultimate tensile stress between native and 
decellularised porcine mitral valve annuli for the same region (Fig 5.23). 
There were however significant differences in the ultimate tensile stress 
results between region 3 and the other regions for both the native and 
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decellularised porcine mitral valve annuli. Analysis of the data revealed that 
the ultimate tensile stress was significantly higher in region 3 (p<0.05; 
MSD=0.70) compared to region 1, region 2 and region 4 for the native 
porcine mitral valve annuli and significantly higher in region 3 (p<0.05; 
MSD=0.63) compared to region 1, region 2 and region 4 for the 
decellularised mitral valve annuli.  
 
 
Fig 5.23 – The ultimate tensile stress in each region of the native and 
decellularised porcine mitral valve annulus. Data is presented as 
the mean (n = 12) ± 95 % CI. Data was analysed by two way ANOVA 
with replication followed by calculation of MSD using the T-test. Results 
showed significant variation between region 3 and the other regions for 
both native (p<0.05*; MSD=0.70) and decellularised tissue (p<0.05*; 
MSD=0.63) but not between the tissue types in the same region. R1 = 
Posterior annulus, R2 = Right commissure, R3 = Anterior annulus, R4 = 
Left commissure. 
 
The results for the ultimate tensile strain of native and decellularised annuli 
in the four regions tested is presented in Fig 5.24. The data showed little 
variation between the regions of the annulus in the native tissue, with values 
of 76.14 % in region 1, 81.65 % in region 2, 60.26 % in region 3 and 87.00 % 
in region 4. The data was analysed by two way analysis of variance. This 
revealed that the effect of decellularisation on the ultimate tensile strain was 
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dependent on the mitral valve annulus region. Further analysis of the data 
using the T-test revealed that the ultimate tensile strain of the decellularised 
tissue was higher than the native tissue in region 1, 2 and 3 (p<0.05). The 
ultimate tensile strain for the native porcine mitral valve annuli in region 4 
was significantly higher than region 3 (p<0.05; MSD=21.95), with no 
significant differences between the ultimate tensile strains in all regions for 
the decellularised porcine mitral valve annulus (Fig 5.24). 
  
 
Fig 5.24 – The ultimate tensile strain in each region of the native and 
decellularised porcine mitral valve annulus. Data is presented as 
the mean (n = 12) ± 95 % CI. Data was analysed by two way ANOVA 
with replication followed by calculation of MSD using the T-test. 
Analysis showed significant variation between regions 3 and 4 for the 
native tissue (p<0.05*; MSD=21.95) and between the native and 
decellularised tissue types in regions 1, 2 and 3 (p<0.05+). R1 = 
Posterior annulus, R2 = Right commissure, R3 = Anterior annulus, R4 = 
Left commissure. 
 
The data for the transition stress of native and decellularised annuli in the 
four regions tested is presented in Fig 5.25. The data showed a high level of 
variation between the regions of the annulus in the native tissue, with a 
value of 0.22 MPa in region 3 compared to 0.06 MPa in region 1, 0.07 MPa 
in region 2 and 0.07 MPa in region 4. The data was analysed by two-way 
analysis of variance which showed that the effect of decellularisation on the 
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transition stress depended upon the annulus region. There were differences 
in the transition stress in regions 1, 2 and 4 between the native and 
decellularised porcine mitral valve annulus but not for region 3. Evaluation of 
the data showed significantly higher transition stresses in the decellularised 
porcine mitral valve annulus compared to the native annulus for regions 1, 2 
and 4  (p<0.05). There were regional differences in the transition stresses for 
both the native and decellularised tissue groups. For the native porcine 
mitral valve annuli the transition stress between regions was significantly 
higher in region 3 compared to region 1, 2 and 4 (p<0.05; MSD=0.06) and 
for the decellularised porcine mitral valve annulus, significantly higher in 
region 3 compared to regions 2 and 4 (p<0.05; MSD=0.15).  
 
 
Fig 5.25 – The transition stress in each region of the native and 
decellularised porcine mitral valve annulus. Data is presented as 
the mean (n = 12) ± 95 % CI. Data was analysed by two way ANOVA 
with replication followed by calculation of MSD using the T-test. Perusal 
of the data revealed that there was significant differences between 
region 3 and the other regions for the native tissue (p<0.05*; 
MSD=0.06) and between region 3 and regions 2 and 4 for 
decellularised tissue (p<0.05*; MSD=0.15). Significant differences were 
found between the native and decellularised tissue types in regions 1, 2 
and 4 (p<0.05+). R1 = Posterior annulus, R2 = Right commissure, R3 = 
Anterior annulus, R4 = Left commissure. 
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The results for the transition strain of native and decellularised annuli in the 
four regions tested is presented in Fig 5.26. The data showed little variation 
between the regions of the annulus in the native tissue, with values of 36.14 
% in region 1, 33.77 % in region 2, 23.86 % in region 3 and 36.23 % in 
region 4. The data was analysed by two-way analysis of variance which 
showed that the effect of decellularisation on the transition strain was similar 
in each annulus region. Data analysis revealed that there were significantly 
higher transition strains in the decellularised porcine mitral valve annuli 
compared to the native annuli for regions 1, 2, 3 and 4  (p<0.05).  There 
were no significant differences in the transition strains between regions for 
either the native or decellularised porcine mitral valve annulus tissue (Fig 
5.26).  
 
 
Fig 5.26 – The transition strain in each region of the native and 
decellularised porcine mitral valve annulus. Data is presented as 
the mean (n = 12) ± 95 % CI. Data was analysed by two way ANOVA 
with replication followed by calculation of MSD using the T-test. 
Analysis of the data revealed significant differences (p< 0.05+) between 
the native and decellularised tissue types in the same region. R1 = 
Posterior annulus, R2 = Right commissure, R3 = Anterior annulus, R4 = 
Left commissure. 
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5.6 Discussion 
The aim of this chapter was to assess the biological and biomechanical 
properties of decellularised porcine mitral valve annuli and compare them to 
native porcine mitral valve annuli. Results from chapter 4 revealed that 
application of decellularisation Method 8 removed over 95% of DNA from all 
regions of the porcine mitral valve annulus, with residual cell fragments 
remaining in the lacunae of the trigones. In this chapter further studies were 
undertaken to determine the effects of the decellularisation process on the 
porcine mitral valve annulus including, effects on histioarchitecture (Sirius 
red Miller’s), GAG distribution (alcian blue), ECM protein distribution  
(immunohistochemical staining), biocompatibility (cytotoxicity testing) and 
biomechanical properties (uniaxial tensile tests).  
Decellularisation appeared to have no discernible effect on the 
histoarchitecture of collagen and elastin fibres, as revealed by Sirius red 
Miller’s staining. The fibrosa layer of the leaflet formed into the annulus and 
the fibre density and orientation of the leaflet was comparable between the 
decellularised and native tissue. The trigonal region in the anterior annulus 
was also comparable between the native and decellularised annuli, with the 
cartilage-like lacunae being characterised by isotropic fibres. 
There was a visible loss of GAGs from both the anterior and posterior 
regions of the decellularised annulus compared to the native annulus tissue 
in the same region. In the posterior region of the decellularised tissue the 
GAGs had been removed from the annular junction where the leaflet joins 
the annulus. GAGs were retained in the anterior annulus within the trigones 
but alcian blue staining was less intense within this region. The GAG content 
of the annulus is likely to contribute to the absorption of the some of the 
forces generated by the heart during the cardiac cycle as reported in the 
leaflets and chordae of human mitral valves (Grande-Allen et al., 2004). The 
removal of GAGs from the annular junction, at the region where the leaflets 
hinge, may have little effect due to the removal of the leaflets prior to the 
decellularisation of the mitral valve annulus, with the motion of the leaflets 
likely to contribute to the compressive forces in the annular junction. GAG 
removal from the trigones, as a result of decellularisation, would potentially 
affect the biomechanical characteristics, due to the retention of the trigones. 
However, GAGs were present in the trigonal regions after decellularisation 
but staining was reduced compared to the native porcine trigonal region. 
GAG removal from decellularised porcine tissue was also evident in previous 
studies carried out at the University of Leeds, including in pericardium 
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(Morticelli et al., 2013), porcine bladder (Bolland et al., 2007), porcine medial 
meniscus (Stapleton et al., 2008) and porcine pulmonary valves (Luo et al., 
2014).   
Immunohistochemical analysis of both the anterior and posterior regions 
revealed a loss of proteins associated with the basement membrane. 
Sections of decellularised porcine mitral valve annulus stained with 
antibodies to collagen IV and fibronectin revealed less intense staining in the 
annulus and leaflets, as well as the surrounding muscle compared to 
sections of the native porcine mitral valve annulus  from the same regions,  
whilst there was reduced staining of sections labelled with antibodies to 
collagen VI in the myocardium. Sections of the decellularised annulus 
labelled with antibodies to laminin showed no positive staining, with laminin 
appearing to be completely removed by the decellularisation process. 
Removal of antibody staining of basement membrane proteins has been 
shown before in studies using similar decellularisation processes at the 
University of Leeds, for example removal of collagen IV and laminin in 
decellularised porcine bladder (Bolland et al., 2007) and collagen IV in 
porcine pulmonary valves (Luo et al., 2014). Recently it has been suggested 
that the PAA step of the decellularisation protocol is associated with removal 
of antibody staining of collagen IV in the basement membrane (Luo et al., 
2014). Whether the lack of immuno-staining for proteins such as collagen IV 
and laminin following decellularisation is due to a loss of the protein or a 
change in conformation of the protein leading to lack of antibody binding is 
not known. The presence of a functional basement membrane would be 
important for acellular biological scaffolds intended for certain applications 
requiring regeneration with epithelial cells, such as blood vessels. An 
acellular biological annular ring would reinforce mitral valve repair and 
reduce mitral valve orifice area, therefore retention of the collagen fibres 
involved with the biomechanical characteristics, such as collagens I and II, 
would be important, whereas retention of basement membrane components 
would be of no obvious value.  
Whilst PAA has been cited as the chemical involved with removal of 
immunostaining for collagen IV in the basement membrane, studies have 
found that acellular human flexor tendon scaffolds treated with PAA showed  
improved cell attachment and increased matrix porosity (Woon et al., 2011). 
This has also been reported for  decellularised porcine temporomandibular 
joint discs, although PAA treatment did produce scaffolds with weaker 
compressive biomechanical properties (Matuska & McFetridge, 2015). 
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Immunohistochemical analysis of collagens I, II and III in the decellularised 
porcine mitral valve annulus tissue sections showed good retention of these 
structural proteins compared to the native tissue.  
Biomechanical testing was completed on both the native and decellularised 
tissue in four regions of the porcine annulus. It was split into the anterior, left 
commissural, posterior and right commissural sections. The biomechanical 
parameters of the posterior region of the native annulus illustrated the lack of 
a dense collagen structure compared to the anterior region of the native 
annulus. The anterior annulus had a dense collagenous structure and 
biomechanical testing revealed that compared to the rest of the annulus this 
structure was associated with high Young`s modulus and a tissue that 
withstood high load before failure. The anterior annulus attaches to the 
cardiac skeleton which provides a strong foundation to the whole of the 
heart; it ensures structural integrity for the mitral valve when it is functioning 
normally and elucidates the biomechanical requirements of the anterior 
annulus compared to the posterior annulus in the mitral valve. The posterior 
annulus undergoes up to 8% circumferential strain during the cardiac cycle, 
compared to 4% in the anterior (Timek et al., 2003) in ovine hearts. This 
flexibility provides the primary mode of dilation and contraction of the 
annulus during the cardiac cycle (Eckert et al., 2009). The ventricular and 
atrial myocardium were found to run in a circumferential orientation near to 
the annulus. The presence of the muscle close to the annulus may assist in 
leaflet coaptation during the systole phase of the cardiac cycle (Flachskampf 
et al., 2000; Pai et al., 2003). Gunning & Murphy (2014) undertook uniaxial 
tensile testing on porcine mitral valve annuli by segmenting the annulus into 
four regions: anterior, posterior, and left and right commissural sections. 
Tissue was preconditioned prior to uniaxial tensile testing, after which it was 
subjected to a strain rate of 2 mm/min up to a strain of 6 %. Moduli were 
calculated when the tissue had undergone 2 % and 6 % strain. The results 
for the native porcine mitral valve annulus in this study closely resembled the 
general outcomes from the study by Gunning & Murphy (2014). The anterior 
region tested between the trigones, had significantly higher (p<0.05) Young’s 
modulus compared to the other regions of the porcine mitral valve annulus. 
The modulus in the Gunning & Murphy study was only analysed at 2 % and 
6 % strains, the tissue was preconditioned and the true stress and strain was 
calculated instead of the engineering stress and strain, so a direct 
comparison between studies cannot be made.   
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Compared to the native porcine mitral valve annulus the decellularised mitral 
valve annulus demonstrated larger ultimate tensile strains, transition strains 
and transition stresses. Ultimate tensile strains in all regions were 
significantly higher in the decellularised tissue compared to the native tissue, 
apart from region 4, the left commissure region, in which levels did not reach 
significance. These changes were comparable to alterations to 
biomechanical characteristics found in previous studies that have utilised 0.1 
% (w/v) SDS during decellularisation. For example, the ultimate tensile strain 
was decreased in acellular porcine bladder matrix compared to native 
porcine bladder (Bolland et al., 2007), whilst in decellularised human 
pericardium (Mirsadraee et al., 2006) and decellularised porcine aortic 
leaflets (Korossis et al., 2002) there was an increase in extensibility 
compared to native tissue. Transition stresses were all higher in the 
decellularised regions of the porcine mitral valve annuli compared to the 
same native tissue regions but significance was not reached in the anterior 
region, this has also been found in decellularised porcine pericardium 
(Morticelli et al., 2013). Transition strains were all significantly higher in the 
decellularised mitral valve annulus compared to the native mitral valve 
annulus, similar results have been found in decellularised porcine aortic 
roots (Korossis et al., 2005) and decellularised porcine pericardium 
(Morticelli et al., 2013). Similar to the biomechanical results for decellularised 
porcine mitral valve annuli, there was no impact on the ultimate tensile 
strength of the various tissues studied previously, and apart from the study 
by Korossis et al. (2002) there has been found to be no impact on the 
collagen phase slope. The increased extensibility of decellularised porcine 
aortic roots was attributed to increased collagen crimping and disruption of 
the cells in the matrix. Treatment with low concentration SDS does seem to 
have different effects on the biomechanical characteristics depending on the 
types of tissues. For example,  0.1 % (w/v) SDS treatment resulted in an 
increased collagen phase slope and a significant decrease in failure strain 
for porcine bladder tissue (Bolland et al., 2007), in contrast to findings with 
porcine cardiovascular tissues as discussed above. Decellularisation using 
SDS has also been reported to induce changes in collagen crimp pattern 
and tissue structure, leading to reduced cell attachment in ligamentous 
tissues (Gratzer et al., 2006) and increased extensibility caused by the 
crimping and the removal of cells during the decellularisation protocol 
(Korossis et al., 2002). 
In the elastic phase of the stress-strain curve decellularisation caused a 
reduction in the Young’s modulus only for region 3, the anterior region. The 
- 226 - 
 
other regions of the native tissue had lower Young’s modulus compared to 
the native tissue region 3. After decellularisation the Young’s modulus in 
region 3 was comparable to the other decellularised regions. This phase of 
the slope represents the region where the forces are distributed through the 
elastin fibres, which offer minimal resistance to elongation. A reduction of the 
Young's modulus in this region suggests that the elastin fibres offer less 
resistance to elongation compared to the native tissue in the same region 
and will be more compliant in the physiological range of the tissue. No 
changes were observed in the ultimate tensile stress or collagen phase 
slope, so the overall strength of this region did not appear to be affected. 
The other regions were not affected in the same way which is likely due to 
the different ECM characteristics identified in the histological and 
biomechanical studies of the native porcine annulus. The anterior annulus is 
in close proximity to the aortic and pulmonary walls which also exhibited 
similar changes in decellularisation studies, with a significant decrease in the 
elastin phase slope in the decellularised porcine aortic wall (Korossis et al., 
2005) and porcine pulmonary walls (Luo et al., 2014).  
When compared to the biomechanical characteristics of glutaraldehyde 
treated autologous pericardium (Ozolins et al., 2008), the only other 
biological tissue used as an annuloplasty device (De La Zerda et al., 2008), 
the decellularised porcine annulus provides a better match to the different 
regions of the collagenous anterior and more muscular posterior regions of 
the human annulus, with the structure of the porcine heart closely matching 
that of the human heart (Kunzelman et al., 1994, Hearse & Sutherland, 
2000). 
Extract and contact cytotoxicity assays confirmed that the acellular porcine 
mitral valve annulus tissue was biocompatible. This inferred that potential 
toxic chemicals used during the decellularisation process, notably SDS has 
been adequately washed out.  SDS is cytotoxic to cells so it is important that 
is has been removed from the scaffold (Caamaño et al., 2009; Sakai et al., 
1998), BHK and L929 cells  grew in contact with the scaffold and scaffold 
extracts demonstrating that a suitable number of wash cycles had been 
undertaken as the final step in the decellularisation protocol.  
Lectin staining was undertaken to visualise α-gal distribution in the native 
and decellularised tissue. The α-gal distribution was reduced but not entirely 
removed from the tissue post decellularisation, the residual α-gal was 
primarily present within the muscle and not within the annulus. Alpha-gal is 
the target of pre-formed antibodies in humans and can cause hyperacute 
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reactions of vascularised tissues and organs (Konakci et al., 2005). 
Rejection has been identified with antibodies binding to the α-gal epitope on 
the surface of endothelial cells (Liu et al., 2002). 
Whether the presence of residual α-gal in acellular biological scaffolds is a 
clinical concern is a matter for debate. However,  biological scaffolds with 
residual α-gal have been implanted in millions of patients (D’Eredità, 2015; 
McPherson et al., 2000; Mostow et al., 2005). Alpha-gal epitopes have been 
found on commercially available glutaraldehyde fixed bioprosthetic heart 
valves, although patients implanted with these valves exhibited increased 
titres of anti-gal antibodies (Konakci et al., 2005). The elimination of the α-
gal epitopes on the decellularised tissue could be achieved using α-
galactosidase. This has already been used to remove α-gal on porcine aortic 
valve and pericardial tissue (Park et al., 2009) without detrimental effects on 
the biomechanical properties (Choi et al., 2012) or by using endo-beta-
galactosidase C as used to remove the α-gal epitope from porcine kidneys 
(Liu et al., 2002).  
The results of the biological and biomechanical characterisation of the 
decellularised porcine mitral valve annulus illustrate that the scaffold could 
be suitable for use as clinical product. The functional capabilities of the ring 
will be investigated in the next chapter to determine if it could be considered 
for future use as a biological acellular annuloplasty ring. 
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Chapter 6 
In vitro evaluation of decellularised porcine mitral annulus 
for annuloplasty repair  
6.1 Introduction  
To evaluate the biological acellular annuloplasty ring for use in annuloplasty 
repair it was necessary to develop an explanted porcine heart model. The 
gold standard for mitral valve repair is synthetic ring annuloplasty (Fundarò 
et al., 2007) which necessitated the development of a suitable procedure to 
compare synthetic rings with the biological acellular annuloplasty ring 
developed in the previous chapter. Developing a medical device for heart 
valve repair can be complex, costly and require ethical approval if 
performing animal trials (Perry, 2007). To reduce this burden a preclinical in 
vitro explanted heart static pressure model was developed to test 
annuloplasty rings for repair.  
In a study by Richards et al. (2009), an in vitro dynamic heart system was 
developed in which saline was pumped through the left atrium of porcine 
hearts at physiological pressures and heart rates. Regurgitation was induced 
in the hearts by manually dilating the mitral valve annulus and severing 
chordae tendinae connecting the P2 leaflet to the papillary muscles. For the 
present study, a static system was proposed rather than a dynamic system 
as it provided a simple system to measure the rate of regurgitation at 
maximum normal valve pressures of 120 mmHg. Clinically, annuloplasty 
repairs are tested by re-pressurising the valve with saline solution to check 
that the valves are competent before completing the repair procedure. The 
static method offered an analogous method to in-vivo repair whilst ensuring 
pressures were controlled to the maximum expected during systole, when 
the mitral valve leaflets are closed and regurgitation occurs. The American 
Society of Echocardiography defines the rate of regurgitation as mild when 
regurgitation is less than 30 ml.beat-1, moderate when it is between 30 and 
59 ml.beat-1 and severe when regurgitation is more than 59 ml.beat-1 
(Zoghbi, 2003).  
The model to be developed to test the decellularised porcine annuloplasty 
rings therefore had the following requirements: 
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 Be able to achieve repeatable regurgitation volumes at correct 
pressures that are significantly higher than normal heart regurgitation 
rates 
 To be quick to manufacture 
 To be cost effective 
 To be suitable for undertaking annuloplasty repair using synthetic and 
decellularised annuloplasty rings 
To reproduce mitral valve regurgitation, porcine hearts were obtained from a 
local abattoir and the mitral valve complex, which includes the mitral valve 
leaflets, chordae, papillary muscle and the annulus, was tested under 
various regurgitation scenarios in a static heart rig.  
The main causes of mitral valve regurgitation are ischaemic and non-
ischaemic mitral valve disease. These are further subcategorised as 
functional, which includes ventricular remodelling, or organic, which only 
involves the mitral valve complex (Enriquez-Sarano et al., 2009). 
Remodelling of the heart due to ischaemic mitral valve disease can cause 
annulus dilation (Boltwood et al., 1983; Kaplan et al., 2000; Mihalatos et al., 
2007), whilst non-ischaemic regurgitation tends to be caused by 
myxomatous mitral valve disease in which the connective tissue is 
weakened causing valve prolapse and mitral annular dilation (Bulkley & 
Roberts, 1975; Ormiston et al., 1982; Mihalatos et al., 2007). It has also 
been reported that annular dilation can occur independently of mitral valve 
prolapse and left ventricular remodelling (Mihalatos et al., 2007) although 
this finding is controversial with other studies reporting that this is not the 
case (Otsuji et al., 2002). Other causes of mitral regurgitation include 
endocarditis, chordae rupture due to myxomatous valve disease, papillary 
muscle rupture due to myocardial infarction (Stout & Verrier, 2009) and 
annulus dilation alongside mitral valve prolapse, due to rheumatic mitral 
valve disease (Marcus, 1994). It was therefore logical to investigate models 
that were representative of these modes of mitral valve regurgitation. 
Previous methods of inducing regurgitation in-vivo in the mitral valve include 
chordal rupture in dogs (Urabe et al., 1992, Pat et al., 2010) and the 
application of collagenase in the hearts of dogs (Fujiki et al., 2000). In-vitro 
methods used chordal rupture alongside annular dilation in porcine hearts 
(Richards et al., 2009).The protocol that provided repeatable rates of 
regurgitation whilst being suitable for annuloplasty repair would be 
developed and utilised as the regurgitation model for testing the rings.  
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6.1.1 Aims and objectives 
Aims: 
The aim of this chapter was to establish methods for invoking regurgitation in 
the mitral valve of porcine hearts and to undertake a comparative in-vitro 
evaluation of biological acellular rings to synthetic annuloplasty rings 
currently used for valve repair due to mitral valve regurgitation. 
 
Objectives: 
To perform in-vitro evaluation of the acellular annuloplasty rings by 
comparing the decellularised annuloplasty rings with synthetic rings using an 
explanted porcine heart regurgitation model: 
 
 To develop a method for producing regurgitant porcine hearts in-vitro 
 To repair the regurgitant porcine hearts using synthetic annuloplasty 
rings 
 To repair the regurgitant porcine hearts using decellularised 
annuloplasty rings 
 To compare the decrease in regurgitant volume as a result of repair 
using decellularised porcine mitral valve annuli vs synthetic 
annuloplasty rings. 
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6.2 Material and methods 
6.2.1 Working solutions 
6.2.1.1 PBS wash buffer with EDTA (0.1 % w/v), Aprotinin (10 KIU.ml-1 
aprotinin) 
Ten Oxoid Dulbecco PBS tablets were dissolved in 1 L of distilled water and 
pH adjusted to 7.2 – 7.4. EDTA (1 g) was added to the solution with 1 ml of 
aprotinin (10000 KIU.ml-1). 
6.2.1.2 Transport medium 
Aprotinin (1 ml, 10,000 KIU.ml-1) and HEPES (5 ml, 1M) was added into 500 
ml of HBSS and made up for each heart. 
6.2.1.3 Trypsin (11250 U.ml-1) solution  
Trypsin (1 g) was added to 15 ml of PBS and mixed using a magnetic stirrer. 
 
6.2.2 Static regurgitation testing of porcine mitral valves 
To compare the functional repair capabilities of the decellularised 
annuloplasty rings compared to synthetic annuloplasty rings, regurgitation 
testing of the porcine mitral valve was undertaken using a static heart test 
rig. The tests quantified the regurgitant volumes under four different 
scenarios: 
1. Normal healthy mitral valve  
2. Valve with induced mitral regurgitation  
3. Repaired mitral valve using synthetic annuloplasty rings 
4. Repaired mitral valve using biological acellular annuloplasty rings 
Two controls were used for the testing. The negative controls were fresh 
porcine hearts without any induced regurgitation. Positive controls were 
hearts with a hole punched in the anterior leaflet to invoke regurgitation at 
clinically relevant levels of 100 ml.s-1. The time taken for the pressure to drop 
from 120 mmHg to 100 mmHg and from 120 mmHg to 80 mmHg was 
recorded and used to calculate leakage rates. Leakage rates were converted 
from ml.s-1 to ml.beat-1 by equating one beat to 0.3 seconds which is 
equivalent to the time period of the systolic contraction of the heart (Weissler 
et al., 1961). 
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6.2.2.1 Fresh porcine heart preparation 
Fresh porcine hearts were supplied by local abattoirs. These had been 
removed from Large White pigs approximately 24-26 weeks old which had 
been slaughtered within 24 hours of transport to the laboratory. Excess non- 
heart tissue and pericardium was removed (Fig 6.1a) and an incision was 
made around the aorta, where it branches to the brachiocephalic artery, the 
left common carotid artery and the left subclavian artery, preserving the 
ascending aorta (Fig 6.1b). The pulmonary and aortic roots were separated 
via the membrane connecting them. Using scissors, an incision was made in 
the membrane and the roots were separated (Fig 6.1b). An incision was 
made in the left auricle just above its junction with the left ventricle and the 
left auricle was removed to reveal the left atrium (Fig 6.1c). Aortic leaflets 
were removed by holding each leaflet in a tissue clamp and carefully cutting 
it with scissors (Fig 6.1d). The right coronary artery branching from the aorta 
was identified, adipose tissue surrounding the right coronary artery was 
removed with scissors. Sutures (size 3-0) were tied around the artery to 
prevent saline flowing to the myocardial tissue, tissue clamps were also 
used to clamp the artery. The left coronary artery branching from the aorta 
was identified. Adipose tissue surrounding the left coronary artery was 
removed with scissors. Sutures (size 3-0) were tied around the artery to 
prevent saline flowing to the myocardial tissue, tissue clamps were also 
used to clamp the left coronary artery. The prepared hearts were washed in 
PBS wash buffer with EDTA and aprotinin for 30 minutes three times at 
room temperature and then stored overnight in transport medium at 4 oC.  
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 a)  b) 
   
 c) 
d)  f)  
Fig 6.1 – Preparation of porcine tissue for static testing. Whole heart (a), 
splitting of aorta and pulmonary valve (b), removal of left auricle (c), 
cutting of aortic valve leaflets (d). AA: Ascending aorta, AU: Left auricle, 
AVL: Aortic valve leaflet, LA: Left atrium, LV: Left ventricle, RV: Right 
ventricle. 
 
6.2.2.2 Static test rig preparation 
A Perspex column 1832 mm high was used to create a pressure head of 120 
mmHg for testing the hearts (Fig 6.2). The test rig was marked with 
pressures in 20 mmHg intervals up to 120 mmHg and could be drained via 
an outlet drainage pipe at the base. A valve mounting block was attached to 
the column at the base where the hearts were cannulised by a spigot. The 
test rig was placed into a large plastic container and secured to the bench 
with a clamp (Fig 6.3a). Hearts were attached to the static test rig via a 
medium sized spigot, ‘o’ rings were placed on either side of the spigot and 
inserted together into the valve mounting block (Fig 6.3b). The assembly 
LA 
LA 
LV 
AVL 
LV 
RV 
AU 
AU 
LV 
AU 
AA 
P 
AA 
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was fixed into position by a Perspex plate attached by three bolts. The spigot 
was cannulised via the aorta and secured by cable ties (Fig 6.3b). 
 
 
Fig 6.2 – Side profile of static test rig Static test rig to test regurgitation on 
porcine hearts using a column of saline to pressurise the left ventricle. 
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 a)  b) 
 
 
 
Fig 6.3 – Porcine heart attachment to the static test rig Fresh porcine 
hearts were cannulated to the static test rig (a) via a spigot and 
fastened using a cable tie (b). Anterior and posterior coronary arteries 
were closed using tissue clamps. Ao: Aorta, C: Cable tie, H: Heart, MB: 
Mounting Block, S: Spigot. 
Prior to testing, the aorta was clamped to prevent saline from entering the 
heart before the timer was started (Fig 6.3b). The column was filled to the 
120 mmHg mark using 0.9% (w/v) saline. At the beginning of the test the 
clamp was removed from the aorta and the heart checked for leaks from 
regions other than the mitral valve. The primary cause of leaks was from the 
coronary arteries. This was resolved using sutures or tissue clamps to tie off 
the arteries. Once leaks were stopped the aorta was clamped and the 
column was re-filled to 120 mmHg. Hearts were covered with a plastic 
container to prevent the saline from spraying during the test. Each test 
started with the removal of the clamp and a stop watch started. 
 
6.2.2.3 Healthy heart model 
The time for the column to drop from 120-100 mmHg and 120-80 mmHg was 
recorded. The valve was considered to be competent if the pressure head 
did not drop from 120 mmHg to 80 mmHg after a period of 20 minutes.  
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6.2.2.4 Positive control heart model 
A hole was punched in the A2 cleft of the anterior leaflet. The diameter of the 
hole required to cause moderate regurgitation was estimated using the 
Bernoulli equation (Eq 6.1) and the equation for flow rate through a pipe (Eq 
6.2): 
𝑃1 + 0.5 × 𝜌 × 𝑣1
2 + ℎ1𝜌𝑔 = 𝑃2 + 0.5 × 𝜌 × 𝑣2
2 + ℎ2𝜌𝑔   (6.1)  
𝑃𝑖𝑝𝑒 𝑑𝑖𝑎𝑚𝑒𝑡𝑒𝑟 =  √
4 × 𝑓1
𝜋 × 𝑣2
   (6.2) 
Where: 
𝑃1 = 𝑀𝑎𝑥 𝑝𝑟𝑒𝑠𝑠𝑢𝑟𝑒 (𝐾𝑔. 𝑚
−2) 
𝑃1 =
16000 (𝐾𝑔. 𝑚−2) (120 𝑚𝑚𝐻𝑔) 
 
𝑃2 = 𝑃𝑟𝑒𝑠𝑠𝑢𝑟𝑒 𝑖𝑛 𝑎𝑡𝑟𝑖𝑢𝑚 (𝐾𝑔. 𝑚
−2) 
𝑃2 = 0(𝐾𝑔. 𝑚
−2)  
 
𝑝 = 𝐷𝑒𝑛𝑠𝑖𝑡𝑦 𝑜𝑓 𝑠𝑎𝑙𝑖𝑛𝑒 (𝐾𝑔. 𝑚−2)  
𝑝 = 1004.6 (𝐾𝑔. 𝑚−2)  
 
ℎ1  = 𝑟𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒 ℎ𝑒𝑖𝑔ℎ𝑡 (𝑚)  
ℎ1  = 0 𝑚  
ℎ2  = ℎ𝑒𝑖𝑔ℎ𝑡 𝑎𝑡 𝑝𝑢𝑛𝑐𝑡𝑢𝑟𝑒 ℎ𝑜𝑙𝑒 (𝑚)  
ℎ2  = 0.1 𝑚  
 
𝑣1  = 𝑣𝑒𝑙𝑜𝑐𝑖𝑡𝑦 𝑎𝑡 ℎ1 (𝑚. 𝑠
−1)  
𝑣1  = 0 𝑚. 𝑠
−1  
 
𝑣2  = 𝑣𝑒𝑙𝑜𝑐𝑖𝑡𝑦 𝑎𝑡 ℎ𝑜𝑙𝑒(𝑚. 𝑠
−1)  
 
𝑓1  = 𝑟𝑒𝑞𝑢𝑖𝑟𝑒𝑑 𝑓𝑙𝑜𝑤 𝑟𝑎𝑡𝑒(𝑚
3. 𝑠−1)  
𝑓1  = 0.0001 𝑚
3. 𝑠−1 for moderate 
regurgitation
16000 + (0.5 × 1004.6 × 0) + 0 
= 0 + (0.5 × 1004.6 × 𝑣2
2) + 0.1 × 1004.6 × 9.81    
 
16000 = (502.3 × 𝑣2
2) + 985.5    
𝑣2 = √
15014.5
502.3
 
𝑣2 = 5.47 𝑚. 𝑠
−1 
𝐻𝑜𝑙𝑒 𝑑𝑖𝑎𝑚𝑒𝑡𝑒𝑟 =  √
4 × 0.0001
𝜋 × 5.47
    
𝐻𝑜𝑙𝑒 𝑑𝑖𝑎𝑚𝑒𝑡𝑒𝑟 = 4.82 𝑚𝑚  
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A hole 4.82 mm in diameter was required to cause a moderate rate of 
regurgitation of 100 ml.s-1. Using a 5 mm biopsy punch a hole was punched 
into the A2 cleft of the anterior leaflet (Fig 6.4), ensuring that the part of the 
leaflet punched did not fold into another cleft on the posterior leaflet during 
coaptation and prevent leakage.  
 
 
Fig 6.4 – Positive control for the regurgitant porcine heart model. Holes 
of 5 mm were punched into the A2 cleft of the anterior leaflet using a 5 
mm biopsy punch. Ao: Aorta, AU: Left auricle, AML: Anterior mitral 
valve leaflet, LA: Left atrium, LV: Left ventricle, RV: Right ventricle. 
 
6.2.2.5 Regurgitant porcine heart model  
The regurgitant model was designed to permit backflow of saline solution 
through the mitral valve. Various methods, described below, were assessed 
to establish a protocol that would provide a repeatable and appropriate rate 
of regurgitation whilst being suitable for repair.  
  
AML 
Ao 
LA 
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 a)  b) 
 
 
c) d) 
e) f) 
g) h) 
i)  
Fig 6.5 – Different methods of inducing mitral valve regurgitation in the 
porcine heart. Stretch (a), Trypsin treatment (b), Chordae cutting (c, 
d), Papillary muscle elongation (e), Cyanoacrylate glue (f), Annulus 
cutting (g), Ventricular muscle trimming (h, i). Ao: Aorta, AU: Left 
auricle, LA: Left atrium, LV: Left ventricle, RV: Right ventricle. 
LA 
Ao 
VM 
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Methods used to replicate physiological causes of mitral valve 
regurgitation  
For each method tested to replicate mitral valve regurgitation, n=3 hearts 
were tested using the protocol for measuring regurgitation described in 
Section 6.2.2.2. If the method resulted in tests that met the criteria of having 
repeatable regurgitation volumes significantly higher than normal heart 
regurgitation rates then a further n=3 hearts were subject to the tests. 
6.2.2.5.1 Stretching the annulus using retractors 
Clinically, the mitral valve annulus dilates in the anterior to posterior 
dimension up to 25 % which can cause regurgitation. The aim was to 
replicate this process using this method. Medical grade self-retaining 
retractors were used to gradually increase the size of the mitral valve orifice 
by stretching in the anterior to posterior dimension (Fig 6.5a). The 
dimensions of the valve in the anterior to posterior dimensions were 
measured using Vernier callipers with the hearts at a pressure of 120 
mmHg, hearts were clamped at the aorta to prevent backflow of saline 
through the mitral valve whilst the valve was stretched. The retractors were 
opened until the anterior to posterior dimensions were increased by 25 %. 
Retractors were left in position for ten minutes. The dimensions of the 
annulus were measured after stretching the tissue and the saline column re-
pressurised to 120 mmHg, the retractors were removed before 
measurement and testing. Hearts were then tested for regurgitation using 
the method described in Section 6.2.2.2. If sufficient regurgitation had not 
occurred the aorta was clamped and the annulus was stretched further. The 
process was repeated until moderate regurgitation occurred or the open 
limits of the retractors had been met.  
6.2.2.5.2 Injecting trypsin around the mitral valve annulus with annulus 
dilation 
Myxomatous mitral valve disease can cause weakening of the mitral valve 
connective tissue which can lead to regurgitation. To replicate this mode of 
regurgitation, trypsin (11250 U.ml-1) was applied via injection around the 
mitral valve annulus of the porcine mitral valve (Fig 6.5b). The points of 
injection (Fig 6.6) were marked on the valve using surgical marker pen. 
Trypsin volumes of 0.25 ml were used for each injection site. The trypsin 
was injected in parallel to the circumference of the annulus, uniformly 
distributing the trypsin around the annulus. To ensure the trypsin was as 
uniformly distributed as possible the needle was inserted 5 mm prior to the 
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injection point and moved into the tissue until the needle tip lined up with the 
marker. Trypsin (0.125 ml) was injected at the marker and 0.125ml injected 
gradually as the needle was pulled out. 
The trypsin treated tissue was incubated in a humidified container at 37oC 
for two hours with transport medium surrounding the hearts and padded with 
tissue paper to stop the hearts falling over, after two hours the trypsin 
(11250 U.ml-1) was reapplied and the hearts again incubated in a humidified 
container at 37oC for two hours in transport medium. The hearts were 
removed from the container and stored in transport medium overnight at 4oC 
until testing the next day. 
Prior to testing, the hearts were stretched by 25 % to increase in anterior – 
posterior diameter, following the method outlined in Section 6.2.2.5.1. 
 
 
Fig 6.6 – Injection sites for trypsin Syringes were inserted at the blue dot 
and pushed 5 mm into the annulus in parallel to the circumference. 
6.2.2.5.3 Rupturing chordae with annulus dilation 
Acute mitral valve regurgitation can be caused by chordal rupture. The 
chordae attached at the free edge of the A2 leaflet in the mitral valve was 
identified and cut (Fig 6.5c-d). The method described in Section 6.2.2.5.1 
was followed until 25% dilation had occurred to the porcine mitral valve 
annulus in the anterior to posterior direction, under a pressure of 120 mmHg.  
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6.2.2.5.4 Papillary muscle dilation with annulus dilation 
The chordae can elongate due to myxomatous mitral valve disease. In order 
to replicate the elongation and subsequent mitral valve prolapse the papillary 
muscles were partially ruptured. The partial rupture simulated elongation of 
the chordae. The anterolateral papillary muscle was identified in mitral valve 
of the porcine heart (Fig 6.5e). Using scissors, the muscle was cut behind 
the chordae attachment to the muscle until the leaflet attached to the 
chordae of the muscle displayed signs of prolapse, being careful not to 
remove the muscle fully from the left ventricular wall. Following papillary 
muscle partial rupture the annulus was dilated by 25% in the anterior to 
posterior direction following the protocol described in Section 6.2.2.5.1. 
6.2.2.5.5 Super gluing the annulus and leaflets alongside annulus dilation 
Endocarditis and rheumatic mitral valve disease can cause the mitral valve 
to form fibrinous vegetations. Superglue was applied to the mitral valve 
leaflets to replicate this process. The aorta was clamped and saline solution 
was removed from the left atrium and left ventricle, using tissue paper to 
absorb excess solution around the mitral valve. Drops of ethyl cyanoacrylate 
were applied around the annulus using the insertion points shown in Fig 6.6 
for the application points. Drops of ethyl cyanoacrylate were then applied to 
the atrial surface of the anterior and posterior leaflets ensuring the glue had 
dried before any tests were conducted. Prior to application of the glue the 
annulus was dilated by 25 % in the anterior to posterior direction following 
the protocol described in Section 6.2.2.5.1. 
6.2.2.5.6 Trimming the muscle of the left ventricular  
Ischaemic mitral valve disease causes the left ventricle to dilate. In order to 
simulate that effect, the majority of the muscle of the left ventricle was 
removed. The muscle of the left ventricle was removed until there was 
approximately 10 mm of muscle remaining between the endocardium and 
epicardial side of the left ventricle. Muscle was removed from around the 
annulus in the atrial and ventricular myocardium to increase annulus dilation, 
until the thickness of the myocardium was approximately 5 mm. The 
circumferential fibres of the left ventricle were cut axially from the epicardial 
side of the annulus down towards the apex of the heart in three equally 
spaced regions (Fig 6.5h-i) to further increase dilation. Following myocardial 
removal the annulus was dilated by 25% in the anterior to posterior direction 
following the protocol described in Section 6.2.2.5.1. 
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6.2.2.5.7 Bisecting the mitral valve annulus at the left commissure 
To increase the circumference of the mitral valve annulus and simulate 
mitral valve dilation, the annulus was bisected. The annulus of each heart 
was cut at the left commissure where the leaflet length from the annulus was 
the smallest. It was cut at this point to prevent leakage occurring through the 
leaflet which would require a more complex repair. The cut intersected the 
annulus and partially into the muscle wall which also permitted some 
regurgitation through the cut. 
 
Non-physiological causes of regurgitation 
6.2.2.5.8 Cauterising the mitral valve leaflets 
Anterior and posterior leaflets were reduced using medium temperature, 
thick tipped cauterisers. The anterior leaflet was heated until the leaflet 
shrunk back until no more shrinking occurred. The posterior leaflet of the 
mitral valve was also heated using cauterisers, until no further shrinkage 
was visible.  
6.2.2.5.9 Zinc fixing the porcine mitral valve complex 
Zinc fixative was prepared as described in Chapter 2, Section 2.2.3.1. The 
left ventricle of each heart was filled with zinc fixative until it covered the 
mitral valve leaflets. Each heart was placed into a plastic container and the 
container was padded with tissue paper to keep the hearts upright. The 
hearts were immersed in transport medium and kept at 4oC for 16 hours 
overnight. Hearts were then washed in PBS for 30 minutes and placed into 
transport medium for storage before testing.  
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6.2.2.6 Repaired heart model 
The final method chosen to induce regurgitation in the porcine mitral valve 
annulus was the method in Section 6.2.2.5.7 in which the annulus was cut in 
the left commissure. This caused annular dilation, alongside regurgitation 
through the perforation. For each test using the synthetic or decellularised 
porcine mitral valve annulus rings for repair n=5 hearts were used. Prior to 
the insertion of the annuloplasty rings the perforation was closed using 3-0 
sutures (Fig 6.7a) and then the synthetic or decellularised porcine 
annuloplasty ring was used to reinforce the repair. Training was provided by 
Dr Rodolfo Paniagua to Dr Tayyebe Vafaee and myself to demonstrate the 
correct clinical procedure for suturing the synthetic rings to the mitral valve. 
In the subsequent repairs of the mitral valves all repairs, both with synthetic 
and biological annuloplasty rings were carried out by Dr Tayyebe Vafaee. 
6.2.2.6.1 Synthetic annuloplasty rings 
A Carpentier-Edwards classic annuloplasty ring was used for each repair. 
This device consisted of a solid titanium core with a polyester knit fabric with 
commissure markers for ease of insertion. To insert the annuloplasty ring, 
fresh porcine hearts were first prepared as described in Section 6.2.2.1 and 
then placed into a heart holder (Fig 6.7b). To secure the hearts in the holder, 
sutures (3-0) were inserted into remaining left auricle tissue and secured into 
the heart holder on three sides. The annuloplasty ring was sized for the 
heart by stretching the anterior leaflet across the plane of the annuloplasty 
ring and ensuring that the leaflet covered the whole area of the annuloplasty 
ring (Fig 6.7c). The left and right trigones were identified as the primary 
anchoring points for the annuloplasty ring. Using the markers for the trigones 
on the ring, the first suture was threaded through the ring at the marker and 
then through the annulus at the right trigone and back through the 
annuloplasty ring a second time. A second suture was then placed through 
the annuloplasty ring at the left trigone marker and threaded through the left 
trigone and back through the ring (Fig 6.7d). Two further sutures were 
inserted horizontally into the annuloplasty ring at the fibrous mitral to aortic 
continuum. In the posterior region four sutures were inserted spread evenly 
across the posterior annulus. Each suture was threaded through the 
annuloplasty ring and into the annulus, carefully threading the suture behind 
the leaflet and back up into the annulus and through the annuloplasty ring 
(Fig 6.7e). Once all the sutures were inserted into the annulus the 
annuloplasty ring was lowered into the mitral valve and all the sutures tied 
and cut (Fig 6.7f).  
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 a)  b) 
 c)  d)  
 e)   f) 
Fig 6.7 – Preparation of porcine heart tissue repaired with synthetic 
annuloplasty ring for static testing. Sutures were inserted into the 
mitral valve annulus to repair the cut created in the left commissure (a), 
whole heart fixed into position with sutures into the heart holder (b), 
sizing of the annuloplasty ring using the anterior mitral valve leaflet for 
reference (c), attaching the mitral valve annuloplasty ring into position 
using the left and right trigones as anchoring points (d), annuloplasty 
ring lowered into position in the porcine mitral valve (e), sutures tied off 
and cut to secure the annuloplasty ring into position in the porcine 
mitral valve (f). AA: Ascending aorta, AML: Anterior mitral valve leaflet, 
LA: Left atrium, AT: Anterior annulus, P: Posterior mitral valve. 
6.2.1.6.2 Decellularised porcine mitral valve annuloplasty ring 
The annuloplasty rings were tested in the physiological orientation, in which 
each trigone in the decellularised annuloplasty ring matched up with the 
trigone in the fresh porcine heart. A reverse annuloplasty ring was also 
tested, the ring was reversed so that the left trigone matched up with the P1 
cleft on the posterior leaflet and the right trigone matched up with the P3 on 
the posterior leaflet.  
AA 
LA 
AT 
P 
AML 
AA 
AA 
AVL 
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Decellularised porcine mitral valve annuloplasty rings (n=5) processed using 
Method 8 as described in Chapter 4, Section 4.5.8 were used for each 
orientation. To insert the decellularised annuloplasty rings, fresh porcine 
hearts were first prepared as described in Section 6.2.2.1 and then placed 
into a heart holder, if required, to aid annuloplasty insertion. The 
annuloplasty ring was sized for the heart by stretching the anterior leaflet 
across the plane of the annuloplasty ring and ensuring that the leaflet 
covered the whole area of the annuloplasty ring. The left and right trigones 
were identified as the primary anchoring point for the decellularised 
annuloplasty ring (Fig 6.8b). 
Physiological orientation 
Using the trigonal regions on the decellularised annuloplasty ring as markers 
the first suture was threaded through the annuloplasty ring at the right 
trigone (Fig 6.8a) and then through the annulus of the heart at the right 
trigone and back through the annuloplasty ring a second time. A second 
suture was then placed through the decellularised annuloplasty ring at the 
left trigone and threaded through the left trigone in the heart and back 
through the ring. Two further sutures were inserted horizontally into the 
annuloplasty ring at the fibrous mitral to aortic continuum. In the posterior 
region four sutures were inserted spread evenly across the posterior 
annulus. Each suture was threaded through the annuloplasty ring and into 
the annulus, carefully threading the suture behind the leaflet and back up 
into the annulus and through the annuloplasty ring. Once all the sutures 
were inserted into the annulus the annuloplasty ring was lowered into the 
mitral valve and all the sutures were tied and cut (Fig 6.8d).  
Reverse orientation 
Using the trigonal regions on the fresh porcine heart as an anchor, the 
annuloplasty ring was inserted as described for the physiological ring 
orientation but in reverse, so that the anterior region of the annuloplasty ring 
was inserted into the posterior annulus in the heart (Fig 6.8 e). 
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 a)  b) 
 c)  d)  
e)    
Fig 6.8 Preparation of porcine heart tissue repaired with decellularised 
porcine mitral valve annuloplasty ring for tissue for static testing. 
Fresh porcine heart with sutures in anterior and posterior coronary 
artery (a), orientation of the decellularised annuloplasty ring into the 
porcine heart using the left and right trigones on the annuloplasty ring 
as reference (c), sutures tied off and cut to secure the annuloplasty ring 
into position in the porcine mitral valve (d), sutures tied off and cut to 
secure the annuloplasty ring into a reverse position in the porcine mitral 
valve (e). AA: Ascending aorta,  AC: Anterior coronary artery, AVL: 
Anterior mitral valve leaflet, LA: Left atrium, AT: Anterior annulus, P: 
Posterior mitral valve. 
  
LA 
AA 
LA 
AC 
P 
AT 
AA 
AT 
LA 
AA 
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6.3 Results 
6.3.1 Healthy porcine heart model 
The results of regurgitation testing of the healthy porcine heart model are 
displayed in Table 6.1. There were very mild rates of regurgitation occurring 
through the mitral valve of the hearts when there was no intervention to 
induce regurgitation. The average time for columns of saline to drop from 
120 to 80 mmHg was not recorded as none of the hearts reached the 80 
mmHg level in 20 minutes. The average regurgitation rate was 0.05 ± 0.05 
ml.beat-1, calculated from the difference in volume of saline solution in the 
column from 120 mmHg to the level of the pressure column head measured 
at 20 minutes. 
Table 6.1 – Regurgitation rates for mitral valves of healthy porcine 
hearts 
Heart Average regurgitation rate 
(ml.s-1) 
Average regurgitation rate 
(ml.beat-1) 
Class 
1 0.36 0.11 Mild 
2 0.35 0.11 Mild 
3 0.16 0.05 Mild 
4 0.06 0.02 Mild 
5 0.02 0.01 Mild 
6 0.06 0.02 Mild 
Average 0.17 0.05 Mild 
95% CI 0.16 0.05  
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6.3.2 Positive control heart model 
The results for the regurgitation testing of the positive control porcine heart 
model are displayed in Table 6.2. There were mild to moderate rates of 
leakage through the 5 mm hole punctured in the anterior leaflet.  
The average time for the column to drop from 120 to 80 mmHg was 16.79 ± 
5.54 s which was equivalent to a rate of 30.51 ± 12.72 ml.beat-1. 
Table 6.2 – Regurgitation rates for mitral valves of positive control 
hearts  
Heart Time of column leak  
120 – 80 mmHg (s) 
Rate to 80 
mmHg (ml.s-1) 
Rate to 80 
mmHg 
(ml.beat-1) 
Class 
1 8.72 176.39 52.92 Moderate 
2 19.54 78.72 23.62 Mild 
3 20.09 76.56 22.97 Mild 
4 13.63 112.85 33.85 Moderate 
5 15.37 100.07 30.02 Moderate 
6 23.41 65.70 19.71 Mild 
Average 16.79 101.72 30.51 Moderate 
95 %CI 5.54 42.40 12.72  
 
6.3.3 Regurgitant models 
6.3.3.1 Stretched annulus  
When the porcine heart annulus was stretched using retractors, there was 
no leakage in two of the three hearts and mild leakage in one heart. The 
- 249 - 
 
average time for the column to drop from 120 to 80 mmHg was 675.20 s 
which was equivalent to an average rate of 5.24 ml.beat-1. The range of 
leakage rates meant that this method would not deliver repeatable 
regurgitation rates required for the final regurgitation model. 
 
6.3.3.2 Trypsin injection around the mitral valve annulus 
The treatment of the porcine mitral valve annulus with trypsin produced only 
mild rates of leakage through the leaflets of mitral valves. The average time 
for the column to drop from 120 to 80 mmHg was 531 s which was 
equivalent to a rate of 2.58 ml.beat-1. The limited regurgitation together with 
extended preparation time compared to other methods meant this method 
was not suitable for the final regurgitation model. 
 
6.3.3.3 Ruptured chordae 
The results for hearts with their chordae ruptured are displayed in Table 6.3. 
There were mild to severe rates of regurgitation through the anterior leaflet. 
The average time for the column to drop from 120 to 80 mmHg was 41.82 ± 
75.15 s which was equivalent to a rate of 48.53 ± 55.29 ml.beat-1. 
Table 6.3 – Regurgitation rates for porcine mitral valves with ruptured 
chordae  
 Time of column leak 
120 – 80 mmHg (s) 
Rate to 80 mmHg 
(ml.s-1) 
Rate to 80 
mmHg 
(ml.beat-1) 
Class 
1 187.42 8.21 2.46 Mild 
2 17.28 89.01 26.70 Mild/ Moderate 
3 19.83 77.57 23.27 Mild 
4 15.54 98.98 29.69 Moderate 
5 3.09 497.77 149.33 Severe 
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6 7.73 198.98 59.69 Severe 
Average 41.82 161.75 48.53 Moderate 
95 % CI 75.15 184.29 55.29  
 
6.3.3.4 Papillary muscle dilation 
Three hearts were tested using papillary muscle dilation. There were mild 
rates of leakage through a prolapsed leaflet caused by the dilation. One 
heart failed due to complete dissection of the papillary muscle. The average 
time for the column to drop from 120 to 80 mmHg was 38.73 s which was 
equivalent to a rate of 12.84 ml.beat-1. No further testing was completed due 
to the poor reproducibility of the test procedure including the complete failure 
of the papillary muscle. 
 
6.3.3.5 Super glued leaflets and annulus 
Three hearts were tested using the method of coating the top leaflet 
surfaces and annulus with superglue. There were mild rates of leakage that 
occurred where the anterior and posterior leaflets closed together at the 
coaptation point. The average time for the column to drop from 120 to 80 
mmHg was 95.88 s which was equivalent to a rate of 5.49 ml.beat-1. It was 
determined that due to the difficulty in repairing the lesions created using this 
method, that no additional tests with this method would be completed. 
 
6.3.3.6 Trimmed left ventricular myocardium 
Three hearts with ventricular muscle removed were tested for mitral valve 
regurgitation. There were mild rates of leakage in hearts with simulated left 
ventricular dilation. The average time for the column to drop from 120 to 80 
mmHg was 954 s which was equivalent to a rate of 0.58 ml.beat-1. No further 
testing was completed due to the poor leakage rates. 
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6.3.3.7 Bisected mitral valve annulus at the left commissure 
The results for the hearts with the annuli cut at the left commissure are 
displayed in Table 6.4. There were mild rates of leakage through the valves. 
The average time for the column to drop from 120 to 100 mmHg for all 
hearts was 54.04 ± 23.74 s which was equivalent to a rate of 4.36 ± 1.90 
ml.beat-1. 
Table 6.4 – Regurgitation rates for porcine mitral valves with bisected 
mitral valve annuli 
 Time of column leak  
120 – 80 mmHg (s) 
Rate to 80 mmHg 
(ml.s-1) 
Rate to 80 
mmHg 
(ml.beat-1) 
Class 
1 150.53 10.22 3.07 Mild 
2 126.11 12.2 3.66 Mild 
3 85.69 17.95 5.38 Mild 
4 104 14.79 4.44 Mild 
5 202 7.61 2.28 Mild 
6 62.84 24.48 7.34 Mild 
Average 121.86 14.54 4.36 Mild 
95 % CI 52.20 6.34 1.90  
 
6.3.3.8 Cauterising the mitral valve leaflets 
There were mild rates of leakage through the valves of hearts in which the 
leaflets had been cauterised. One heart did not reach 80 mmHg in the time 
limit of 20 minutes and so it met the criteria for no regurgitation. The average 
time for the column to drop from 120 to 100 mmHg for all hearts was 649 s 
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which was equivalent to a rate of 0.99 ml.beat-1. The minimal rate of 
regurgitation meant that this test would not be suitable for the final 
regurgitation model and no additional tests were performed. 
 
6.3.3.9 Zinc fixed mitral valve 
The zinc fixed hearts used in this test failed prior to the test or during the test 
procedure. Due to these failures no extra hearts were tested due to the poor 
reliability of the procedure. 
 
6.3.4 Mitral valve repair  
The disease model that produced replicable rates of mitral valve 
regurgitation as well as being simple to repair with an annuloplasty ring was 
the method Section 6.2.2.5.7, the bisection of the mitral valve annulus. 
Hearts were first tested for regurgitation with the cut in the annulus at the left 
commissure as described in Section 6.2.2.5.7 and then repaired with either a 
synthetic annuloplasty ring or decellularised porcine mitral valve 
annuloplasty rings. In the disease model before the annulus was repaired 
with a synthetic ring there was a regurgitation rate of 4.33 ± 2.51 ml.beat-1, 
after the annulus had been repaired with a synthetic annuloplasty ring there 
was a regurgitation rate of 0.41 ± 0.49 ml.beat-1 (p < 0.05) (Fig 6.7) and a 
reduction in regurgitation of 90.60% (Fig 6.10).  
In the disease model for the biological acellular annuloplasty rings, inserted 
in a physiological orientation, there was a regurgitation rate of 4.55 ± 2.23 
ml.beat-1 and with post annuloplasty repair there was a regurgitation rate of 
0.42 ± 0.30 ml.beat-1 (p < 0.05) (Fig 6.9) and a reduction in regurgitation of 
90.74% (Fig 6.10). In the disease model for the biological acellular 
annuloplasty rings, inserted in a reverse orientation to the physiological 
makeup, there was a regurgitation rate of 5.10 ± 1.96 ml.beat-1 and with 
annuloplasty repair in the reverse orientation there was a regurgitation rate 
of 0.55 ± 0.52 ml.beat-1 (p < 0.05) (Fig 6.9) and a reduction in regurgitation 
of 89.20% (Fig 6.10). There was no statistical significance found between 
repair groups.  
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Fig 6.9 – Regurgitation testing of porcine hearts using synthetic and 
decellularised annuloplasty rings. Data is presented as the mean 
(n=5) ± 95% C.I and was analysed by paired student`s t-test that 
showed significant difference between groups (p < 0.05*). 
 
 
Fig 6.10 – Percentage decrease in regurgitation after repair with an 
annuloplasty ring (n=5). Data is presented as the mean decrease in 
regurgitation rate after repair compared to the rate before repair (n=5). 
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6.4 Discussion 
The aim of the research described in this chapter was to assess the 
functional capabilities of the decellularised mitral valve annulus for use as an 
annuloplasty ring. Porcine decellularised mitral valve annuli were implanted 
into an explanted porcine heart with induced regurgitation and tested under 
static pressure. Synthetic annuloplasty rings were implanted under the same 
conditions and compared against the decellularised porcine mitral valve 
annuli. Numerous methods to invoke mitral regurgitation were initially 
attempted. The ideal outcome for these tests were regurgitation volumes 
that replicated moderate to severe regurgitation in-vivo which would warrant 
the insertion of an annuloplasty ring. All procedures tested apart from 
chordae rupture with annulus dilation resulted in mild rates of regurgitation. 
Whilst the chordae rupture model was considered for final testing purposes it 
was decided that chordae resection alone would likely contribute to 
successful reduction in regurgitation without the requirement for 
annuloplasty. Of all the methods tested, annulus bisection was considered to 
be simple to replicate with repeatable results and provided a suitable repair 
choice for annuloplasty.  
 
Previous methods of inducing regurgitation in-vivo in the mitral valve include 
chordal rupture in dogs (Urabe et al., 1992, Pat et al., 2010) and the 
application of collagenase in the hearts of dogs (Fujiki et al., 2000). For 
explanted heart models chordal rupture alongside annular dilation has been 
carried out (Richards et al., 2009). A similar method designed to digest 
collagen in the heart was attempted in this study. Trypsin treatment was 
used in an attempt to replicate some of the effects of myxomatous mitral 
valve disease. The trypsin was only applied to the mitral annulus rather than 
the whole of the mitral valve complex, possibly limiting the effectiveness of 
this approach. Trypsin treatment was combined with annular dilation but 
proved ineffective at producing moderate regurgitation and results were also 
quite variable. The in-vivo model by Fujiki et al., (2000) permitted long term 
changes to take place in the heart which produced ventricular dilation and 
remodelling which was possibly the major factor why this type of model did 
not work in-vitro. Chordal rupture was successful in producing mitral valve 
regurgitation, regurgitation was caused by leaflet prolapse into the left 
atrium. The ruptured chordae model was the only model that produced 
moderate and severe rates of mitral valve regurgitation with results closest 
to regurgitation rates in the positive controls. Consultation with a 
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cardiovascular surgeon revealed that this type of repair would be better 
suited to chordae resection and might not offer insight into the effectiveness 
of mitral annular repair using the decellularised porcine mitral valve 
annuloplasty ring compared to a synthetic ring. Inducing regurgitation with 
mitral annular dilation alone produced mild regurgitation and variable results. 
Isolated mitral annular dilation can cause mitral valve regurgitation 
(Mihalatos et al., 2007) but other factors may prevent regurgitation when 
annular dilation is present. The main factor preventing a moderate rate of 
regurgitation appears to be the redundant leaflet coaptation area present in 
the mitral valve (Kunzelman et al., 1994), allowing appropriate leaflet 
coaptation even with increased dilation. Other unsuccessful methods to 
invoke repeatable rates of regurgitation included papillary muscle dilation to 
replicate chordae elongation and coating the leaflets with cyanoacrylate to 
replicate leaflet vegetation caused by endocarditis and rheumatic mitral 
valve disease. Some of the methods had very little effect on regurgitation, 
these included cauterising the leaflets and removal of left ventricular muscle 
and left atrial muscle.  
 
The only model that produced results that were repeatable whilst also being 
suitable for the assessment of annuloplasty repair was the cutting of the 
mitral annulus at the left commissure. The main limitation of this method was 
the mild rates of regurgitation achieved. After consultation with a 
cardiovascular surgeon it was decided that this method would be the most 
suitable for providing a regurgitant valve model that could be used for 
comparing repairs using synthetic and decellularised porcine mitral valve 
annuloplasty rings. All repairs, using both the synthetic and decellularised 
annuloplasty rings produced significantly lower regurgitation rates compared 
to the hearts with induced regurgitation. No difference was found between 
groups. Static testing did not allow the comparison of the dynamic 
performance of each type of annuloplasty ring as experienced by the mitral 
valve during the cardiac cycle. There were limitations to the method of 
inducing regurgitation in the static test rig; alongside the annuloplasty, suture 
repair was carried out on the annulus tear. It was decided that the repair in 
vivo would necessitate the use of annuloplasty to ensure sufficient 
reinforcement for the repair, as it is unlikely that sutures would hold in this 
area alone. 
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Failure to invoke moderate regurgitation using some of the methods may be 
explained from studies of mitral valve regurgitation. Valves that have 
fibrinous vegetation such as with rheumatic heart disease show few signs of 
regurgitation with acute episodes (Veasy & Tani, 2005), only in chronic 
rheumatic heart disease does mitral valve regurgitation usually occur. 
Annular dilation is present in acute rheumatic heart disease but only in 
chronic rheumatic valve disease does mitral regurgitation increase. This 
occurs when the left ventricle and left atrium dilate and remodel due to long 
term regurgitation, causing annular dilation, chordal elongation and leaflet 
prolapse (Marcus, 1994). Other studies have identified mitral annular dilation 
contributing to only modest rates of regurgitation, the contributing factor 
leading to significant mitral valve regurgitation was papillary muscle tethering 
caused by left ventricular dilation and dysfunction (Otsuji et al., 2002). It 
appears that only acute forms of mitral regurgitation, such as with sudden 
chordae or papillary muscle rupture due to myocardial infarction or annular 
bisection, would provide for a sufficient model for testing regurgitation 
volumes that would warrant mitral valve repair when using a static heart 
regurgitation model, unless pigs had regurgitation induced 6-12 months prior 
to slaughter to replicate some of the chronic effects of the disease, as 
described by Urabe et al. (1992) Fujiki et al. (2000) and Pat et al. (2010).  
The static pressure test rig was designed to keep costs and complexity low 
as a precursor to animal trials. The advantage of the design allows multiple 
trials to be undertaken whilst maintaining low development and time costs. 
Porcine hearts are available from the local abattoirs with a cost of £5 per 
heart which can be tested under multiple test methods with little effect on 
cost or time involved. The major limitation of this model was that 
annuloplasty rings could not be tested dynamically. Valves tested 
dynamically would reduce variability in the regurgitation for each sample and 
provide a system capable of testing the durability of repair. A dynamic 
system would also permit the calculation of regurgitation fraction which 
would give a better understanding of the functional implications of a repair 
on the heart valve by normalising the regurgitation results for the size of 
each individual heart.  
 
An array of dynamic models have been used previously, in two different 
studies the mitral valve complex was excised, including the papillary 
muscles, from the heart (Arita et al., 2004; He et al., 1997) whilst one model 
retained the whole heart taken from pigs (Richards et al., 2009), both of 
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which used a pulsatile flow system. Whilst the first models provided some 
advantages in allowing more control over test parameters such as papillary 
muscle placement, the similarities to the in vivo environment were reduced. 
The whole heart model comprised of a pulsatile flow system simulating some 
of the physiological type conditions seen in vivo in the left ventricle and 
atrium by permitting physiological pressure waveforms and flow rates. More 
complex solutions have been utilised by maintaining the contractile 
properties of excised porcine hearts ex vivo using chemical techniques 
(Araki et al., 2005; Chinchoy et al., 2000). This required increased 
preparation time, costs, access to laboratory animals as well as knowledge 
of the correct transplantation procedures which would negate many of the 
benefits associated with using ex vivo hearts, when attempting to remove 
the use of laboratory animals in testing. 
There are advantages of fully beating heart models as they maintain the 
contractile muscle properties of the left ventricle and papillary muscles which 
would permit the change of left ventricular volumes during the cardiac cycle. 
The contractile elements of this model would include the geometric changes 
to the mitral valve annulus which cannot be replicated with the other models 
mentioned. This would allow an improved comparison between the 
decellularised annuloplasty ring and the synthetic ring and establish if the 
annuloplasty ring improved the dynamic performance compared to synthetic 
rings. Synthetic rings can impede the dynamic motion of the annulus in vivo 
by abolishing changes to the mitral annular area and annular circumference 
during the cardiac cycle (Dagum et al., 2001; Glasson et al., 1999) as well 
as restricting leaflet motion during the cardiac cycle (Green et al., 1999).  
The simplicity of the static system used in this study provided control over all 
test conditions whilst maintaining the natural heart structure and allowed 
regurgitation to be easily quantified by measuring the volume change in the 
column of saline. Future studies can be compared against this study using 
the same criteria making this process highly repeatable. 
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Chapter 7 
Discussion 
7.1 General Discussion  
Every year more than 300,000 people undergo open heart surgery for 
treatment of mitral valve disease worldwide (Bonow et al., 2006), with mitral 
valve regurgitation being the second most common form of valve disease in 
Europe (Iung et al., 2003). In the United States 1.7% of the population suffer 
from mitral valve regurgitation (Nkomo et al., 2006). In a healthy heart, the 
mitral valve leaflets coapt in apposition to each other which prevents 
regurgitation. The mitral annulus in the healthy valve is of the best possible 
size to ensure correct leaflet closure whilst being optimally shaped to reduce 
leaflet stresses across the valve (Salgo, 2002). The chordae and papillary 
muscles work in tandem to prevent restricted leaflet motion or leaflet 
prolapse which are governed by the forces generated during contraction of 
the myocardium during the cardiac cycle. The continual relationship between 
all these components is therefore paramount for normal valve performance 
(Van Mieghem et al., 2010). 
Current treatment strategies include mitral valve repair and mitral valve 
replacement, with repair offering the advantage of preserving left ventricular 
systolic function. Repair also avoids the requirement for lifelong 
anticoagulation treatment and offers improved survival compared to mitral 
valve replacement (Otto, 2003; Enriquez-Sarano et al., 2009), with mitral 
valve annuloplasty being the most common repair procedure. Current 
annuloplasty rings can change annular dynamics, geometry and force 
distribution of the mitral valve (Glasson et al., 1999; Jensen et al., 2008; 
Yamaura et al., 1997) whilst the motion of the posterior leaflet can be 
restricted (Green et al., 1999; Timek et al., 2002; Zhu et al., 2005). In 
children, the use of annuloplasty rings is not recommended as it can cause 
secondary mitral valve stenosis as the heart of the child grows. Long term 
results show that significant regurgitation can reoccur in patients that have 
mitral valve repair using rigid or flexible annuloplasty rings, although 
reoperation rates are quite low (Chang et al., 2007). Pericardium has also 
been used as an annuloplasty device in both adults and children, permitting 
the growth of the mitral valve in children whilst correcting the mitral valve 
regurgitation (Delmo Walter et al., 2010; Miura et al., 2012; Bruno et al., 
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2013; Salvador et al., 2014). An acellular biological scaffold approach has 
the potential to overcome the problems with synthetic rings, particularly for 
paediatric patients, whilst offering advantages over autologous pericardium 
such as being readily available, retaining the pericardium, removal of 
additional risk associated with removing the pericardium and possessing 
biological and biomechanical similarities to the mitral valve region.  
The overall aim of this study was therefore to explore the potential for 
annuloplasty repair utilising decellularised tissues. Human and porcine mitral 
valve annuli were initially considered as the primary source materials due to 
their similar macroscopic characteristics, of which the porcine mitral valve 
annulus was identified as a suitable candidate. Human tissue was rejected 
as a suitable tissue because of heavy calcification in the tissue that was 
obtained and the limited availability of human tissue for use in the research 
and possible future use in the clinic. The use of a cell seeded strategy was 
avoided as it was envisaged that, following implantation resident cells in the 
patient would integrate and gradually regenerate and remodel the donor 
scaffold over time. Development costs and complexity would also be 
reduced as well as minimising regulatory hurdles necessary for taking the 
concept to market. 
Decellularisation protocols for the porcine mitral valve annuli were adapted 
from methods developed by Booth et al. (2002) and Stapleton et al. (2008) 
for the decellularisation of porcine aortic valves and menisci. The process 
involved the optimisation of protocols developed and patented at the 
University of Leeds using repeated cycles of low concentration SDS in the 
presence of proteinase inhibitors and hypotonic buffer wash cycles. The 
removal of cellular components during the development of the 
decellularisation of the mitral valve annulus was assessed using histology, 
DAPI staining of tissue sections and total DNA quantification until a suitable 
protocol had been established. Further analysis of the acellular tissue 
produced by optimised process was then undertaken using histochemistry, 
immunohistochemistry and biomechanical tests to determine any changes in 
the overall composition and structure compared to native porcine mitral 
valve annuli. The decellularised porcine mitral valve annuli were then 
functionally tested using a static test rig to investigate the effectiveness of in-
vitro mitral valve repair. Synthetic annuloplasty rings were compared to 
decellularised annuloplasty rings when used to repair explanted regurgitant 
porcine hearts.  
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Histological characterisation of human and porcine mitral valve annuli 
revealed some differences between species. Collagen II was isolated to the 
trigones in the porcine tissue whilst collagen II presence in human annuli 
was likely due to disease. GAG distribution differed in the trigones between 
species but similarities between species existed for GAG distribution in the 
posterior annulus at the annular junction. Further differences in the trigones 
were found between species, the human trigones were absent of the 
cartilaginous tissue identified in the porcine mitral valve and the human 
fibrosa was thicker, with an increase in the deposition of adipose tissue 
surrounding the human annulus. Histological characterisation of both 
species revealed that on the whole there were similar macroscopic and 
microscopic features in both the anterior and posterior annulus. The anterior 
mitral valve annulus consisted of a dense collagenous mitral- aortic 
continuum bordered by thick trigones on the right and left sides of the 
annulus. Towards the posterior, the fibrosa layer of the posterior leaflet in 
both species formed into a thin collagenous annulus region that separated 
the atrial and ventricular myocardium. Immunohistochemical staining of 
tissue sections showed that the distribution of collagens in the porcine and 
human annulus and surrounding regions were comparable, with the 
exception of collagen II. Overall, the results indicated that the porcine mitral 
valve annulus would be suitable as a start material for the development of a 
decellularised annuloplasty ring. Human mitral valve annuli were not further 
investigated for the development of a decellularised annuloplasty device 
because the donated human tissue was heavily calcified and exhibited some 
signs of ossification. The human tissue was obtained from older donors, due 
to the limited supply of tissue from younger donors. The incidence of valve 
calcification and mitral valve thickness increases with age (Kitzman & 
Edwards, 1990). Hence, it is likely mitral valves taken from younger donors 
would be more comparable to the porcine tissue whilst also being absent of 
calcification and ossification, therefore suitable to be investigated for use as 
an acellular annuloplasty ring.  
Following histological characterisation the biomechanical properties of the 
porcine mitral valve annulus were investigated using uniaxial tensile testing. 
The biomechanical characteristics of the native porcine mitral valve regions 
illustrated the difference in the biomechanical properties between the 
anterior region of the mitral annulus and the posterior regions. The anterior 
region was stiffer and underwent a higher load before failure compared to 
the posterior regions. This was likely because the anterior region forms part 
of the cardiac skeleton that supports and anchors the valve, whereas the 
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posterior region undergoes the majority of contraction and dilation during the 
cardiac cycle (Eckert et al., 2009). The biomechanical characteristics of the 
anterior and posterior regions of the mitral annulus can be attributed to the 
underlying histoarchitecture, with a dense fibrosa that forms into the annulus 
in the anterior region alongside thick cartilaginous regions in the trigones 
and a thin fibrosa surrounded by myocardium in the posterior region. The 
biomechanical properties of the human tissue that was available for study 
was not established due to the calcification.  
Histological analysis of the porcine mitral valve annulus post 
decellularisation revealed that the structural components of the extracellular 
matrix were largely retained, although there was a reduction in the 
distribution of GAGs and collagens associated with the basement membrane 
following decellularisation. The collagen and elastin fibres appeared intact 
following decellularisation when analysed with Sirius red Miller’s stain. The 
thick fibrosa layer formed into the annulus in both the native and 
decellularised tissue, with the density and fibre orientation comparable. The 
trigonal region of the anterior annulus was similar when compared using 
histological analysis, with cartilage-like tissue characterised by lacunae. 
Sirius red Miller’s staining of the decellularised tissue sections showed the 
retention of the elastic cartilage-like tissue found in the native tissue 
sections. The structural collagens I and II were maintained following 
decellularisation but changes were identified in mitral valve annulus sections 
labelled with collagen IV, collagen VI, fibronectin and laminin. The basement 
membrane proteins of collagen IV, fibronectin and laminin were most 
affected by the decellularisation procedure. It is thought that SDS removes 
these components of the ECM apart from collagen IV which has been 
reported to be altered by the use of PAA during the sterilisation step of the 
decellularisation protocol (Luo et al., 2014). 
Following the application of the final decellularisation protocol to the porcine 
mitral valve annuli a reduction in total DNA content of over 95 % was 
achieved in both the anterior and posterior regions, however histological 
evaluation revealed residual “nuclear ghosts” in the lacunae of the trigones. 
In future studies it would be important to analyse these structures in more 
detail. This could be carried out using laser capture microdissection of tissue 
sections to extract the nuclear remnants in the trigones. This would allow the 
DNA content of the cellular remnants to be analysed using quantitative DNA 
analysis and determination of the size of any DNA fragments present. The 
results could then be compared to extracts from the lacunae of native tissue 
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in the same region. The current literature suggests that DNA fragments less 
than 180 base pairs in length (Nagata et al., 2010) should not cause an 
immune response, hence fragments less than this length found present in 
the lacunae of the decellularised tissue would not be an issue. In-vitro 
cytotoxicity assays showed that BHKs and L929s grew up to the acellular 
porcine mitral valve tissue in contact assays and were not inhibited when 
grown in extracts of the decellularised tissue, illustrating that the post wash 
cycles of PBS removed any potentially cytotoxic chemicals  from the 
scaffolds. 
Biomechanical testing of the decellularised tissue revealed larger ultimate 
tensile strains, transition stresses and transition strains compared to the 
native porcine mitral valve annulus tested in the same regions. The increase 
in ultimate tensile strain of the tissue following decellularisation was similar 
to results for other cardiovascular tissues in other studies using 0.1 % (w/v) 
SDS combined with hypotonic buffer washes (Korossis et al., 2002; 
Mirsadraee et al., 2006). Transition stresses and transitions strains were 
larger in all regions of the decellularised porcine mitral valve annuli 
compared to that of the native tissue which corresponded with previous 
studies in which decellularisation protocols were  performed using 0.1 % 
SDS and hypotonic buffer washes (Korossis et al., 2002; Morticelli et al., 
2013). The changes in the biomechanical properties of tissues following 
decellularisation have been attributed to the use of SDS detergent (Gratzer 
et al., 2006), hypotonic buffer washes and the removal of cells (Korossis et 
al., 2002). GAG removal was also evident in the decellularised porcine 
annulus trigones. In order to determine if the removal of GAGs has any 
effects on the biomechanical characteristics of the porcine mitral valve 
trigones, future studies should use indentation testing to evaluate the 
compressive stiffness of this region compared to native porcine mitral valve 
annuli. Whilst such studies would determine the changes in the porcine 
tissue due to the decellularisation process, these studies would not however 
determine any differences between the properties of the human and porcine 
mitral valve. It would be important to determine whether the properties of the 
acellular porcine mitral trigones were matched with those of human tissue.  
To establish the biomechanical characteristics of the human trigones it 
would be important to use healthy human tissue without the associated 
calcification found in the older heart tissue, thereby requiring younger human 
hearts.  
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Flexible, semi rigid and rigid annuloplasty rings have all been shown to 
reduce annular dynamics and may partially obstruct the aortic outflow tract 
(Dagum et al., 2001). The region of the acellular ring that will be closest to 
the outflow tract is the mitral to aortic continuum. The similarities in the 
underlying architecture between human and decellularised porcine mitral 
valve annuli may extend to the biomechanical characteristics in this region. 
These similarities may help reduce any obstruction that normally occurs 
when synthetic rings are used. The changes caused to the porcine tissue 
due to the decellularisation process may also be an advantages because of 
the reduction in the elastic phase Young's modulus in the mitral to aortic 
continuum, making the tissue more compliant in this region. Thus, there will 
be less resistance to elongation and any obstruction of the aortic outflow 
tract will be decreased compared to the native porcine tissue. Future 
biomechanical testing of the healthy native human annulus would be 
required to understand any differences in mechanical properties between the 
different tissue species. Functional assessment of the obstruction to the 
outflow track would also offer further insights into any advantages the 
decellularised ring would offer compared to synthetic rings in reducing any 
obstruction at the aortic outflow tract.  
In-vitro functionality testing of the decellularised annuloplasty rings was 
undertaken as a pre-clinical test. The aim was to compare the decellularised 
rings with the current gold standard for mitral valve repair, synthetic 
annuloplasty rings, by repairing explanted porcine hearts in which mitral 
regurgitation had been induced. Decellularised annuloplasty rings inserted in 
physiological and reverse positions showed similar reduction in regurgitation 
compared to the synthetic ring. There were two main limitations of this in-
vitro model; the testing utilised statically pressurised hearts rather than 
dynamically pressurised hearts and the porcine hearts were healthy and so 
regurgitation was artificially induced. Previous studies have used dynamic 
explanted heart models, including a pulsatile flow model (Richards et al., 
2009) and a working heart model that kept the heart pumping post 
explantation (Chinchoy et al., 2000; Araki et al., 2005). These models would 
have increased complexity, time to delivery, time for each test and increased 
cost. The advantage is that the use of the dynamic models would have 
permitted the calculation of regurgitation fractions and enabled better 
assessment of the durability of the decellularised rings compared to the 
synthetic rings. With further time and funding it would have been beneficial 
to develop a dynamic pressure pulsatile heart model as described by 
Richards et al. (2009) to allow these parameters to be determined. A 
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dynamic pressure pulsatile heart model could also be used for testing 
devices in other regions of the heart such as in the aortic and pulmonary 
valves. Working heart models that retain the cardiac function of the porcine 
hearts would require in-depth knowledge of heart transplant techniques and 
awareness of procedures required to maintain physiological activity whilst 
also demanding high costs. Whilst such models would have many 
advantages for the physiological testing of annuloplasty rings they would 
negates advantages of using in-vitro models as a pre-curser to studies in 
living large animal models.   
For the functional tests regurgitation was induced artificially because it was 
not possible to obtain porcine hearts which were regurgitant due to disease. 
Previous methods of inducing regurgitation in-vivo include chordal rupture in 
dogs (Urabe et al., 1992, Pat et al., 2010), the application of collagenase in 
the hearts of dogs (Fujiki et al., 2000) and causing ischaemic mitral 
regurgitation by restricting blood flow to the myocardium (Cui et al., 2014), 
all of which were performed long term and had effects on the left ventricle 
and diastolic volume, left atrial volume and stroke volume. The problems 
encountered in the present study in  obtaining moderate to severe rates of 
mitral valve regurgitation in the functional testing of the annuloplasty rings 
may have been caused by the lack of long term remodelling that commonly 
occurs with mitral valve regurgitation. Porcine hearts with regurgitation 
induced prior to explantation would have been useful for this study to enable 
the long term effects of mitral regurgitation on the hearts to be taken into 
account. There are disadvantages associated with this process because the 
function of the heart could only be assessed immediately after repair, long 
term remodelling and changes to cardiac function post repair could not be 
evaluated.  
In children, mitral valve repair is recommended because left ventricle 
function is better preserved by retaining the mitral valve complex making 
congenital repair a well-established procedure. Mitral valve replacement in 
children tends to occur because either the repair has failed or the valve is 
comprehensively damaged. Compared to repair, replacement of the mitral 
valve is associated with poor long term survival (Caldarone et al., 2001; 
Ackermann et al., 2007; Beierlein et al., 2007; Selamet Tierney et al., 2008; 
Alsoufi et al., 2009) as well as there being limited options for replacement 
valves due to lack of appropriate valve sizes for children (Lee et al., 2010). 
Children who undergo replacement will require secondary replacement later 
in life to account for the growth of the heart. Whilst repair offers better long 
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term survival in children, challenges remain due to the growth of the mitral 
valve region in children, various pathologies causing MR and the fragility of 
the paediatric valve (Oppido et al., 2008; Curi-Curi et al., 2010; Stellin et al., 
2010). Children who have their heart valves repaired only have annuloplasty 
rings implanted if the mitral valve is large enough to accommodate an adult 
size annuloplasty ring due to the risk of stenosis. The smallest ring available 
is usually about 26 mm in diameter. It has been suggested that biomaterials 
for annuloplasty repair, that can be absorbed whilst permitting growth of the 
valve should be developed (Quinonez & Del Nido, 2015). A decellularised 
annuloplasty ring of the correct size for the child's heart would permit the 
growth of the mitral valve annulus over time whilst reducing regurgitation. 
Due to the ability of the decellularised ring to integrate with the mitral valve it 
will avoid the risk of mitral valve stenosis as the heart grows. A 
decellularised annuloplasty ring device also has the potential to remove the 
requirement of reoperation later in life by avoiding stenosis associated with 
synthetic annuloplasty repairs and mitral valve replacement. 
Pericardium is an example of a biological device being used to enable 
growth of the mitral valve long term. Glutaraldehyde treated (Borghetti et al., 
2000; De La Zerda et al., 2008; Ng et al., 2001; Roshanali et al., 2012; 
Salvador et al., 2014) and untreated (Salati et al., 1991) autologous 
pericardium has been used as an annuloplasty repair device to stabilise the 
posterior annulus in children and adults, providing an insight into the 
possible benefits of biological rings compared to synthetic rings. Pericardial 
annuloplasty prevents further posterior annulus dilation whilst allowing 
growth of the anterior annulus in relation to the body over time and 
preserves the flexible properties of the mitral valve annulus when used in 
children (Delmo Walter et al., 2010).  Studies have established that it is a 
durable solution whilst being superior to rigid prosthetic rings by offering 
improved mitral annulus dynamics and preserved left ventricular function 
(Borghetti et al., 2000). It is also superior to the use of flexible rings in some 
areas by offering improved left ventricular function under stress conditions 
(Roshanali et al., 2012) without signs of long term degeneration. 
Furthermore, long term it has been reported that glutaraldehyde treated 
pericardial annuloplasty, combined with neochordal implantation, was safe, 
offered long term durability with high survival rates and low rates of 
reoperation. At reoperation, it has been shown that the pericardium is 
covered with an endocardial like covering and is not in contact with the flow 
of blood (Salvador et al., 2014) with the covering being indistinguishable 
from the atrial endocardium (Delmo Walter et al., 2010). A study by 
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Bevilacqua et al., (2003) was less favourable, they found that glutaraldehyde 
treated pericardial annuloplasty was a risk factor for repair failure and 
reoperation whilst it did not offer durable remodelling of the annulus. This 
study included a limited number of patients with limited follow-up periods and 
used different techniques which may have contributed to the poor outcomes.  
Repair of mitral regurgitation with an acellular biological annuloplasty ring 
may provide a superior repair to pericardial repair and consequently 
synthetic ring repair. Pericardial repair often only involves posterior 
annuloplasty which does not include the anterior annulus, even though the 
fibrous anterior annulus can undergo dilation due to mitral valve disease, just 
like the posterior annulus (Kwan, 2003; Tibayan et al., 2003; Kaji et al., 
2005). The primary aim of annuloplasty repair is to reinforce and stabilise the 
annulus whilst reducing leaflet stresses, along with correcting and preventing 
annular dilation whilst reintroducing leaflet coaptation. The acellular porcine 
mitral valve annulus has the potential to provide anchor points at the left and 
right trigones which might reinforce the repair and improve durability as well 
as absorbing some of the forces generated during the cardiac cycle, which 
are largest at the trigones (Kunzelman et al., 2007). The decellularised 
porcine annuloplasty ring closely resembles the histoarchitecture of the 
native human annulus, therefore should provide a suitable environment for 
cell attachment and integration thereby enhancing durability of the repair.  
Traditional methods of mitral valve repair involve open heart surgery, but the 
age of the patient, expertise of the surgeon and comorbidities can prevent 
patients having this type of surgery. In these cases the emergence of 
transcatheter techniques becomes valuable. Existing technology includes 
direct and indirect methods of transcatheter repair (Van Mieghem et al., 
2010). Direct methods of transcatheter annuloplasty involve the manipulation 
of the mitral valve annulus via catheter insertion through the left atrium or left 
ventricle which avoids the requirement of cardiopulmonary bypass. Indirect 
methods involve manipulating the orifice area from outside the mitral valve. 
A decellularised ring would only be suitable for direct transcatheter repair. 
However, current strategies using this technique have avoided annuloplasty 
using complete rings and have instead focussed on inserting pledgets into 
the annulus and reducing the length of small sections of the annulus, such 
as with the Mitralign system (Mitralign, Inc., Tewksbury, Massachusetts) and 
Accucinch (Guided Delivery Systems, Inc., Santa Clara, California). As 
further techniques are developed for direct transcatheter annuloplasty, the 
use of decellularised mitral valve annuli may become more feasible in this 
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emerging field. The major obstacles to the potential use of direct 
transcatheter repair would be suturing of the decellularised annuloplasty ring 
to the annulus and the size of the porcine annuloplasty ring for insertion via 
a catheter. 
One of the main advantages of the decellularised annuloplasty ring 
compared to a synthetic alternative is that the biological device has the 
potential to provide a biocompatible supporting structure to the mitral valve 
annulus that can integrate with the endogenous tissue and cells at the repair 
site and regenerate over time. Durability may, however be affected by the 
lack of functional cells within the implanted decellularised annuloplasty ring 
immediately following repair. This may lead to degradation of the 
extracellular matrix due to cycling loading on the ring during the cardiac 
cycle. Future studies could also consider seeding cells into the 
decellularised ring prior to implantation so that remodelling might occur 
immediately upon implantation of the device. It is critical with the cell seeding 
approach that a sufficient oxygen supply reaches the cells in the scaffold 
once implanted, this can often impair the use of cell seeding prior to 
implantation as lack of oxygen and nutrients can lead to cell death resulting 
in matrix degradation caused by the release of enzymes by the cells (Martin 
et al., 2004).  
In addition to the biocompatibility testing of the decellularised annuloplasty 
rings in-vitro, it will be important  to determine whether the acellular tissue 
elicits an immune response in-vivo using a small animal model, for example 
subcutaneous implantation in mice.  Adverse reactions to the implanted 
scaffolds could be analysed using histology and immunohistochemistry of 
the explants, enabling the evaluation of cell integration. Various regions of 
the decellularised annuloplasty ring could be tested so that regional 
differences in the decellularised rings could be evaluated, this would be 
important for the trigonal region where the presence of “nuclear ghosts” 
might provoke an immune response. Further optimisation of the process to 
produce the decellularised annuloplasty ring would be necessary if there 
were adverse host responses.  
To assess the remodelling of the porcine mitral valve annulus in-vivo and to 
determine functional performance as an annuloplasty repair device it will be 
necessary to implant the acellular annuloplasty ring in a large animal model. 
Sheep are often the animal model of choice for the assessment of cardiac 
valves (Ali et al., 1996). Sheep hearts closely match human hearts in 
regards to the mechanical properties and haemodynamics (Rashid et al., 
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2004) whilst they also grow less rapidly compared to other species such as 
calves and pigs, making studies easier to control (Ali et al., 1996; Rashid et 
al., 2004). Due to accelerated calcification in juvenile sheep they have also 
become a standard model for assessing calcification (Ali et al., 1996) which 
means implanted devices can be studied for signs of calcification in relatively 
short time periods (Paniagua Gutierrez et al., 2015). For a sheep model to 
provide useful data, it would be necessary to induce mitral valve 
regurgitation in the animals up to 6 months before the implantation of the 
acellular biological annuloplasty rings in order to evaluate the effects of the 
repair in a chronic mitral valve regurgitation model. The study would need to 
be performed over a period of 6 months in order to provide information on 
functional performance, remodelling, any local immune response and 
regeneration of the acellular tissue over the course of the study. Explant 
analysis at various time points would enable investigations using histology, 
immunohistochemistry, biochemical assays and biomechanical testing to 
assess any changes in the structure, composition, cellularity and 
biomechanical properties of the scaffold. 
Studies of long term outcomes after mitral valve repair have shown that 
significant levels of mitral regurgitation can reoccur after the initial repair 
(Gillinov et al., 1998; Flameng et al., 2003; Chang et al., 2007). Durability of 
the repair is one of the main factors in failure and understanding the complex 
relationship between all components of the mitral valve complex is cited as 
one of the main solutions to reducing this problem. Chronic mitral valve 
regurgitation causes left ventricular remodelling which enlarges the ventricle 
and alters the position of the components of the valve, including annular 
dilation and papillary muscle contraction. It has been suggested that superior 
outcomes may be obtained by repairing the whole of the mitral valve, not just 
the annulus (McGee et al., 2004). The maintenance of the full mitral valve 
complex using mitral valve repair has been reported to offer superior 
outcomes compared to replacement (David, 1994). Preservation of the 
whole mitral valve may not be feasible due to calcification, fibrosis and 
surgical experience, amongst other reasons. It has been suggested that 
components that cannot be retained, such as chordae should be replaced by 
artificial chordae to maintain the mitral valve complex (David, 1994). The 
preservation of the full mitral valve complex, by retaining the link between 
the mitral valve annulus and the left ventricle wall via the leaflets, chordae 
and papillary muscles has been reported to be essential for recovery of 
myocardial function following the correction of mitral valve regurgitation 
(Ishihara et al., 1992; Moon et al., 1999). Disruption  of these links has been 
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shown to cause myocardial systolic deformation and inferior outcomes 
(Moon et al., 1999). Studies have shown that following the preservation of 
mitral valve components, such as the chordae, ventricular contraction 
returns, even if the mitral valve is replaced by a mechanical or bioprosthetic 
valve rather than being repaired (Ishihara et al., 1992). Following on from the 
development of an acellular biological mitral valve annulus repair device, as 
described here, it may be possible to produce an acellular mitral valve 
complex. This would comprise the mitral valve annulus, mitral valve leaflets, 
chordae and the chordal attachment to the papillary muscles. This would 
offer further options for repair of the mitral valve and provide an alternative to 
mitral valve replacement using mechanical and bioprosthetic devices. The 
combined use of a glutaraldehyde treated pericardial annuloplasty repair 
alongside neochordal implantation was found to have high survival rates and 
low rates of reoperation after long term follow up (Salvador et al., 2014). This 
study provides evidence of the potential to improve outcomes by use of a 
decellularised mitral valve complex compared to annuloplasty alone. In 
children chordal repair techniques are not recommended because the native 
chordae are thin and can break when sutured (Quinonez & Del Nido, 2015). 
In valves that require annuloplasty repair and chordal shortening a complete 
mitral valve replacement using a decellularised mitral valve complex could 
potentially offer an alternative solution. A recent study by Iablonskii et al. 
(2015) undertook preliminary research into a decellularised ovine mitral 
valve which showed cell removal and favourable leaflet characteristics. 
The decellularised annuloplasty ring described here was developed with a 
view to creating a device that would be clinically relevant and a potential 
candidate for commercial development as a medical device for annuloplasty 
repair. Following successful large animal studies in the university, the next 
step in the development of the biological acellular annuloplasty ring would be 
to transfer the technology to an industrial partner to initiate the procedures 
for obtaining a CE mark so the device can be sold in Europe. In order to 
follow the correct route to market the porcine mitral valve annuloplasty ring 
would need to meet the requirements set out in the European Council 
Directive 93/42/EEC which applies to medical devices. These directives 
categorise the decellularised annuloplasty ring as a Class III medical device 
which is identified as high risk as a result of being derived from porcine 
tissue and implantable into the body. To gain approval for being placed on 
the European market and be awarded a CE mark the device would need to 
meet the guidelines set out in the directives. Acellular devices such as the 
decellularised mitral valve annuloplasty ring however avoid the complex 
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regulatory hurdles faced by cellular technologies as they are classed as 
medical devices rather than Advanced Therapy Medicinal Products.  
The process of obtaining a CE mark would involve meeting all the essential 
requirements set out in the directives including following the appropriate 
quality management system for medical devices, ISO 13485:2003 and 
establishing that the device was safe and works as intended by following the 
harmonised standard for risk assessments, ISO 14971:2007. Clinical data 
forms a major component of gaining regulatory approval for a Class III 
device such as the annuloplasty ring; this data may be obtained from similar 
devices that exist in the literature or from data collected from a clinical trial. 
In the UK any devices that are placed onto the European market are 
regulated by the Medicines and Healthcare Regulatory Agency (MHRA), the 
MHRA designate notified bodies to carry out audits of facilities and product 
information before awarding a CE mark. Upon passing the audit the 
manufacturer of the annuloplasty ring would declare that the device meets 
the provisions of the appropriate Directives and could be sold on the 
European market. 
7.2 Conclusion 
In conclusion, this study has described the initial research towards 
development of a novel decellularised annuloplasty ring for potential use in 
mitral valve repair. It has been shown that it is possible to decellularise the 
porcine mitral valve annulus without substantial changes to the biological 
structure and biomechanical properties. The acellular tissue contained less 
than 50 ng.mg-1 wet weight residual DNA in all regions representing over 95 
% of DNA removal. Functional assessment of the acellular biological rings 
compared to synthetic annuloplasty rings demonstrated that acellular 
biological annuloplasty rings performed as well as synthetic rings in in vitro 
tests, however further functional tests need to be performed. Future studies 
should focus on evaluation of the durability of annuloplasty repair using the 
decellularised porcine mitral valve annulus in a physiologically relevant large 
animal model to establish the potential of the device for commercial 
development. 
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